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I 
Abstract 
Skin sensitization resulting for allergic contact dermatitis (ACD) is an occupational and 
environmental health issue. The allergic hazard for workers and consumers is a serious problem 
for individuals, employers and marketing certain products. Consequently, it is necessary to 
accurately identify chemicals skin sensitization potential. According to the new EU chemical 
regulation REACH (Registration, Evaluation, Authorization and Restriction of Chemicals), 
information of skin sensitization of chemicals manufactured or imported at or above 1 ton/year 
should be available. 
Currently, valid approaches assessing skin sensitization rely on animal testing, such as 
local lymph node assay (LLNA). However, it now ultimately eliminates using animals for this 
purpose. Based on the fact that a key step in the skin sensitization process is formatting a 
covalent adduct between allergic sensitizers and proteins and/or peptides in skin, a lot of 
additional approaches are proposed and developed for replacing or reducing animal used. In this 
research, three bioassays, 24 h growth inhibition toward Tetrahymena pyriformis, long term (24 
h) and short term (30 min) bacterial toxicity (to Vibrio fischeri), and a kinetic glutathione 
chemoassay are applied for predicting the organic chemicals’ skin sensitization potential. The 
major results and conclusions obtained are listed as follows: 
1. Toxicity enhancement (Te) of 55 chemicals comprising different sensitization potencies 
were determined and compared with their narcotic toxicity to predict their skin 
sensitization. Three linear regressions yielded for all allergic sensitizer without 
nonsensitizers for each bioassay. The linear regressions are improved after classifying 
sensitizers into five different reaction mechanistic domains. Correspondingly, five 
different slopes from various reaction mechanisms indicate a decreased sensitivity of 
toxicity enhancement to skin sensitization potential with order SNAr > SN2 > acylation § 
Schiff base > aromatic Michael addition. Based on the fact that a key step in the skin 
sensitization process is forming a covalent adduct between allergic sensitizers and 
proteins and/or peptides, Te > 10 as a threshold is applied to discriminate these allergic 
sensitizers, with 100% accuracy for strong (with extreme) and weaker sensitizers, up to 
72% accuracy for moderate sensitizers and less than 69% accuracy for nonsensitizers. 
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Compared with these bioassays, a decreasing order of sensitivities is 24 h growth 
inhibition (Tetrahymena pyriformis) > 24 h growth inhibition (Vibrio fischeri) > 30 min 
bioluminescence inhibition (Vibrio fischeri). These three bioassays are useful tools for 
screening sensitization potency of allergic chemicals, and the toxicity enhancement (Te) 
can be used to discriminate sensitizers from weak or nonsensitizers. However, in this 
context we should separate aromatic from aliphatic Mas (Michael acceptors). Moreover, 
metabolic biotransformation should be considered during predicting nonsensitizers’ skin 
sensitization. 
 
2. Chemical reactivity of selected 55 compounds measuring through kinetic glutathione 
chemoassay applies to predict their skin sensitization. This chemoassay confirms the fact 
that the key step of sensitizers eliciting skin sensitization is formatting a covalent adduct 
between sensitizers and skin proteins or peptides. The chemical reactivity of tested 
sensitizers strongly relates with their sensitization potential, with strong (extreme) 
sensitizers presenting the highest reactivity as followed with moderate sensitizers, weak 
sensitizers as well as nonsensitizers. Moreover, an integrated platform of this chemoassay 
data and three bioassays data is performed, and this performance shows good sensitivity 
for monitoring skin sensitization potency, with more rational accuracy for each 
sensitizing classifications.  
 
3. Thiol reactivity (kGSH) as well as toxicity enhancement (Te) of additional 21 aliphatic Į,ȕ-
unsaturated compounds are determined for predicting their skin sensitization potential. 
The linear regressions of skin sensitization versus thiol reactivity and skin sensitization 
versus toxicity enhancement are significantly improved after classifying these 21 
compounds to four chemical subgroups (acrylates, other esters, ketones and aldehydes). 
Thiol reactivity of these subgroups presented different sensitivity to skin sensitization, 
with a decreasing order as acrylates (ˉ2.05) > other esters (ˉ1.26) > ketones (ˉ0.43) > 
aldehydes (ˉ0.21). Moreover, thiol reactivity is confirmed to be a more sensitive tool for 
predicting skin sensitization, compared with toxicity enhancement. Although the datasets 
are probably too small to give a definite decision, hydrophobicity reveals contribution to 
skin sensitization for aliphatic MAs, which is different with literature report. This study 
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suggests that aliphatic MAs should be treated separately into different chemical 
subgroups for analysis, and their skin sensitization potency can be predicted using kinetic 
glutathione chemoassay as well as toxicity enhancement bioassay. 
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1 Introduction  
1.1 Basic Information of Skin Sensitization  
 
Skin sensitization, allergic contact dermatitis (ACD), is a common occupational and 
environmental health issue and is certainly the most frequent expression of an adverse effect of 
chemicals on the human immune system. By definition, skin sensitization is an immune response 
induced by the chemical allergen topical exposure.1 Nowadays, many of chemicals have been 
implicated as skin sensitizers, and allergic contact dermatitis (skin sensitization) is undoubted the 
most common immunotoxicity in human beings. 
 
1.2 Biological and Chemical Mechanism of Skin Sensitization 
1.2.1 Biological Mechanism of Skin Sensitization 
 
Skin sensitization is a T-cell mediated immunological endpoint, which an important 
occupational and environmental disease is caused by topical exposure to chemical allergens. 
There are two phases, induction and elicitation phase, during the process of allergic contact 
dermatitis In the first phase, the chemical (allergen) penetrates through the horny layer into the 
viable epidermis layers and contacts with carrier protein or peptide to give a positive ACD 
(allergic contact dermatitis) reaction. Five major steps in this phase are: First, chemical (allergen) 
binds with skin protein or peptide that abundantly exist in epidermal antigen presenting cells, 
named Langerhans cells (LC). Second, induced hapten activates allergen presenting cells. In this 
step, activated and mature allergen-carrying LC travel to regional lymph nodes, where they settle 
as named interdigitating cells (IDC) in the T-cell areas. Third, recognition of allergen-modified 
LC. On the nonsensitized condition the T cells with special characters is normally lower than one 
per million. In the paracortical zone, allergen-carrying IDC encounter naïve T cells easily, which 
specifically recognize the allergen-major histocompatibility complex (MHC) molecule 
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complexes. The dendritic morphology of these allergen-presenting cells strongly facilitates 
multiple cell contacts, leading to binding and activation of allergen-specific T cells. Fourth, 
specific T cell proliferates in draining lymph nodes. Activated T cells start producing by support 
of interleukin (IL)-1 and release of allergen-presenting cells. Fifth, systemic propagation of the 
specific T-cell progeny. During this step, the expanded progeny is subsequently released through 
efferent of lymphatics into the blood flow and start to recirculate. Thus, the frequency of specific 
effector memory T cells in the blood may rise to as high as one in a thousand, whereas most of 
these cells display receptor molecules facilitating their migration into peripheral tissues. In the 
absence of further allergen contacts, their frequency gradually decreases in subsequent weeks or 
months, but does not return to the low levels found in naive individuals. In the second phase, 
begins upon elicitation and reactivates these specific T cell to produce different proinflammatory 
cytokines that trigger the inflammatory response, for which normally need about 1 to 4 days to 
develop, whereas induction phase requires at least 4 days. And the main step in the second phase 
is increased frequency of specific T cells meet with allergen-presenting cell, and lead to 
proinflammatory action causing the arrival of more inflammatory cell.  
Thus, a compound must go through several steps to induct skin sensitization. Please keep 
in mind that all of these steps cannot be equally important factors. The most important step, 
termed rate determining step, has been discussed by Roberts and Aptula that is covalent binding 
of a compound with the skin proteins or peptides.2 
 
1.2.2 Chemical Mechanism of Skin Sensitization 
 
Usually, the sensitizers (haptens) acting as electrophiles are covalently bonding to skin 
proteins or peptides acting as nucleophiles. It is estimated that about one third of the sensitizers 
are not themselves electrophiles but convert to electrophiles through abiotic or biotic 
transformation.3-5 These kinds of sensitizers are termed as prohaptens or prehaptens.5 (Pre-
hapten: a nonreactive sensitizing molecule is transforming into a hapten by simple chemical 
transformation, such as air oxidation, and without any requirement for a specific enzymatic 
system. Pro-hapten: a nonreactive sensitizing molecule is transforming into a hapten by a 
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specific enzymatic system.) It is widely accepted that the low molecular weight compounds 
cannot induce skin sensitization unless form a covalent adduct with skin proteins or peptides.6 
There are several types of reaction mechanism domains involved in skin sensitization, and the 
most frequently encountered mechanism are Michael addition domain, Schiff base domain, SNAr 
reaction, Acylation formation and SN2 reaction.7-10 The chemical understanding of skin 
sensitization give researchers the hints that categorized compounds into different subgroups 
through their different reaction mechanisms.7 The details and application of five major reaction 
mechanisms will be discussed in the following section.  
 
1.3 Hurdles for a Sensitizer Inducing Skin Sensitization 
 
There are several hurdles for a compound inducing skin sensitization potential. These steps 
are (1) bioavailability/ skin penetration, (2) haptenization/covalent binding to carrier protein, (3) 
keratinocyte (KC) response, (4) dendritic cell (DC) maturation and (5) T-cell activation.2,11 
Although all of these hurdles determine whether or not a compound can induce skin sensitization, 
the capability of compound binding to protein or peptides in the skin is considered a key step 
eliciting skin sensitization. However, please keep in mind, penetration of the compound through 
surface of skin into epidermis is the first step, and it is an important factor. Therefore, there are 
two possible reasons for a compound acting a nonsensitizer. The one is not reactive enough; the 
other is not hydrophobic enough.10 Thus, these most important two factors are discussed in 
following section. 
 
1.3.1 Penetration 
 
No doubt, the penetration of compound to epidermis is the first hurdle for induction of skin 
sensitization. It is supposed that a compound with greater bioavailability than another compound, 
other things being equal, will be a stronger sensitizer. Bioavailability is a proportion of the 
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sensitizer applied to the outside of skin which reaches the epidermis in the exposure time in the 
skin sensitization assay.2 Thereby, there are basically two situations. In the first case, the 
compound apply to complete penetration through the surface of skin receiving in the epidermis 
during the assay, which means the dose applied is same concentration as the dose received in the 
epidermis. In the second case, the concentration of compound received in the epidermis is less 
than the applied concentration topically, since the compound is not penetrating into the epidermis 
completely during the assay time scale.10 Figure.1.112 an excellent example illustrated the 
relationship of skin sensitization with hydrophobicity (which is used for modelling 
bioavailability of sensitizer in the skin assay). Inspection of the Figure 1.1, biphase change of 
skin sensitization are response to increasing hydrophobicity. In the first phase, skin sensitization 
increase with increasing hydrophobicity, and reached greatest potential at the point of log Kow 
equal to 4. In the second phase, skin sensitization decrease responded to increase hydrophobicity. 
 
Figure 1.1: pEC3 vs log P of azlactones.12 
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Hydrophobicity modelling bioavailability of compounds in epidermis is expressing as the 
partition coefficient between octanol and water, log Kow, which is applied in nonanimal 
approaches for screening skin sensitization.10,13-17 Moreover, Natsch applied log Kow as a 
surrogate for bioavailability in "battery approach" proposal to investigate influence of the log 
Kow to sensitization potential18, in which chemicals are presenting a log Kow lower than –2 or 
higher than 5 to account for lack bioavailability, and presenting a –0.5 < log Kow < 3 to account 
for higher bioavailability. This is agreement with report that log Kow value of 2 is optimum for 
penetration.19 Thus, it is easily understanding that penetration of a compound into skin increases 
with increasing hydrophobicity, but the relative partitioning of compound from skin surface to 
epidermis and dermis will be decreased with very highly lipophilic compounds.20 Moreover, 
previous investigations found that sensitization potency of SN2 electrophiles10 and Schiff base 
electrophiles13 are dependent both on reactivity and on hydrophobicity. For Michael acceptors14 
and SNAr electrophiles.17 However, skin sensitization potential are singly dependent on the 
reactivity and no contribution coming from hydrophobicity.  
 
1.3.2 Reactivity 
 
It is widely accepted that to induce skin sensitization, an allergic compound must be able, 
either directly or through metabolic or abiotic activation, to react covalently with skin protein. 
Thus, compared with others hurdles, covalent binding of sensitizers to carrier protein or peptide 
is the key factor for inducing skin sensitization potential. The evidence of this understanding 
reported in 1936.21 20 benzene derivatives were investigated comprising ten sensitizers (from 
guinea pig test) with ten nonsensitizers. The ten sensitizers were found to be reactive toward 
methanolic aniline (a model nucleophile), in contrary, ten nonsensitizers were found to be 
unreactive. Thus, reactivity of compounds should be determined for monitoring skin 
sensitization.2 Correspondingly a lot of alternative approaches, such as in vitro, in silico and in 
chemo, are proposed and developed for replacing or reducing currently animal (see below). 
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1.4 Animal and Nonanimal Approaches For Skin Sensitization 
Identification 
1.4.1 Animal Approaches for Skin Sensitization Identification 
 
Until recently, identifying potential allergens are completely relied on animal testing, such 
as Guinea pig maximization test (GPMT)22 and local lymph node assay (LLNA) in mice.23 
The guinea pig maximization test (GPMT) has been used as a standard method to screen 
compounds whether or not can cause human skin sensitization (allergens). This method was 
firstly proposed by B. Magnusson and Albert Kligman in 196922 and had been accepted as a 
standard method to assess skin sensitization potential of chemicals by Organisation for Economic 
Co-operation and Development (OECD).24 Briefly, the test animals are exposed intradermally to 
the test compounds, along with an adjuvant to enhance the immune reaction of the guinea pig. 
The guinea pigs are then a short while later exposed to a lower concentration of the test 
compounds measuring their allergic reaction. Generally, 15% of guinea pigs must show a 
reaction for the test to be considered positive and 20 animals would typically be used to ensure 
against false negative results. 
Although the guinea pig maximization test (GPMT) had been widely used for evaluating 
the skin sensitization, it still have some disadvantages as well as advantages, which are 
summarized in below.1 
The advantages are: a) Guinea pig test data for many existing chemicals are readily 
available and these may allow comparative interpretation. In such instance, additional testing 
may not be necessary. b) Methods such as the open epicutaneous test (OET) provide dose 
response information for the induction, as well as for the challenge, phase. c) In the OET, 
determination of sensitization and elicitation thresholds is possible. 
The limitations are: a) The standard GPMT, performed with one induction concentration 
and one challenge concentration, do not provide information on thresholds. (When more than 
one challenge concentration is introduced, some information on dose response may be obtained). 
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b) The range for dose selection is limited and based on skin irritation threshold. c) Adjuvant tests 
are based on the principle of worst-case condition testing and are therefore not suitable for 
potency assessment. d) For new chemicals normally only one study is likely to be available. 
The murine local lymph node assay (LLNA) was developed originally as another in vivo 
method for identification of compounds that have potency to cause skin sensitization and allergic 
contact dermatitis. The mouse local lymph node assay is now accepted by the Environmental 
Protection Agency (EPA), Organisation for Economic Co-operation and Development (OECD), 
and Food and Drug Administration (FDA) as the preferred "stand-alone alternative" assess skin 
sensitization of compounds.25 The assay relies on measurement of events induced during the 
induction phase of skin sensitization, speci¿cally lymphocyte proliferation in the draining lymph 
nodes which is a hallmark of a skin sensitization response. The measuring process is illustrated 
in Figure 1.2. In summary, authorization, ordering and equilibration of mice are determined 
during pre-test. And then, 20 to 25 CBA female mice (7-12 weeks of age) have been grouped 5 
subgroups for vehicle control, positive control, test group 1 (low concentration), test group 2 
(mid concentration) and test group 3 (high concentration). The exposure was topically on the 
dorsum of both ears and performing daily for 3 consecutive days. And then, all mice were 
injected via the tail vein with 250 ȝL of phosphate-buffered saline containing 20 ȝL of tritiated 
thymidine, after five days of initiation of exposure. The incorporation of tritiated thymidine 
measured by beta scintillation counting was reported in disintegrations per minute. Then, SI 
(stimulation index) was calculated for each chemical-treated group.  
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Figure 1.2: Schematic of local lymph node assay 
 
Using this method, the EC3 value is determined by linear interpolation of points on the 
dose-response curve, immediately above and below the 3-fold threshold. The equation used for 
calculation of EC3 is:  
͵ ൌ  ൅ሾሺ͵ െ ሻȀሺ െ ሻሿ ൈ ሺ െ ሻ   (1.1) 
 
In which, a represent the lowest concentration giving stimulation > 3; b represent the actual 
stimulation index caused by a; c represent the highest concentration failing to produce a 
stimulation index of 3; and d represent the actual stimulation index caused by c. Please keep in 
mind, the vehicle control data (stimulation index = 1) should not be used for coordinates c and d. 
Applying this approach, one possible criterion would be to group chemicals into the 
following potency categories: chemicals with EC3 < 0.1% are classed as extreme sensitizers, 
with EC3 between 0.1 and 1% as strong sensitizers, with EC3 between 1 and 10% as moderate 
sensitizers, with EC3 between 10 and 100% as weak sensitizers and with EC3 = 100% as 
nonsensitizers, Table 1.1.26 
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Table 1.1: Classification of Skin Sensitization Potency by chemicals’ Local Lymph Node Assay EC3 Values. 
EC3 (%) Classification 
< 0.1 Extreme 
0.1 – < 1 Strong 
1 – < 10 Moderate 
10 – < 100 Weak 
100 Nonsensitization 
 
 
Although the LLNA is a "stand-alone alternative" method to replace the Guinea Pig 
Sensitization Test, there are several advantages and disadvantages identifying for skin 
sensitization potentials, which are summarized below.1,27 
The advantages are: a) The LLNA is relatively rapid and cost-effective, and compared with 
guinea pig tests, confers important animal welfare benefits (fewer animals are required and a 
reduction in the trauma to which animals are potentially subject); b) The end-point measured is 
necessary for, and correlates closely with, the acquisition of skin sensitization; c) An index of 
potency (EC3 value) can be derived directly from mathematical interpolation of LLNA dose 
response analyses; d) Experience to date reveals that there exists a close association between 
derived EC3 values and what is known of the relative skin sensitization potential of chemicals 
among humans.  
The disadvantages are: a) The use of EC3 values derived from LLNA dose responses has 
not yet been validated extensively or endorsed formally. b) The standard LLNA cannot be used 
for evaluating potency at the elicitation stage. c) The standard LLNA cannot be used for 
predicting for metals’ skin sensitization. 
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1.4.2 Nonanimal Approaches for Skin Sensitization Determination 
 
Under the European Union (EU), Registration, Evaluation and Authorization and 
Restriction of Chemicals (REACH) programme, all chemicals produced or imported > 1 ton per 
annum (tpa) in the EU will need to be assessed for human and environmental hazards. For this 
requirements/test strategy, this assessment will use a huge number of test animals and will be 
neither resource nor time effective. The excellent example have been illustrated in the previous 
(2013) literature that 8,000 chemicals have been registered with ECHA due to REACH and 
1,000,000 animals and more than €50 million are needed in the animal test.16 Thus, the 
development of alternative approaches for replacing or reducing currently animal assay is 
significantly urgent. Consequently, research aimed at developing in vitro, in chemico, and in 
silico methods, and combinations of them, for prediction of skin sensitization potency, is an area 
of high research activity. Non-animal analysis is widely accepted to replace current animal tests 
in skin sensitization assessment for allergic chemicals. Ideally, these novel approaches should 
not only predict the hazard of compounds, but also rank the potential of skin sensitization.  
 
1.4.2.1 In Silico Approaches  
 
In silico approaches to predict of skin sensitization potential of compounds are majorly 
falling into three broad categories: read across, QSAR, and QMM. 
Read across: read across is that endpoint information for one substance (source analogue) 
is used to predict the same endpoint for another substance (target),10 which is considered to be 
similar in some way (usually on the basis of structural similarity, though not exclusively so). A 
common functional group or common constituents or chemical classes or similar carbon range 
numbers are needed for prediction. Several publications successfully applied read across as a 
nonanimal method to predict skin sensitization of compounds.28-30 Moreover, an excellent 
example of prediction skin sensitization potential of tetrachlorosiophthalonitrile (TCPN) 
employed read across method is found that tetrachlorosiophthalonitrile (TCPN) is more reactive 
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and more hydrophobic than 2,4-dinitrochlorobenzene (DNCB) and should therefore be a 
significantly stronger sensitizer than DNCB.12 Although read across had been suggested as a 
useful tool for prediction of toxicological endpoints within a given mechanism of action,28 such 
as skin sensitization, there is existing limitation that two compounds, which are known their skin 
sensitization potential (EC3 values) and used for linear extrapolation, are need for predicting skin 
sensitization applied read across approach employing the selected parameters, one is higher 
value of parameters and one is lower value of parameters. 
QSAR: QSAR (quantitative structure-activity relationship) is an equation relating 
quantitative parameters, either experimentally measured or derived from chemical structure, with 
a quantitative measure of end point. As noted the recently proposed form EU-REACH system, 
QSARs and other non-animal methods are widely used for prediction skin sensitization potential 
of compounds.31-32 Furthermore, QSARs is fulfilling the ‘OECD principles’ which are statement 
as follow: “To facilitate the consideration of a QSAR model for regulatory purpose, it should be 
associated with the following information: 
1) a defined endpoint  
2) an unambiguous algorithm 
3) a defined domain of applicability 
4) appropriate measures of goodness-of-fit, robustness and predictivity 
5) a mechanistic interpretation, if possible” 
The widely accepted that sensitizing compounds should be divided into several 
applicability domains according to their suspected reaction mechanism,7,10 during the QSAR 
models developed and applied. Up to now, a lot of QSAR models have been successfully applied 
to screen skin sensitization of compounds that are covering five major reaction mechanism 
domains, such as Michael addition,14,16,33-34 Schiff base,13 SN2 formation,35-36 Acylation 
formation and SNAr formation.15 Moreover, a SAR for skin sensitization for regulatory purpose 
is applied a number of aldehydes and haloalkanes suggested that compounds would be classified 
as sensitising in accordance with EU classification and labelling rules.37  
QMM: QMM (quantitative mechanistic modeling) is equation relating toxicological 
endpoints and physicochemical parameters, which could be derived from the mechanism of 
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action or applied establishing principles of chemistry and physics.12 There are severally excellent 
examples for QMM applied for skin sensitization prediction16-17. In which, a QMM had been 
applied for SNAr domain17 that correlates LLNA EC3 data on a range of SNAr electrophiles, with 
an eq 1.2. Moreover, this equation had been successfully applied to prediction historical guinea 
pig and human data.17 
 
pEC3 = 2.48 Ȉı – + 0.60 ı* – 4.51    (1.2) 
 
1.4.2.2 Chemoassay 
 
Since the protein or peptide reactivity is the key step of skin sensitization induction, 
researchers have been interested in developing in chemico quantitative peptide-based reactivity 
assay to screen skin sensitization potential of compounds.8,14,26,38 The pioneers are Landsteiner 
and Jabcobs (1936) measuring the relationship of skin sensitization potential of 20 benzene 
derivatives with their reactivity.21 In the excellent investigation, ten of these compounds were 
found to be reactive toward methanolic aniline, and the rest ten compounds were found 
nonreactive. All of these ten reactive compounds are sensitizers derived from their guinea pig 
tests, and all of ten nonreactive compounds are nonsensitizers according to their guinea pig tests. 
So far, several methods/ parameters, such as depletion of model peptides8,26 and reaction rate 
constants,14 and many modeling nucleophiles, such as glutathione (GSH), lysine, cysteine and 
histidine peptide,26,38 have been applied for measuring. It was found that in these different 
modeling nucleophiles cysteine is the highest sensitivity peptide to sensitizers, whereas histidine 
is the least sensitive.26 In the investigation, a strong correlation exists between allergen potency 
and the depletion of GSH, lysine, and cysteine but not histidine.26 Moreover, a classification 
model approach has been developed for ranking of skin sensitization potential as minimal, low, 
moderate and high.38 All of these chemoassays have demonstrated that a good correlation is 
existing between chemical reactivity and allergenic potency. 
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Since many compounds such as prehaptens or prohaptens would act as sensitizers after 
being transformed into haptens through either chemical or biological transformation, recent 
investigations use modified chemoassays to successfully screen skin sensitization potency of 
prehaptens and prohaptens. Research into prohaptens demonstrated that all selected prohaptens 
presented a good association between chemical reactivity with allergenic potency.4,39 However, 
the investigation to prehaptens employed rat liver S9 fractions as metabolic activation system 
found that only a small fraction of sensitizers’ activation need S9 system, which means this 
modified chemoassays are singly suitable for screening skin sensitization of a specific classes of 
prehaptens.3 
 
1.4.2.3 In Vitro Bioassay 
 
In vitro bioassay approaches had been widely used for screening skin sensitization of 
compounds. Two aspects exist in this assay that the one is cell assay, the other is nonanimal 
bioassay. Several excellent reviews summarized the different types of cells are used in cell 
assays and with different biomarkers.40-42 In summary, dendritic cell (DC) have been widely 
employed in vitro assays,43 in which the primary cells, such as CD34+ derived dendritic cells and 
monocyte from dendritic cells, as well as DC like cell lines, including THP-1, U-937, MUTZ-3, 
KG-1, HL-60 and K562, are applied in assays.40,42 The different biomarkers used in cell assay 
sensitization models are surface markers, chemokines/cytokines and their receptors, kinases, 
genomics and proteomics.40,42 Several considerations need to be considered during developing 
cell assay sensitization model. In all cases, in vitro assay models should be able to discriminate 
the sensitizers from nonsensitizers. And the most important aspect in cell assays prediction skin 
sensitization is correlation with human data. In vitro bioassays are another accepted alternative 
approach to replace animal testing for screening skin sensitization.44-45 Furthermore, a combined 
method employing chemoassay and bioassay have been applied for screening skin sensitization.8 
In this investigation, thiol reactivity to glutathione (GSH) and toxicity enhancement toward 
Tetrahymena pyriformis of selected sensitizers are determined. Interestingly, toxicity 
enhancement of compounds to Tetrahymena pyriformis > 0.50 and/or pEC50 thiol (EC50 being 
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de¿ned as the concentration of the test substance which gives 50% depletion of free thiol) have 
been suggested to indicate the compounds will be skin sensitizers. That is significant agreement 
with the hypotheses that any potential sensitizer has the capability of binding to proteins or 
peptides. 
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1.5 The Different Reactive Mechanisms 
 
At present, the only validated in vivo method to conclusively identify skin sensitization 
potential is local lymph node assay in mice.46 Based on requirement of legislation and animal 
welfare, such as REACH (registration, evaluation, authorization of chemicals) and the 7th 
Amendment to the Cosmetics Directive (which poses a ban on animal testing), alternative 
approaches or risk assessment strategies to replace currently animal testing are urgently needed. 
Of cause, in the past decades, researchers developed a lot of in vitro or in silicon approaches to 
replaced currently animal test in skin sensitization hazard. In these investigations, the compounds 
are classifying according to their chemical classes, which means according to the functional 
groups of the compounds, such as ketone, aliphatic aldehyde and halogenated compound.47-49 As 
mentioned above, the key step of a sensitizer (electrophile) eliciting skin sensitization is binding 
to proteins or peptides (nucleophile) in skin. How the electrophiles (sensitizers) binding to 
nucleophilic groups on proteins in skin are decided by their reaction mechanisms. Therefore, 
sensitizers have been suggested classifying into different subgroups according to their suspected 
reaction mechanisms are supposed.7 There are five major reactive mechanism domains involved, 
which are Michael addition, Schiff base formation, SN2 reaction, SNAr reaction and acylation 
formation.7 
 
1.5.1 SNAr Reaction 
 
SNAr (aromatic nucleophilic substitution) reaction mechanism is one of the most common 
reaction mechanisms that cause hazards, such as aquatic toxicity50, skin sensitization17 and 
mutagen toxicity or genotoxicity51 to organisms or human beings. Undoubtedly, compounds 
reacting via SNAr mechanism show toxicity greater than compounds with similar structure that 
only acting narcotic toxicity.50 The compounds binding to nucleophiles through SNAr reaction 
mechanism are quite easy to identify from their structure seeing Scheme 1.1. Two or more 
activating groups (such as NO2 group in Scheme 1.1) in ortho or para positions and a leaving 
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group X are necessary. In most cases of the SNAr reaction mechanism, the rate-determining step 
is dependent on formation of an intermediate anion, but not on the nature of the leaving groups. 
Thus, the reaction rate of reaction k2 > k–1 is usual, which means that substituted benzenes have 
greater ability to accept and delocalize negative electron density in the intermediate will have 
higher potency to react with electrophiles in the skin.52 Based on this mechanism, a wider range 
of substituents can serve as leaving groups X for SNAr reaction than for the SN2 reaction. For the 
SNAr reaction, groups such as SO2R (leaving as sulfinate ion), SO3Na (leaving as sulphite ion) 
and NO2 (leaving as nitrite ion) can act as leaving groups.  
X
NO2
NO2
H Nu
X
Nu
NO2
NO2
+
Nu
NO2
NO2k2k1
k
usually the k2 !k
+ H+ HX
 
Scheme 1.1: SNAr reaction mechanism. X denotes the leaving groups, such as halogens or pseudohalogen. k 
denotes the reaction rate 
 
Moreover, recent research 17 employs quantitative mechanistic model (QMM) to predict 
skin sensitization of SNAr electrophiles. This model takes a QMM eq 1.1 (based on the Hammett 
ıí values for the activating groups and Taft ıേ value for the leaving group). In this investigation, 
the skin sensitization potential of SNAr electrophiles is found depending on their reactivity, and 
insignificant role of hydrophobicity is found. That is the same application for the Michael 
acceptor (MA) domain, but with steeper slopes of reactivity (0.660 (SNAr) vs 0.253 (MA)).53 
Furthermore, researchers found that compounds with three activating nitro groups in the ortho 
and para positions are more reactivity than the compounds with only two activating groups. It is 
supposed that any SNAr electrophiles with three or even more strong activating groups are more 
potent sanitizers than their counterparts with only two such activating groups, although the skin 
sensitization is expected to be lower than predicted by the eq 1.2. 
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1.5.2 SN2 Reaction 
 
SN2 reaction is a common reaction mechanism in organic chemistry. In this mechanism, 
the reaction occurs in one step, which means the nucleophilic attack and leave a leaving group 
happen synchronously, illustrated in Scheme 1.2. This is very different with SN1 reaction that the 
leaving group leaves firstly, whereupon a carbocation forms that is attacked by the nucleophile. 
Therefore the rate determining step for SN2 reaction is dependent on both the nature of 
nucleophile and leaving group. 
X
R
+ Nu H Nu
R
+ HX
 
Scheme 1.2: SN2-type reaction mechanism. X donates the leaving groups, such as halogens or pseudohalogen 
 
Previous investigations found that the SN2 reaction will more readily for a compound with 
methyl group than with a higher alkyl group.9 It is expected that, excluding hydrophobicity, the 
haloalkanes with short alkyl chains could be higher sensitizers than haloalkanes with longer 
chains, especially the compound with a second alkyl group bonded to the leaving group is not 
reactive as sensitizer.9 For a given activating group the reactivity of the halides present the 
increasing order of the leaving groups: F ا Cl ا Ĭ I,54 it is supposed that the compounds 
with fluoride (F) or alkyl as the leaving groups are expected to be weak sensitizing or 
nonsensitizing, compared with haloalkanes containing other halogens.9  
Furthermore, compounds with bifunctional groups via SN2 reaction mechanism, either 
SN2-type ring-opening or normal SN2-type reaction44,55 (see Scheme 1.3), were overpredicted.36 
The possible reason is that both of these two functional groups, which mean two reaction 
pathways, significantly affect reactivity as well as skin sensitization of compounds. This point 
had been confirmed by Ida B. Niklasson with his colleagues that skin sensitization potential of 
phenyl glycidyl ether (PGE) decreased with increasing length chain between the epoxide moiety 
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and the ether oxygen as well as increasing the distance between the ether oxygen and the 
aromatic system.56 
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Scheme 1.3: SN2-type reaction mechanism. Top: the SN2-type ring opening reaction. Bottom: SN2 reaction 
mechanism at the methylene carbon with phenoxide as the leaving group.  
 
1.5.3 Acylation Formation 
 
Acylation mechanistic domain is an important reaction mechanism in organic chemistry. A 
nucleophilic attacking at the carbonyl (or sulfinyl) of compounds has been demonstrated as being 
acylation domain.57 The reaction mechanism is illustrated in Scheme 1.4. The rate determining 
step for the acylation mechanism is depending very much on the ability of group X to be 
expelled from the tetrahedral intermediate.12 Thus, the more acidic XH, the more stable 
electronegative leaving group and thus the more reactive RCOX is. Undoubtedly, acyl halides (X 
is halogen or pseudohalogen) and anhydrides (X = OCOR) have highly sensitization potential, 
aryl esters (XH is a phenol) are somewhat less reactive but usually reactive enough to sensitize, 
however simple alkyl ester (X = alkyl) are not reactive enough to be sensitizers.12 
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Scheme 1.4: Acylation mechanistic domain. X denotes the leaving groups, such as halogens or pseudohalogen 
 
1.5.4 Schiff Base Formation 
 
A Schiff base is a class of compounds that are derived by a chemical condensation between 
a primary amine and aldehydes or ketones. For compounds binding via Schiff base formation to 
proteins, the functional group C=N or C=O is necessary, see Scheme 1.5. But for some pro-
Schiff base electrophiles, convert the CH-N into C=O group after oxidation are required. There 
are several classes of compounds identified to be capable of covalently binding to proteins or 
peptides via Schiff base formation. The covered structure alerts of Schiff base formation are:  
A) Monocarbonyls: in this case, the functional group C=N or C=O directly connect with 
hydrogen or any carbons, but cannot connect with the aromatic, heteroaromatic and/or 
unsaturated heterocyclic ring. The possibility of reason is that carbonyl group is deactivated; 
because of the activation energy required in going from a resonance stabilized parent compound 
to an intermediate.33 However, some electron withdrawing ortho-position substituents could 
delocalise ʌ-system between the carbonyl group and aromatic ring system, which results in the 
Schiff base formation possibility.33,37  
B) Di-substituted Į,ȕ-unsaturated aldehydes: In principle, if the R group is unsaturated 
functional group, the compounds could bind to proteins via Michael addition domain. However, 
in case of the di-substituted Į,ȕ-unsaturated aldehydes , the compounds expect to react through 
Schiff base formation instead of Michael addition mechanism, because of  the steric hindrance 
effect and electron donating effect of the alkyl substituent deactivating Michael addition 
mechanism.37 The excellent example is trans-2-methyl-2-butenal (CAS: 497-03-0) that has 
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definite Į,ȕ-unsaturated functional group, but show lower reactivity and weak skin sensitization 
only.58  
C) Dicarbonyls (including both 1,2-dicarbonyls and 1,3-dicarbonyls): in this case, 
dicarbonyl chemicals have been identified to be able to undergo a second Schiff base formation 
and thus cross-linking reaction is expected,59 because of the double functional groups in one 
compounds. But please keep in mind, the directly linked aromatic rings with C=N or C=O will 
deactivate Schiff base formation, accounting for the activation energy that mentioned above.33 
Previous investigation developed a QSAR model for screening skin sensitization potential 
of 11 aliphatic aldehydes, one Į ketoester and four Į,ȕ-diketones13 that via Schiff base formation. 
The simple ketones are expected to be no more than very weak sensitizers in the LLNA.13 
Simple ketones (alkenones) with general structure RCOR (both Rs are alkyls) had been 
evaluated as nonsensitizers. Furthermore, acetone is often employed as a vehicle in LLNA. Thus, 
it is supposed that ketones with appropriately hydrophobic and electronegative substituents in the 
vicinity of the keto group will be greater reactive than simple alkanones and will more likely to 
be sensitizers. Aromatic rings are strongly deactivating for skin sensitization potential during 
reaction at the carbonyl group.13,33 The excellent examples are Vanillin and Ethyl vanillin, which 
are identified nonsensitization potential in LLNA. But please keep in mind, although 
benzaldehyde had been reported a nonsensitizer in LLNA, the recent investigation found that 
benzaldehyde present a clear sensitization potential in humans and the skin sensitization potential 
equal to an LLNA EC3 of around 10%.60 
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Scheme 1.5: Schiff Base Formation mechanism 
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1.5.5 Michael Addition 
 
Some compounds are Michael acceptors with an electron-deficient double bond that well 
be easily attacked by nucleophilic group on proteins, without the presence of a leaving group in 
the molecule (seeing Scheme 1.6). Other compounds, pro-Michael acceptors, that are not directly 
reactive with proteins via Michael acceptors, but after either metabolic conversion in vivo or 
abiotic transformation in vitro. The capable of nucleophilic attacks to C=C-X depends on the 
ability of the X group to stabilize the negative charge in the intermediate. Still, the substituents 
on the Į- and ȕ-carbon atoms have significant influences on reactivity of Michael addition, for 
which are electron-donating substituents, such as methyl groups, reducing reactivity with protein 
or peptide by the alkyl group substitution alters the electron density. This indicates acrylates 
show high skin sensitization potential than methacrylates, since the electronic effect but not for 
steric effect.9 In contrast, the electronic-drawing substituents are strong increasing reactivity. 
Moreover, previous investigation suggested that aliphatic Į,ȕ-unsaturated compounds, such as 
Į,ȕ-unsaturated aldehydes, ketones and esters, show different sensitivity of reactivity with 
surrogate peptides (glutathione (GSH)).61 Compared with others reaction mechanisms, Michael 
addition formation show the lowest slope value (0.24) for against skin sensitization potential 
with peptide reactivity.53 These outcomes indicate that Michaels acceptors should be tread 
separately.  
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Scheme 1.6: Michael addition reaction mechanism 
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2. Theoretical considerations  
2.1 The Different Toxicological Modes of Action  
 
Toxicological modes of action are defined as a common set of biochemical and 
behavioural signal characterized a type of adverse biological response.62 Please keep in mind, 
toxicological mode of action is not the same as mechanism of action, which refer to the 
biochemical procedure underlying the given toxicological mode of action. Although, the 
biochemical mechanism of action determines the toxicological mode of action, 9 toxicological 
mode of action is more important and widely used in ecotoxicology and toxicology. This is 
because of the easy classification of compounds according to their type of toxicological mode of 
action.63 
Toxicologically, there are three important toxicological modes of action, narcosis, specific 
toxicity and reactive toxicity. 
Narcosis considers nonspecific reaction mechanism, but associates with altering structure 
and function of cell membranes of organisms at specific sites, such as the lipid layers or the 
proteins in membranes. Thus, narcotic toxicity, or baseline toxicity, is the minimal toxic effect, 
since its nonspecifically acting toxicant. Narcotics toxicity usually correlate with hydrophobicity 
in terms of log Kow. Even through narcosis is reversible, if the exposure of organisms to the 
toxicant (compounds) is continuous, a narcotic toxicant can produce death.  
In contrast, specific toxicity relates a specific acting mode of toxic action through 
modification or inhibition some receptors or biological procedure at some specific molecular 
sites with a low concentration of compounds.62 Thus, if a compound identifies a specific toxicity, 
its specific toxicity will be shown firstly compared with narcotic toxicity, since specific toxicity 
required a lower concentration. There are several types of specific modes in reaction:64 
1) Oxidative uncouplers: the toxic process of this kind of compounds links two biochemical 
produces, electron transfer and adenosine triphosphate (ATP), which occurs in oxidative 
phosphorylation. The examples are phenols with -Cl and -NO2 substituent. 
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2) Acetylcholinesterase (AChE) inhibition: AChE is an enzyme associated with nerve 
synapses. When toxicants bind to AChE, the nerve synapses will be broken down. Some 
compounds are acting as AChE inhibitors, such as organophosphorus compounds, which 
are easily founding in pesticides. 
3) Respiratory blocked: Respiration affect by binding to compounds through interfering 
with the electron transport chain in the mitochondria. Examples of respiratory blockers 
are rotenone and cyanide.  
Reactive toxicity is a non-specific covalent interaction between electrophiles or pro-
electrophiles with biological macromolecules (such as proteins, membrane components, 
substrates, DNA). It can disrupt many different cellular and/or organismal processes.65 This kind 
of reactive toxicity is responsible for variously adverse outcomes including acute failure of 
energy flow and nerve function, skin irritation/sensitization, immune system dysfunction, 
reproductive and developmental impairment, as well as mutagenicity and carcinogenicity.9,65 For 
the understanding of reactive toxicity, a series of chemoassays are applied for measuring 
reactivity of compounds. Moreover, these chemoassays have been successfully applied for 
screening aquatic toxicity, skin sensitization, respiratory sensitization and mutagenicity. The 
summary information is illustrated in Table 2.1 (see below).  
 
28 
Table 2.1: The list of in chemoassay studies review in different toxicological endpoints 
Toxicological 
endpoint 
Surrogate 
nucleophiles 
Electrophiles 
studied 
Descriptors QSAR Equations Other information 
Aquatic toxicity 
Respiratory toxicity 
Hepatocyte 
cytotoxicity65 
GSH 
Michael 
acceptor 
compounds 
log kGSH 
EC50 (RC50) 
Aquatic toxicity 
 ቀ ଵ
୍ୋେఱబ
ቁ ൌ ͲǤͻ͹ͷ  ቀ ଵ
୉େఱబ
ቁ െ ͲǤͷͻʹ 
˷n = 12, r2 = 0.952, s =0.24, F=221, PR > 
F = 0.001˹ 
Respiratory toxicity 
 ହ଴ ൌ ͲǤͷͻͺ  ହ଴ ൅ ͳǤͲ͵ ˷n = 
10, r2 = 0.846, s = 0.31, F = 44, PR > F = 
0.001˹ 
Hepatocyte cytotoxicity 
 ହ଴ ൌ െͲǤͺ͹ͻ  ݇ୋୗୌ ൅ ͸ǤͳͷͲ ˷n 
= 7, r2 = 0.95, s = 0.13, F = 92.793, P < 
0.001˹ 
 
Skin sensitization26,38 GSH Various GSH, 
A moderately strong correlation between 
skin sensitization and GSH depletion (r = 
Skin sensitization seems not 
significantly correlated with 
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Cysteine 
Lysine peptides 
compounds Cysteine and 
Lysine 
peptides 
depletion 
(10%) 
ˉ0.645, p = 0.0010), Cysteine depletion (r 
= ˉ0.463, p = 0.0205) and Lysine 
depletion (r = ˉ0.445, p = 0.0259) 
histidine depletion. 
Aquatic toxicity NBP 
Organic 
halides 
log kNBP 
log Kow 
Various equations 
 ͷͲ ൌ െͲǤ͵͵ ή ܭ௢௪ െ ͳǤͲʹ ή
 ݇ே஻௉ െ ͳǤͷͳ ˷n = 15, r2 = 0.81˹ 
Theoretical results agree with 
experimental descriptors. 
Mutagenicity NBP 
Epoxides, 
thiiranes, 
oxetanes and 
thietane 
log kNBP 
୘୅ଵ଴଴ ሾǤ ߤΤ ሿ ൌ
ሺͳǤͻͶ േ ͲǤ͵͹ሻ ή
 ݇୒୆୔ ሺିଵିଵሻ൅ሺͷǤʹͶ േ
ͲǤ͹Ͳሻ˷n = 9, r2 = 0.80, rms = 0.31, F1,7 = 
28.0˹ 
 
Skin sensitization14 
Ac-RFAACAA (SH- 
based peptide) 
Michael 
acceptors 
log k 
݌͵ ൌ ͲǤʹͶሺേͲǤͲͶሻ  ݇ ൅
ʹǤͳͳሺേͲǤʹͶሻ ˷n = 10, r2=0.836, s = 0.11, 
F = 40.8˹ 
Inclusion of log Kow did not 
improve the Equation. 
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Skin sensitization66 NBT 
Michael 
acceptors 
SN1/SN2 
reactors, 
Acylating 
agents 
log ka 
݌͵ ൌ ͲǤͺͳሺേͲǤͳͳሻ  ݇௔ ൅
ʹǤͳ͵ሺേͲǤʹ͵ሻ ˷n = 10, r2 = 0.87, s = 0.65, 
F = 52.3˹(only equation of Michael 
addition are presented here, and see 
original study for further details) 
This method is simple and 
fast. 
Aquatic toxicity54 GSH 
Haloaliphatic 
compounds 
pRC50 
݌ܫܩܥହ଴ ൌ ͲǤͻͶሺേͲǤͲ͹ሻ ݌ܴܥହ଴ ൅
ͳǤ͵ͶሺേͲǤͲ͹ሻ ˷n = 22, r2 = 0.889, s = 0.27, 
F = 161˹(aquatic toxicity) 
 
The underestimate toxicity 
probably due to hydrolysis 
and evaporation 
Skin sensitization8 GSH 
(aquatic 
toxicity ) 
Various 
compounds 
(skin 
sensitization) 
pRC50 
pRC50 > í0.55 indicates the compounds 
will be sensitizers 
 
Toxicity enhancement > 0.50 
are combined with pRC50 
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2.2 The Differences between Skin Sensitization and Aquatic 
Toxicity 
 
Aquatic toxicity is an adverse effect to organisms resulting from toxicants (or compounds). 
It relates with contaminants and degraded water quality, environmental stressors on aquatic 
organisms, bioaccumulation and toxicity of contaminants from water, sediment and food. 
The difference between skin sensitization and aquatic toxicity, are illustrated in Table 2.2. 
Obviously, the biological mechanism of skin sensitization and excess aquatic toxicity are 
different. However, their chemical mechanisms, formatting covalent binding to protein and/or 
peptides, are partly same in these two different endpoints. For skin sensitization, compounds 
(electrophiles) react with nucleophilic groups on proteins to form antigenic modified proteins, 
which proliferate of T-cell in lymph nodes causing the development of the sensitized state. Thus, 
single mode of action, phenomenon of skin sensitization presents several mechanisms of action 
during electrophiles bind to protein. In contrast, aquatic toxicity involves many modes of action 
and mechanisms of action. For example, narcotic toxicity (to fish) can cause aquatic organisms 
lethargic and comatose or death de¿ned by hydrophobicity.9 Penetration of the compound 
through surface of skin into epidermis is the first step for a sensitizer induction skin sensitization. 
Thus, hydrophobicity could be an important parameter to influence penetration of compounds 
through epidermis to inside of skin. Also, hydrophobicity can affect toxicity enhancement. 
The data source and quantitative expression are other differences between skin 
sensitization and aquatic toxicity. These days, the major in vivo data source of skin sensitization 
is from the mouse local lymph node assay (LLNA). During measuring process, test compound is 
applied in ear skin. After five days exposure, proliferations of lymph node indicated by T-cell are 
evaluated. The skin sensitization potential express as a stimulation index (SI), which is the ratio 
of tritiated thymidine uptake in treated animals to uptake in control animals. In the assay, a range 
of dosages of test compounds are carried out from dose-response analysis, then, EC3 value are 
obtained derived from SI = 3. Aquatic toxicity is usually quantified risk assessment in terms of 
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EC50 (eơective concentration yielding 50% growth inhibition) or LC50 (lethal concentration 
50%) values in acute and/or chronic toxicity assays.44-45  
 
Table 2.2: The difference of modes of action, target sites, determined factors and major reaction mechanism 
domains between skin sensitization and aquatic toxicity 
 Skin sensitization Aquatic toxicity 
Adverse outcomes Become sensitized Narcotic toxicity Reactive toxicity 
Target sites Proteins/peptides  Membrane (lipids) 
Proteins/peptides 
DNA/RNA 
Determined factors Hydrophobicity and reactivity Hydrophobicity 
Reactivity and 
hydrophobicity 
Major reaction 
mechanism domains 
Michael type reaction 
Schiff base formation 
SN2 reaction 
SNAr reaction 
Acylation formation 
Non  
Michael type reaction 
Schiff base formation 
SN2 reaction 
SNAr reaction 
Acylation formation 
 
 
2.3 Support Theory  
 
As mentioned in section 1.3.2, a key step for a sensitizer inducing skin sensitization is the 
formation of a covalent adduct between skin sensitizers and skin proteins and/or peptides. Based 
on this chemically mechanistic understanding, the most straightforward approaches to predict 
skin sensitization is evaluating reactivity of a test compound toward proteins and 
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peptides.5,26,38,67 Furthermore, the reactivity of compounds toward proteins and/or peptides 
occurred in aquatic organisms could elicit aquatic excess toxicity. The relationship of 
compounds’ reactivity and toxicity enhancement are evaluated for many years.44,55,68-69 In 2006, 
Aptula, A. O. with co-workers were applied toxicity enhancement combined with thiol reactivity 
to predict skin sensitization potential, with 23 of the 24 compounds correctly.8  
As determined through previous reports that chemical reaction mechanism are partly same 
between chemical reactivity, aquatic excess toxicity and skin sensitization, thus the bonding of 
electrophiles (compounds) to nucleophiles (proteins or peptides) is an excellent channel 
correlating chemical reactivity, aquatic excess toxicity and skin sensitization (illustrated in 
Scheme 2.1). Based on the same chemical reaction mechanism, chemical reactivity (such as thiol 
reactivity) and aquatic toxicity enhancement (Te) are useful tools that could be employed to 
predict skin sensitization potential of compounds.  
 
Scheme 2.1: The chemical reaction mechanism between chemical reactivity, aquatic excess toxicity and skin 
sensitization  
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3. Materials and Methods  
3.1 Data Sets  
 
As mentioned in section 1.5 that sensitizing compounds havd been suggested divided into 
different subcategories according to their reaction mechanism domains. Thus, these selected 76 
compounds classify into five major mechanism domains: Michael addition, Schiff base, SNAr, 
acylation formation and SN2 reaction, with some non-reaction mechanism compounds 
(nonsensitizers). Their basic information of hydrophobicity, in terms log Kow, and skin 
sensitization, in terms log EC3, are illustrated in Table 3.1. Moreover, these compounds are 
covering difference of sensitization classes, extreme, strong, moderate, weak and nonsensitizers, 
which compile in Table 3.2. 
 
Table 3.1: Mechanism domains with each of hydrophobicity and skin sensitization potential of selected 76 
sensitizersa 
Mechanism domains n 
log Kow log EC3 
min max min max 
Michael addition 28 í0.21 4.84 í4.04 í0.005 
Schiff base 8 í1.66 4.36 í2.06 í0.94 
SNAr 11 í1.71 5.12 í4.82 í0.98 
Acylation formation 6 í0.80 3.59 í2.68 í1.00 
SN2 reaction 10 í0.66 3.97 í4.07 í0.72 
Non reaction mechanism 13 0.88 5.02 n.a n.a 
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All 76 í1.71 5.12 í4.82 í0.005 
a The Mechanism domains classify according to QSAR Toolbox 2.2. n = number of compounds; min and max mean 
minimum and maximum value of log EC3 and log Kow, respectively; n.a means not available. The log Kow values, 
octanol/water partition coefficient, were estimated employing EPI Suite 4.1, and the log EC3 values were calculated 
through eq 3.1 
 
Table 3.2: Sensitization classes with their hydrophobicity, log Kow, and skin sensitization potential ranges, log 
EC3, of selected 76 sensitizersa 
Sensitization Classes n 
log Kow log EC3 
min max min max 
Extreme 7 0.25 3.05 í4.82 í3.46 
Strong 8 í1.71 2.80 í3.24 í2.36 
Moderate 28 í1.66 4.42 í2.45 í1.13 
Weak 20 0.80 4.82 í1.29 í0.005 
Nonsensitizer 13 0.88 5.02 n.a n.a 
 
All 76 í1.71 5.12 í4.82 í0.005 
a The sensitization classes classify through the EC3 value (see Table 1.1) that collect from literatures.58,70 n = 
number of compounds; min and max mean minimum and maximum value of log EC3 and log Kow, respectively; n.a 
means not available. The log Kow values, octanol/water partition coefficient, were estimated employing EPI Suite 4.1, 
and the log EC3 values were calculated through eq 3.1 
 
All of test compounds were purchased from Alfa Aesar, Sigma Aldrich, Fluka and Merch, 
with purities of manufacturer report above 97%. However, glutaraldehyde is 50% solution in 
water; and glyoxal is 40% solution in water. Their finally applied concentrations are corrected 
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and applied in the following assays. Caution: For almost of these chemicals are allergic or 
potentially allergic, any direct touches are not recommended.  
 
3.2 Skin Sensitization Data  
 
The EC3 values, an effective concentration of chemical (% w/v) causing threefold increase 
in proliferative activity in lymph node cells comparison with vehicle control, of all chemicals are 
collected from previous data complications,58,70 employing local lymph node assay (LLNA) in 
mice. According to their EC3 values, five different classes are proposed: chemicals with EC3 < 
0.1% are extreme sensitizers; with EC3 between 0.1 and 1% are strong sensitizers; with EC3 
between 1 and 10% are moderate sensitizers; with EC3 between 10 and 100% are weak 
sensitizers and with EC3 > 100% are nonsensitizers,26 see the Table 1.1. Log EC3 values of these 
test chemicals are compiled through eq 3.1, but not for nonsensitizers (missing of the EC3 
values), in which MW is the molecular weight. 
 
͵ ൌ െ ሺ͵ Τ ሻ     (3.1) 
 
3.3 Growth Inhibition Bioassays  
3.3.1 Growth Inhibition of Compounds Toward Tetrahymena pyriformis 
 
Test organism. Tetrahymena pyriformis is a free-living and fresh water genus (Figure 3.1). 
Tetrahymena pyriformis has been widely applied for studying toxic effect and biological toxins 
of compounds. Tetrahymena pyriformis has a lot of advantages during laboratory research 
works.71 These advantages are including that it could be easily cultured and preserved in a small 
volume of chemically defined medium (consisting of 10 g/L glucose, 20 g/L protease-peptone, 1 
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g/L yeast extract with pH = 7.0 ± 0.2); It could grow in 
a large temperature range, with a large cell size (25 
micrometers long approximately) compared to bacteria; 
Its generation time is fast (about 3 h), which means it is 
very easy for investigating the life cycle.  
Test procedure. The test procedure of 50% 
population growth inhibition assay toward ciliate 
Tetrahymena pyriformis is described as previous.72 The 
major difference is that 24 h exposure was employing in this work, rather than 40 h or 48 h 
exposure time as common.44,72  Simply, Tetrahymena pyriformis incubate in an incubator at 
28 °C in darkness without shaking. Logarithmic phase of Tetrahymena pyriformis apply to 24 h 
growth inhibition assay. In this phase, cell amount will reach to 2×105 or 3.5×105 cell per mL 
that determines using CASY Cell Counter (Innovatis AG, Reutlingen, Germany, seeing Figure 
3.2). Total 5 mL cell suspensions, containing initial cell number 2×104 ± 0.5×104 cells per mL, 
employ in 50 mL flasks closed with glass stoppers sealed 
with Glindemann sealing ring (VWR, Bruchsal, 
Germany). Stock solutions of compounds prepared 
dissolved these compounds into distilled water (log Kow < 
1 mol/L) or dimethyl sulfoxide (DMSO) (log Kow  1 
mol/L) (the highest tolerable concentration of DMSO in 
this assay is 1% (v/v)), then these stock solutions were 
diluted into 5 mL cell suspensions to obtain at least 7 
different concentrations gradient. Although the 
experimental research indicated that 1% (v/v) DMSO had 
no toxic effect on Tetrahymena pyriformis’ growth, the 
additional DMSO blank control corresponding of DMSO 
used are necessary.  
After 24 h exposure, the growths of Tetrahymena pyriformis in each of concentrations as 
well as blank controls were measured through counting the cell amount using CASY Cell 
Figure 3.1: Tetrahymena pyriformis 
Figure 3.2: CASY Cell Counter 
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Counter. The difference of initial cell number (0 h) and final cell number (24 h exposure) are 
used for calculating EC50 values according eq 3.6 (see below). 
 
3.3.2 Growth Inhibition of Compounds Toward to Vibrio fischeri 
 
Test organism. The toxicity tests were using 
marine bioluminescent Gram-negative bacteria Vibrio 
fischeri strain NRRL B-11177(seeing the Figure 3.3), 
which is purchased from the German Resource Center for 
Biological Material (DSMZ, Braunschweig, Germany). 
Vibrio fischeri, originally classified as 
photobacteriumfischeri, had been reclassified as 
aliiVibriofischeri.73 For controlling the bioluminescence 
and biological contamination to exclude a genetic drift, the 
bacteria were plated at least every half year. 
Cultivation of Luminescence Bacterial: The cultivation of Vibrio fischeri bacteria 
applied for 24 h growth and 30 min bioluminescence inhibition are exactly according to the 
International Standard ISO 11348-1 (2007).74 In brief, dissolve 30 g sodium chloride (NaCl), 
6.10 g sodium dihydrogenphosphate monohydrate (NaH2PO4·H2O), 2.75 g dipotassium 
hydrogenphosphate trihydrate (K2HPO4·3H2O), 0.204 g magnesium sulphate heptahydrate 
(MgSO4·7H2O), 0.50 g diammonium hydrogenphosphate ((NH4)2HPO4), 3 ml glycerol, 5.00 g 
caso-peptone and 0.50 g yeast extract in distilled water and adjust the pH to 7.0 ± 0.2 using 
sodium hydroxide solution (n(NaOH) = 1 mol/L) or hydrochloric acid (n(HCl) = 1 mol/L). Then, 
it was filled up to 1 L with distilled water and sterilize in an autoclave at 121 °C for 20 min. 
Transfer this species of luminescent bacteria under sterile condition to sterile medium for 
incubation. Usually, incubate in a sharking for 2 or 3 days at room temperature.  
Exposure procedure: Compounds with good water solubility (Sw  1 mol/L) were directly 
diluted into 2% (w/v) NaCl, unless the compounds with Sw < 1 mol/L were dissolved into 
Figure 3.3: Vibrio fischeri 
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dimethyl sulfoxide (DMSO) firstly and then dilute in the 2% (w/v) NaCl. To avoid toxic effect 
on growth of bacteria, the concentration of DMSO was always lower than 0.1% (w/v). In the 
case of DMSO applied as a cosolvent, the additional blank control with DMSO was used. Every 
compound was determined at least twice, with minimum six different concentrations gradient.  
Logarithmic phase of bacteria apply to growth 
inhibition test, with biomass is 2×109 or 3×109 cells 
per mL measuring in multisizer 4 (Beckman Coulter 
Company, USA, seeing Figure 3.4). Calculate and 
diluter the logarithmic phase of bacteria to initial 
cell number between 2×108 or 2.5×108 for every six 
different chemical concentrations gradient. After 24 
h exposure and incubating with shaking at room 
temperature, the Vibrio fischeri cell number (cell/ml) 
of different chemical concentrations gradient 
determine using multisizer 4 (Beckman Coulter Company, USA). Then, 24 h exposure EC50 
values resulted from ¿nal cell concentration subtract initial concentration, and then calculated 
through eq 3.6 (see below). 
 
3.4 Bioluminescence Inhibition Bioassay  
 
The bioluminescence inhibition tests were performed with Gram-negative bacteria Vibrio 
fischeri that had mentioned in section 3.3.2. Bioluminescence inhibition has been widely used to 
assess chemical toxicity of compounds, in which the inhibition of light emission production by 
Vibrio fischeri was measuring.  
The toxic mechanisms underlying the bioluminescence inhibition are varied and complex. 
The possibility of toxic mechanisms are involved in interactions with cell surface receptor, 
disruption of cell membrane function, chemical reaction with cellular components or 
inhibition/competition of enzyme transformation.75 Specially, requirement of metabolic energy 
Figure 3.4: Multisizer 4 
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are necessary for light emission, thus induction of bioluminescence inhibition resulting from 
compounds exposure is involved in interference of metabolic performance of the organism.76 
The measuring procedure was done according to ISO 11348-1 standard procedure.74 In 
brief, stock bacterial suspension or fresh bacteria are applied for bioluminescence inhibition 
measuring. Firstly, dimethyl sulfoxide (DMSO) with the final concentration below 0.1% 
employed as a cosolvent for lower water solubility compounds are applied in test solution that is 
2% NaCl. At this kind of low DMSO condition, the toxic effect for emission of bioluminescence 
from Vibrio fischeri is supposed to due to the tested chemicals but not to this solvent. Secondly, 
different concentrations of test compounds obtained are illustrated Figure 3.5,74 in which 2% 
NaCl control solution always stands in A1 and the highest concentration of sample stands in A2, 
with 1.5 mL of 2% NaCl into residual cuvettes (from A3 to A10). Use a pipette to transfer, 
proceeding from left to right with 1.5 ml sample into the every next cuvette. Draw each sample 
several times using pipette for mixture (no need to change the pipette tip). Moreover, for test 
with equal volumes of test suspension and sample, pipette 500 ȝL portions of the test bacterial 
suspension into the corresponding test cuvettes (layer B and C, two test replications), determined 
and recorded luminescence intensity with a same time intervals (5 s to 20 s). Finally, pipette 500 
ȝL test sample from each layer A cuvettes into corresponding each layer B and C cuvettes, then 
determine and record the luminescence intensity after 30 min exposure. 
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Figure 3.5: The procedure of preparation different concentration samples. Layer A is the different 
concentration of test compounds, and layer B and C are corresponding two test replications74 
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3.5. Kinetic Glutathione Chemoassay  
 
There are two different variant of glutathione (GSH) chemoassays available, the static 
GSH chemoassay and kinetic GSH chemoassay. According to reported experimental 
procedure,77-78 static GSH chemoassay determine 50% of electrophile concentration of GSH 
(0.1375 mM) depleted in the fixed 2 h exposure time. The reactivity of compounds is quantified 
by the RC50 value. Static GSH chemoassay had been widely used for predicting aquatic toxicity 
and skin sensitization. There are, however, some limitations of sensitivity existed in the 2 h RC50 
assay that are:76 
a) The low end of the detectable reactivity is determined by the water solubility (Sw) of the 
test chemical. 
b) The RC50 assay is also less sensitive for differences in electrophilic reactivity at the high 
reactivity end. 
c) Some of the published RC50 data are even lower than the minimum concentration 
required degrading 50% of GSH, which is equal to 50% of the initial GSH concentration 
(0.07 mM). 
d) For determining RC50, a setoff reaction batches with increasing compounds concentration 
is required.  
Comparably, kinetic GSH chemoassay, the second-order rate constants (kGSH), is more 
pleasurably applied in recently researches.14,76 The experimental procedure of kinetic GSH 
chemoassay is according to previous report.76,79 In summary, phosphate buffer solution 
containing 0.0648 mol/L disodium hydrogen phosphate (Na2HPO4) and 0.0153 mol/L potassium 
dihydrogen phosphate (KH2PO4) was prepared and stored in a climate chamber at 25 °C. The 
DTNB solution was obtained through weighed 3,98 g DTNB into a 250 mL-Erlenmeyer flask, 
then adding 200 mL of phosphate buffer solution and employed 1 M solution hydroxide (NaOH) 
until the pH value to 7.4 was reached receiving a clear orange solution.  
Preparation of electrophilic (test compound) stock solution. All electrophilic stock 
solutions are prepared in 50 mL volumetric flasks for test convenience. For liquid test 
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compounds, 3.3 mL (log Kow < 2) or 10 mL (log Kow  2) DMSO are added into flask firstly, and 
then adding weighed test compound and filling phosphate buffer solution. In contrast, solid test 
compounds added into volumetric flasks firstly. The electrophilic stock solution was stored in the 
climate chamber at 25 °C, which the final concentrations of test compounds are ranged from 0.1 
to 25 mmol/L.  
Preparation of GSH (nucleophile) stock solution. Fresh GSH solution are prepared for 
each experiments by diluting 0.0107 g GSH in 25 mL phosphate buffer solution, thus the GSH 
concentration (ܿୋୗୌ଴ ) is 1.4 mmol/L. The GSH stock solution is stored in the climate chamber at 
25 °C until measuring.  
Procedure of kinetic glutathione chemoassay. The procedure of kinetic glutathione 
chemoassay is described as previous.61,76,79 Firstly, 2000 μL phosphate buffer solution added into 
column 1 of the deep 96-well plate, then 1200 μL phosphate buffer solution added into columns 
2 as well as 4-10 for low reactive compounds (the 600 μL approach) or 1600 μL phosphate 
buffer solution added into for high reactive compounds (the 200 μL approach). Secondly, 200 μL 
GSH stock solutions added into columns 2 as well as 4-10. 
Columns 1 and 2 are filled with 40 μL DTNB solution and 
mixing each wells several times using pipette. Moreover, 
600 μL (for low reactive compounds) or 200 μL (for high 
reactive compounds) test compound stock solution ware 
added into columns 4-10 and finally into column 2. 
Importantly, recording time started at filling column 4 
immediately. Followingly, transferred 300 μL mixed 
solution from each well of columns 1 and 2 (transferred 
twice) to the columns 1, 2 and 3 of micro titer plate, 
respectively, for reactivity measuring. Finally, close the 96-
well plate with sealing film and stored it on the shaker in 
the climate chamber at 25 °C. For the following time point measurement, penetrated the sealing 
film of the corresponding each wells with a forceps, and added 40 μL DTNB solution to the 
measured wells of column (recorded the time of adding the DTNB solution). After stirring the 
DTNB solution with measuring solution, transferred 300 μL to the corresponding column of 
Figure 3.6 UV-Vis Spectrometer 
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micro titer plate and measured simples via UV Vis spectrometry at 412 nm (SpectraMax 384 
Plus, Molecular Devices Corporation, United States, seeing Figure 3.6).  
The quantification of the GSH concentration was based on external calibration employed 
measuring different points (6 to 8) of GSH concentrations (ranging from 0.00152 to 0.239 
mmol/L). Previous researches suggested that the highly significant correlation between 
absorbance and GSH concentration (r2 = 0.9996, s = 2×10–6).61,76 Moreover, at least three 
replications (separate experiments) are applied for every test compound, with 6 to 8 data points 
per rate plot. The statistical association r2 values were 0.99 for most compounds, r2 = 0.96 ௅0.98 
hardly for some compounds.76 
Reaction rate calculation. Rate constants of reaction between the GSH and the 
electrophilic test compounds, kGSH, were calculated separately according to chemical reactivity 
potency. For less reactive compounds, the pseudo-¿rst-order kinetics was employed, see eq 3.2. 
The pseudo-¿rst-order rate constant (݇ୋୗୌ୮ୱୣ୳ୢ୭ ) was determined as the slope of the linear 
regression of  ܿୋୗୌ െ  ܿୋୗୌ଴  on reaction time t, which was discussed in previous doctoral 
dissertation.79 
 
݇ୋୗୌ ൌ ݇ୋୗୌ
୮ୱୣ୳ୢ୭Ȁܿ଴      (3.2) 
 
In contrast, second-order kinetics was applied for high reactive compounds, seeing eq 3.3. 
In which, kƍ denotes regression of ln cGSH – ln c on the reaction time t. The associated standard 
deviations of the means were calculated employing Microsoft Excel.79 
 
݇ୋୗୌ ൌ ݇ᇱȀሺܿୋୗୌ଴ െ ܿ଴ሻ     (3.3) 
 
GSSG Formation. The oxidation loss of GSH by DMSO80 and oxygen81 were determined 
under kinetic assay conditions, employing the DMSO/buffer mixture solution (without 
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electrophilic test compound). GSSG formation, the oxidation loss of GSH, resulted from reaction 
of GSH with DMSO or/ and oxygen was determined through the described eq 3.4.  
 
 ൬௖ృ౏ౄ
౪
௖ృ౏ౄ
బ ൰ ൌ െ݇ୋୗୗୋ
୮ୱୣ୳ୢ୭ ή ݐ     (3.4) 
 
The experimental determined values of GSH loss from routes of DMSO mediated and 
oxygen oxidation were significantly marched with determined ݇ୋୗୗୋ
୮ୱୣ୳ୢ୭ value, seeing eq 3.5.76 
Moreover, there was no further side of loss of GSH had been detected.76 The experimentally 
measured pseudo-¿rst-order rate constant of overall oxidative GSH loss through DMSO 
mediated and oxygen oxidation is ݇ୋୗୗୋ
୮ୱୣ୳ୢ୭ = 0.115 (±0.009) h 10–2 min–1, with a half-life of 
GSH t1/2 = 603 min.79  
 
݇ୋୗୗୋ
୮ୱୣ୳ୢ୭ ൌ ݇ୋୗୗୋୈ୑ୗ୓ ൅ ݇ୋୗୗୋ
୓మ      (3.5) 
 
It is suggested that the route of DMSO-mediated GSSG formation proceeds according to 
equation 3.6. This separated analysis of GSH loss through reaction with DMSO at a fixed 
concentration (2% of DMSO) without oxygen, yielding a pseudo-¿rst-order rate constant ݇ୋୗୗୋୈ୑ୗ୓ 
= 0.0741 h 10–2 min–1. 

 ൅  ՜ 
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
ୋୗୌ
ሱۛሮ 

 ൅  ൅ଶ  (3.6) 
 
Moreover, separate analysis of the GSH loss causing reaction with diluted oxygen in solution. 
Equation 3.7 illustrates the oxidative process of GSH loss through oxidized by oxygen, yielding 
the associated rate constant ݇ୋୗୗୋ
୓మ  = 0.0436 h  10–2 min–1. Interestingly, summing up both 
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individual rate constants of GSH oxidized by DMSO and oxygen gives 0.117 h 10–2 min–1, 
which is excellent agreement with the experimental determined ݇ୋୗୗୋ
୮ୱୣ୳ୢ୭ = 0.115 h 10–2 min–1.79 
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 ൅ ଶ ՜ 
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ଶଶ    (3.7) 
 
However, a higher DMSO concentration (10% of DMSO) is applied for lower water solubility 
chemicals. Correspondingly, a modified ݇ୋୗୌ
୮ୱୣ୳ୢ୭ ൌ ͳǤͺ͹ ൈͳͲିଷିଵ  for 10% DMSO are 
determined and applied to correct the calculation of kGSH as the same with previous.79 
 
3.6. EC50 Determination 
 
For 30 min bioluminescence and 24 h growth inhibition tests, their measured data from 
different concentrations were used to calculate the four-parameter logistic concentration-
response curve applied Sigma Plot 11 software, seeing eq 3.8. 
 
ݕ ൌ  ൅ ୫ୟ୶ି୫୧୬
ଵା൬ ೣుిఱబ
൰
షౄ౟ౢౢ౩ౢ౥౦౛     (3.8) 
 
In this Hill model (eq 3.8), x denotes the exposure concentration of the test compounds, 
and y the associated relative expressed inhibition range from –5% - 5% to 90% - 110%. The min 
and max respond minimum and maximum relative inhibition values resulting from curve ¿tting, 
respectively. Hillslope the slope parameter of this Hill concentration–response model. Especially, 
the test compounds concentration, x, are corrected for volatilization or sorption loss (see below) 
during exposure before generating the concentration–response curve.  
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3.7 Exposure Control for Volatilization and Sorption Loss  
 
Compounds loss through volatilization and sorption had been suggested employing HPLC-
DAD during the expose in previous literature.44,55 The Kaw (air-water partition coefficients) are 
collected through EPISuite at 25 °C   Ǥ82 The both of volatilization and 
sorption loss are applied to correct calculation of log EC50. 
 
3.7.1 Volatilization Loss  
 
The volatilization loss of compounds during these bioassays is calculated through 
thermodynamic equilibrium conditions using eq 3.9, as reported before.44,55  Same with 
literatures, flasks applied for volatile compounds are equipped with a cap with septum (22 mm 
silicone/PTFE septum, with 3.2 mm EPE, VWR, Germany) to avoid volatilization loss during 
exposure. As the Kaw (air-water partition coefficients) are used in the corrected model, thus the 
Kaw at 28 °C are calculated through our model as implemented in the ChemProp software, using 
experimental or predicted Kaw at 25 °C.  
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௖౭ሺ୬୭୫ሻି௖౭ሺ୴୭୪ሻ
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ൌ ͳ െ ቆͳ െ ௄౗౭
௄౗౭ା
ೇ౭
ೇ౗
ቇ ൌ ௄౗౭
௄౗౭ା
౒౭
౒౗
ൌ ୟ݂  (3.9) 
 
In this eq 3.9, ¨cw (vol) represents a calculated loss value due to volatilization, cw (nom) 
represents the initial chemical concentration in the bioassay solution, cw (vol) will be the 
volatilized chemical concentration in the headspace, Kaw is the air/water partition coefficient, Vw 
represents the volume of incubated solution (5 mL in the 24 h growth test and 1mL in the 30 min 
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bioluminescence test), and fa represents the chemicals fraction in air. With chemicals having 
relative loss of > 5%, specifically manufactured caps were used to minimize the headspace of 
shorter cuvettes for 30 min bioluminescence test and speci¿cally manufactured glass Àasks 
equipped with a cap and septum was used for 24 h growth inhibition test. 
 
3.7.2 Loss Through Sorption 
 
Neutral organic compounds can sorb to medium components, cell debris and glass wall. To 
correct this effect, previous investigation has been measured in headspace-free samples 
containing cell suspensions of nonvital cells and cell debris.44 Consequently, the observed 
compounds loss only due to sorption to medium components in the aqueous medium, and this 
sorption loss are dependent on hydrophobicity only.44 
The sorption loss of compounds in 24 h exposure bioassay with Tetrahymena pyriformis 
are calculated employed eq 3.8, as documented before.44  
 
ୱ݂ ൌ ͲǤͲ͹ͺሺേͲǤͲͳ͵ሻ ή  ܭ୭୵ െ ͲǤͲ͸͸ሺേͲǤͲͶ͹ሻ 
݊ ൌ ͻǡ ݎଶ ൌ ͲǤͺͶǡ ݍୡ୴ଶ ൌ ͲǤͺͲǡ ݎ݉ݏ ൌ ͲǤͲͷ͸ǡ ݎ݉ݏୡ୴ ൌ ͲǤͲ͹͸ǡ ܨଵǡ଻ ൌ ͵͹Ǥͻ (3.10) 
 
3.8 Toxicity Enhancement 
 
Toxicity enhancement (Te) is a dimensionless ratio, considering enhanced toxicity 
compared with narcotic toxicity. First, narcotic toxicity of tested compounds are predicted by eqs. 
3.11, 3.12 and 3.13 from literatures for 24 h growth inhibition (for both Tetrahymena pyriformis 
and Vibrio fischeri) and 30 min bioluminescence (Vibrio fischeri):44,76  
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݊ ൌ ͳ͸ǡ ݎଶ ൌ ͲǤͻͻǡ ݍୡ୴ଶ ൌ ͲǤͻͻǡ ݎ݉ݏ ൌ ͲǤͳͻǡ ݎ݉ݏୡ୴ ൌ ͲǤʹ͵ǡ ܨଵǡଵହ ൌ ͳʹͳ͵ (3.11) 
 
 ହ଴௏ி ሺǡ ʹͶሻሾሿ ൌ െͲǤ͹͹ሺേͲǤͲͷሻ ή ܭ୭୵ െͲǤͺͳሺേͲǤͳ͵ሻ 
݊ ൌ ͳ͸ǡ ݎଶ ൌ ͲǤͻͶǡ ݍୡ୴ଶ ൌ ͲǤͻ͵ǡ ݎ݉ݏ ൌ ͲǤ͵͹ǡ ݎ݉ݏୡ୴ ൌ ͲǤͶʹǡ ܨଵǡଵହ ൌ ͵ͷͳ (3.12) 
 
 ହ଴௏ி ሺǡ ͵Ͳሻሾሿ ൌ െͳǤͲͳሺേͲǤͲ͸ሻ ή ܭ୭୵ െͲǤͺͷሺേͲǤͳͷሻ 
݊ ൌ ͳ͹ǡ ݎଶ ൌ ͲǤͻͷǡ ݍୡ୴ଶ ൌ ͲǤͻ͵ǡ ݎ݉ݏ ൌ ͲǤͶͶǡ ݎ݉ݏୡ୴ ൌ ͲǤͷʹǡ ܨଵǡଵହ ൌ ͵Ͷ͸ (3.13) 
 
with root-mean-square errors (rms) for log EC50 of 0.19 (Tetrahymena pyriformis growth 24 h), 
0.37 (Vibrio fischeri growth 24 h) and 0.44 (Vibrio fischeri bioluminescence, 30 min), 
respectively.  
Toxicity enhancement calculate through eq 3.14, in which EC50 (narc) represents a 
calculated narcotic toxicity and, in contrast, the denominator (EC50 (exp)) represents the effect 
toxicity derived from the measured concentration-response data. While it is difficult to justify a 
certain Te threshold for discriminating narcosis from other modes of toxicological actions, Te 
values > 10 can still be applied to indicate a significant toxicity enhancement driven by specific 
or reactive mechanism domains, corresponding the toxicity enhancement of tested compounds 
(seeing eq 3.14) 
 
ܶୣ ൌ ୉େఱబሺ୬ୟ୰ୡሻ
୉େఱబሺୣ୶୮ሻ
     (3.14)  
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4. Result and Discussion 
4.1. Application of Toxicity Enhancement of Sensitizers Toward 
Tetrahymena pyriformis for Predicting Skin Sensitization Potency 
 
4.1.1 Background  
 
Currently, the in vivo tests are valid approaches for detecting skin sensitization potency of 
chemicals, such as guinea pig maximization test and local lymph node assay (LLNA).22-23 
According to the new EU chemical regulation REACH, information of skin sensitization of 
chemicals manufactured or imported above 1 ton/year should be available. According to this 
requirements/test strategy, the assessment would use a huge number of test animals and could be 
neither resource nor time effective. The excellent example have been illustrated in the previous 
(2013) literature that 8,000 chemicals have been registered with ECHA due to REACH and 
1,000,000 animals and more than €50 million are needed in the animal test.16 Thus, in vitro 
methods are widely accepted to replace current animal tests in skin sensitization assessment. 
Growth inhibition assay with Tetrahymena pyriformis had been successfully applied to 
assess the toxicity and toxicity enhancement of compounds.44,83 In this research, toxicity of 
sensitizers, which are covering five different reactive mechanisms ( SN2, Schiff base formation, 
SNAr, Michael Addition and acylation) and five different sensitization potencies (extreme, strong, 
moderate, weak and nonsensitization), had been determined employing 24 h growth inhibition 
with Tetrahymena pyriformis in terms of EC50 (effective concentration yielding 50% growth 
inhibition). Toxicity enhancement of these sensitizers accounting for electrophilic (sensitizers) 
reacting to nucleophiles (skin proteins) calculated through comparison with their narcotic 
toxicity use to discriminate sensitizers from nonsensitizers.  
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4.1.2 Toxicity Data to Tetrahymena pyriformis 
 
The toxicity to Tetrahymena pyriformis and physiochemical properties of 55 test chemicals 
in this study is presented in Tables 4.1 and 4.2. The log Kow vary over 6.8 orders of magnitude 
(from í1.71 to 5.12), toxicity cover 4.4 fold range (from í6.02 to í1.62), and parallel level of 
toxicity enhancement, in terms of log Te, with 3.3 orders of magnitude (from í0.15 to 3.11). As 
mentioned above, the binding of sensitizers to skin proteins and/or peptides is key step for 
inducing skin sensitization. In aquatic toxicity, the covalent binding of compound to 
macromolecule can result in toxicity enhancement (Te). Based on this chemical understanding, Te 
will be applied to screen skin sensitization potency rather than EC50. Figure 4.1 shows the plot of 
sensitization potency (log EC3) vs toxicity enhancement (log Te). Strong (with extreme) and 
moderate sensitizers show a significant toxicity enhancement (average log Te are 2.22 and 1.34, 
respectively); expectedly, weak sensitizers and nonsensitizers are shown no toxicity 
enhancement (average log Te = 0.21 and 0.42, respectively). This result confirms previous 
understanding that chemical mechanism is partly the same for skin sensitization and aquatic 
toxicity.9,28 
As the same with discriminating excess toxic compounds from narcotic-level compounds 
in aquatic toxicity, log Te = 1 is applied as a threshold to separate sensitizers from nonsensitizers. 
In Table 4.3, strong (with extreme) and moderate sensitizers yield 100% and 77.8% accuracy, 
respectively (diethyl sulfate has a log Te = 0.92, which is very close to 1). The four compounds 
showing log Te less than 1 are 2-methyl-3-phenylacrolein (26), 10-undecenal (28), 2-
phenylpropanal (29) and edaravone (30) in moderate sensitizers group. For 2-methyl-3-
phenylacrolein and 2-phenylpropanal, the toxicity enhancement is 0.80 and 0.87, respectively, 
illustrating the toxicity is still 6 or 7 times higher than narcotic toxicity. The high hydrophobicity 
will the possible reason for decreasing toxicity enhancement44 for 10-undecenal (log Kow is 4.12), 
but could no dramatic effect on sensitization potential. Edaravone (30) for some unknown reason 
only showed narcotic toxicity in the present bioassay.  
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Weak sensitizers is shown a perfect 100% accuracy, but nonsensitizers only obtain a low 
accuracy, 69% (bromobutane shown a log Te = 0.95 that almost equals to 1). Possible 
explanation is given below (section 4.14). 
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Figure 4.1: Log Te, enhancement toxicity of 24 h growth inhibition with Tetrahymena pyriformis presented in 
Table 4.1. vs potency of sensitization according to EC3 values: extreme, < 0.1%; strong, 0.1 – 1%; moderate, 
1 – 10%; weak, 10 – 100%; and nonsensitizer, > 100%. 
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Table 4.1: Test Set of 55 Allergic chemicals with their physicochemical properties and sensitization potency 
Number Name CAS Sensitization potency log Kowa log EC3 [M] Reaction mechanism 
1 Chlorothalonil 1897-45-6 Extreme 3.05 í4.82 SNAr 
2 1-Fluoro-2,4-dinitrobenzene 70-34-8 Extreme 1.83 í3.76 SNAr 
3 1-Chloro-2,4,6-trinitrobenzene 88-88-0 Extreme 2.09 í3.69 SNAr 
4 2, 4-Dinitrophenyl thiocyanate 1594-56-5 Extreme 2.04 í3.68 SNAr 
5 1-Chloro-2,4-dinitrobenzene 97-00-7 Extreme 2.17 í3.61 SNAr 
6 1-Brome-2,4-dinitrobenzene 584-48-5 Extreme 2.52 í3.46 SNAr 
7 1-Iodo-2,4-dinitrobenzene 709-49-9 Strong 2.80 í3.24 SNAr 
8 Glutaraldehyde 111-30-8 Strong í0.18 í3.00 SB 
9 2,4,6-Trinitrobenzenesulfonic acid 2508-19-2 Strong í1.71 í2.99 SNAr 
10 Dimethyl sulfate 77-78-1 Strong 0.16 í2.82 SN2 
54 
11 2-Oxetanone 57-57-8 Strong í0.80 í2.68 SN2/ acyl 
12 Phenyl glycidyl ether 122-60-1 Strong 1.60 í2.51 SN2 
13 2-Methyl-3,1-benzoxaza-4-one 525-76-8 Strong 0.83 í2.36 acyl 
14 Bisphenol A diglycidyl ether 1675-54-3 Moderate 3.84 í2.45 SN2 
15 2,4-Dinitrobenzenesulfonic acid 89-02-1 Moderate í1.53 í2.12 SNAr 
16 1-Phenyl-1,2-propanedione 579-07-7 Moderate 1.11 í2.06 SB 
17 Mercaptobenzothiazole 149-30-4 Moderate 2.42 í2.00 SN2 
18 Diethylsulfate 64-67-5 Moderate 1.14 í1.98 SN2 
19 Benzyl glycidyl ether 2930-05-4 Moderate 1.31 í1.82 SN2 
20 4-Vinylpyridine 100-43-6 Moderate 1.71 í1.82 MA 
21 Propylidenephthalide 17369-59-4 Moderate 2.03 í1.67 acyl 
22 Cinnamaldehyde 104-55-2 Moderate 1.90 í1.64 MA 
55 
23 Glyoxal 107-22-2 Moderate í1.66 í1.62 SB 
24 Phenylacetaldehyde 122-78-1 Moderate 1.78 í1.60 SB 
25 Benzylideneacetone 122-57-6 Moderate 2.07 í1.60 MA 
26 2-Methyl-3-phenylacrolein 101-39-3 Moderate 2.37 í1.51 MA 
27 Dihydrocoumarin 119-84-6 Moderate 0.97 í1.42 acyl 
28 10-Undecenal 112-45-8 Moderate 4.12 í1.40 SB 
29 2-Phenylpropanal 93-53-8 Moderate 1.96 í1.33 SB 
30 Edaravone 89-25-8 Moderate 2.56 í1.31 acyl 
31 Hexyl cinnamic aldehyde 101-86-0 Weak 4.82 í1.29 MA 
32 Į-Amyl cinnamic aldehyde 122-40-7 Weak 4.33 í1.26 MA 
33 1-Bromohexane 111-25-1 Weak 3.80 í1.22 SN2 
34 Methyl methanesulfonate 66-27-3 Moderate í0.66 í1.13 SN2 
56 
35 Pentachlorophenol 87-86-5 Weak 5.12 í1.12 SNAr 
36 Benzyl cinnamate 103-41-3 Weak 4.06 í1.11 MA/SN2 
37 Benzyl benzoate 120-51-4 Weak 3.97 í1.10 SN2 
38 Lilial 80-54-6 Weak 4.36 í1.03 SB 
39 Diphenylcarboxylate 93-99-2 Weak 3.59 í1.00 acyl 
40 2,4-Dichloronitrobenzene 611-06-3 Weak 3.07 í0.98 SNAr 
41 Cyclamen aldehyde 103-95-7 Weak 3.91 í0.94 SB 
42 Phenylethyl isovalerate 140-26-1 Weak 3.97 í0.72 SN2 
43 Methylparaben 99-76-3 NS 1.96 n.a. n.b. 
44 Salicylic acid 69-72-7 NS 2.26 n.a. n.b. 
45 4-Hydroxybenzoic acid 99-96-7 NS 1.58 n.a. n.b. 
46 Benzaldehyde 100-52-7 NS 1.48 n.a. n.b. 
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47 4-Acetylanisole 100-06-1 NS 1.74 n.a. n.b. 
48 Ethyl vanillin 121-32-4 NS 1.58 n.a. n.b. 
49 Vanillin 121-33-5 NS 1.21 n.a. n.b. 
50 Butyl alcohol 71-36-3 NS 0.88 n.a. n.b. 
51 Methyl salicylate 119-36-8 NS 2.55 n.a. n.b. 
52 Allyl acetate 591-87-7 NS 0.97 n.a. SN2 
53 Chlorononane 2473-01-0 NS 5.02 n.a. SN2 
54 Bromobutane 109-65-9 NS 2.75 n.a. SN2 
55 1-Iodohexane 638-45-9 NS 4.05 n.a. SN2 
a The Logarithmic octanol/water partition coefficients, log Kow, were predicted using EPI Suite.82 Sensitization classes were classified according to EC3 values: 
extreme, < 0.1%; strong, 0.1 – 1%; moderate, 1 – 10%; weak, 10 – 100%; and nonsensitizer, > 100%.26 Log EC3 was calculated through eq 3.1 represents the 
molar-based EC3 values.58,72 The reactive mechanism domains were suggested by QSAR Toolbox 2.2. n.a. denotes not available, and n.b. denotes no binding 
according to QSAR Toolbox suggestion.  
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Table 4.2: 24 h growth inhibition toxicity data of 55 allergic chemicals with Tetrahymena pyriformis 
Number Name Kaw (28 °C)a fs [%] fa [%] log EC50 [M] Hill slope log Te 
1 Chlorothalonil 8.24ā10-6 17.2 0.0 í6.01 1.68 2.45 
2 1-Fluoro-2,4-dinitrobenzene 4.67ā10-6 7.7 0.0 í5.29 2.62 2.71 
3 1-Chloro-2,4,6-trinitrobenzene 1.21ā10-8 9.7 0.0 í4.70 1.78 1.89 
4 2,4-Dinitrophenyl thiocyanate 1.01ā10-9 9.3 0.0 í5.46 4.92 2.69 
5 1-Chloro-2,4-dinitrobenzene 3.00ā10-6 10.3 0.0 í5.21 5.83 2.33 
6 1-Brome-2,4-dinitrobenzene 1.66ā10-6 13.1 0.0 í5.35 2.67 2.17 
7 1-Iodo-2,4-dinitrobenzene 9.78ā10-7 15.2 0.0 í5.40 3.24 1.97 
8 Glutaraldehyde 5.99ā10-6 0.0 0.0 í3.24 2.07 2.41 
9 2,4,6-Trinitrobenzenesulfonic acid 8.53ā10-15 0.0 0.0 í2.61 0.72 3.11 
10 Dimethyl sulfate 1.16ā10-4 0.0 0.2 í2.91 3.87 1.78 
11 2-Oxetanone 3.49ā10-3 0.0 4.3 í2.43 1.44 2.14 
12 Phenyl glycidyl etherb 4.02ā10-5 5.9 0.1 í3.65 1.50 1.22 
13 2-Methyl-3,1-benzoxaza-4-one 1.71ā10-4 0.0 0.2 í3.97 0.83 2.26 
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14 Bisphenol A diglycidyl ether 2.58ā10-9 23.4 0.0 í5.59 1.12 1.26 
15 2,4-Dinitrobenzenesulfonic acid 2.12ā10-12 0.0 0.0 í2.53 1.39 2.87 
16 1-Phenyl-1,2-propanedione 2.00ā10-6 2.1 0.0 í3.35 1.86 1.39 
17 Mercaptobenzothiazole 1.87ā10-6 12.3 0.0 í4.50 1.71 1.40 
18 Diethylsulfate 2.10ā10-4 2.3 0.3 í2.90 1.54 0.92 
19 Benzyl glycidyl ether 7.99ā10-6 3.6 0.0 í3.41 1.41 1.28 
20 4-Vinylpyridine 1.83ā10-4 6.7 0.2 í4.28 1.23 1.81 
21 Propylidenephthalide 4.49ā10-3 9.2 5.5 í3.94 3.74 1.18 
22 Cinnamaldehydec 8.07ā10-5 8.2 0.1 í3.93 9.67 1.32 
23 Glyoxal 1.94ā10-5 0.0 0.0 í2.37 1.27 2.82 
24 Phenylacetaldehyde 2.82ā10-4 7.3 0.4 í3.64 1.85 1.10 
25 Benzylideneacetone 6.18ā10-5 9.5 0.1 í3.90 3.96 1.10 
26 2-Methyl-3-phenylacrolein 1.24ā10-4 11.9 0.2 í3.91 2.96 0.81 
27 Dihydrocoumarin 1.44ā10-3 1.0 1.8 í3.23 1.11 1.40 
28 10-Undecenal 3.48ā10-2 25.5 31.1 í5.19 14.92 0.62 
29 2-Phenylpropanal 3.79ā10-4 8.7 0.5 í3.60 1.62 0.91 
30 Edaravone 9.46ā10-11 13.4 0.0 í3.85 0.76 0.63 
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31 Hexyl cinnamic aldehyde 5.42ā10-4 31.0 0.7 í5.22 1.66 0.04 
32 Į-Amyl cinnamic aldehyde 4.04ā10-4 27.2 0.5 í5.05 1.94 0.29 
33 1-Bromohexane 1.68ā100 23.0 95.6 í4.22 1.33 1.33 
34 Methyl methanesulfonate 1.87ā10-4 0.0 0.2 í3.46 1.29 3.04 
35 Pentachlorophenol 6.59ā10-6 33.3 0.0 í5.97 1.01 0.52 
36 Benzyl cinnamate 1.82ā10-5 25.1 0.0 í5.13 1.82 0.61 
37 Benzyl benzoate 1.44ā10-4 24.4 0.2 í4.77 2.52 0.33 
38 Lilial 1.34ā10-3 27.4 1.7 í4.64 2.40 í0.15 
39 Diphenylcarboxylate 6.14ā10-4 21.4 0.8 í4.64 1.67 0.52 
40 2,4-Dichloronitrobenzene 5.53ā10-4 17.3 0.7 í4.51 1.73 0.87 
41 Cyclamen aldehyde 9.96ā10-4 23.9 1.3 í4.52 1.51 0.12 
42 Phenylethyl isovalerate 2.32ā10-3 24.4 2.9 í4.68 2.83 0.24 
43 Methylparaben 1.86ā10-7 8.7 0.0 í3.35 2.66 0.66 
44 Salicylic acid 7.74ā10-7 11.0 0.0 í3.27 1.38 0.31 
45 4-Hydroxybenzoic acid 6.14ā10-10 5.7 0.0 í2.28 39.41 í0.08 
46 Benzaldehyde 6.59ā10-4 4.9 0.8 í3.10 1.37 0.82 
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47 4-Acetylanisole 2.94ā10-5 7.0 0.0 í3.05 1.97 0.55 
48 Ethyl vanillin 5.97ā10-9 5.7 0.0 í3.68 3.09 1.32 
49 Vanillin 4.45ā10-9 2.8 0.0 í3.15 3.07 1.11 
50 Butyl alcohold 4.49ā10-4 0.3 0.93 í1.62 2.90 0.00 
51 Methyl salicylate 2.35ā10-4 13.3 0.3 í3.38 2.50 0.17 
52 Allyl acetate 1.11ā10-2 1.0 12.6 í2.20 1.85 0.37 
53 Chlorononane 3.84ā100 32.6 98.0 í6.04 9.56 0.68 
54 Bromobutane 9.31ā10-1 14.9 92.4 í4.34 6.60 0.95 
55 1-Iodohexane 1.11ā100 25.0 93.5 í6.14 0.73 1.62 
a The dimensionless Henry’s law constants in terms of airíwater partition coefficients, Kaw, at 28 °C were calculated employing our model84 as implemented in 
the ChemProp software, using experimental or predicted Kaw at 25 °C. The compound fraction in air, fa, was calculated through eq 3.9, sorption loss of the 
compounds, fs, was calculated through eq 3.10. The log EC50 denotes logarithmic effective compound concentration yielding 50% growth inhibition of the 
Tetrahymena pyriformis after 24 h exposure. Log Te quantifies the Logarithmic toxicity enhancement relative to narcotic toxicity (eq 3.14), and Hill slope refers 
to eq 3.6. b,dThe toxicity data of phenyl glycidyl ether and butyl alcohol are from our previous paper.44 cThe toxicity data of phenyl glycidyl ether is an 
unpublished data from my colleague Dr. Anja Laqua.  
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Table 4.3: Average values of skin sensitization potential and toxicity enhancement for different sensitization 
classifications. Rating each classification with log Te = 1 as a threshold for separating sensitizers from 
nonsensitizersa  
Sensitization 
classification 
n 
Average 
log EC3 
Average 
log Te 
Predicted classification 
Sensitizer Nonsensitizer Accuracy 
Strong (extreme ) 13 í3.27 2.22 13 0 100.0% 
Moderate 18 í1.67 1.34 14 4 77.8% 
Weak 11 í1.08 0.21 0 11 100.0% 
nonsensitizer 13 n.a. 0.42 4 9 69.2% 
a The Sensitization classification according to their EC3 values: extreme, < 0.1%; strong, 0.1 – 1%; moderate, 1 – 
10%; weak, 10 – 100%; and nonsensitizer = 100%;26 n = number of compounds. 
 
4.1.3 Log EC3 vs log Te 
 
Figure 4.2 illustrate a linear regression for all sensitizers (omitting all nonsensitizer for 
missing of their log EC3 values with outlier), with an acceptable statistical fitting r2 = 0.61 and s 
= 0.629. The matched skin sensitization (log EC3) with toxicity enhancement (log Te) suggested 
toxicity enhancement will be a useful parameter and can be used for predicting skin sensitization 
potential. Early research suggested that sensitizers should be categorized by their reactive 
mechanisms7 rather than by their chemical classes. In present research, all these allergic 
chemicals are categorized into five major different reaction mechanisms (Michael addition, 
Schiff base, acylation, SNAr and SN2).  
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Figure 4.2: log EC3, calculated according eq 3.1 not inclusion nonsensitizers for missing EC3 values, vs log Te, 
toxicity enhancement of test chemicals  
 
Correspondingly, the correlation of skin sensitization with toxicity enhancement is 
presented in Figures 4.3-4.8 for separated mechanistic domains, with higher r2 values as well as 
different slopes of log Te regression coefficient (see the Table 4.4). The different slopes of these 
mechanisms indicate a decreased sensitivity of toxicity enhancement to skin sensitization in a 
order SNAr > SN2 > acylation § Schiff base > aromatic Michael addition. It will be discussed 
below for each of the mechanisms.  
 
 
 
 
64 
Table 4.4. Linear regression of the sensitization potency, log EC3, against the toxicity enhancement, log Te, 
for allergic chemicals of different reaction mechanism domainsa 
Mechanism domains n a c r2 s 
  log EC3= a log Te + c   
All sensitizers 41 í0.88 (±0.11) í0.83 (±0.19) 0.61 0.629 
      
SNAr 9 í1.50 (±0.26) í0.23 (±0.53) 0.83 0.560 
SN2 9 í1.05 (±0.20) í0.78 (±0.25) 0.81 0.334 
Schiff base 7 í0.81 (±0.10) í0.89 (±0.12) 0.93 0.209 
Acylation 6 í0.83 (±0.16) í0.62 (±0.24) 0.87 0.258 
Aromatic Michael addition 7 í0.36 (±0.09) í1.16 (±0.09) 0.76 0.135 
Schiff base + Acylation 13 í0.77 (±0.09) í0.82 (±0.12) 0.87 0.244 
a Regression equations and associated statistics are given for different reaction mechanism domains. The slopes of 
toxicity enhancement, log Te, is denoted by a; c denotes intercept of the regression equation; n = number of 
compounds; r2 = squared correlation coefficient; s = standard error of estimate 
 
The SNAr mechanism has a steepest slope (í1.50) in comparison with the others reactive 
domains’ (Fig. 4.3), which means toxicity enhancement of SNAr mechanism induce large 
variations of sensitization potency. Indeed, simply seeing this sensitization class, 72.7% of them 
are strong (extreme) sensitizers, and others are two weak sensitizers (accounting for 18.2% of 
total). Skin sensitization coveres 3.8 orders of magnitude, but toxicity enhancement is only 2.2 
log units. There are two outliers, 2,4,6-trinitrobenzenesulfonic acid (9) and 2,4-
dinitrobenzenesulfonic acid (15), illustrated in Fig. 4.3 with triangle down. The possible reason 
is the low hydrophobicity of the two compounds, í1.71 and í1.53, respectively. Previous 
research suggested the hydrophobicity (log Kow) from í0.5 to 3 could help for eliciting skin 
sensitization.18 Thus, the lower hydrophobicity will decrease the bioavailability of the two 
compounds during LLNA testing,11,18 but will not have too much effect on toxicity enhancement. 
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(Indeed, both of them are shown unmatched higher toxicity enhancement) The other reason for 
2,4,6-trinitrobenzenesulfonic acid (9) presenting high toxicity enhancement is that three –NO2 
groups significantly increase toxicity enhancement.17  
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Figure 4.3: Log EC3 vs log Te for SNAr reactive mechanism chemicals (blue star (ƾ)), two triangles down (ź) 
indicated outliers excluding in the regression equation 
 
Seeing Table 4.4 and Figure 4.4, SN2 mechanism has the second steepest slope (í1.05) 
with omission of methyl methanesulfonate (34) as an outlier. The slope í1.05 indicates similar 
variable trend between log EC3 (from í0.72 to í2.82) and log Te (from í0.05 to 1.79). Methyl 
methanesulfonate (34) is a toxicity enhancement outlier due to the low log Kow (í0.66), which 
means high bioavailability in this bioassay but not in LLNA. Comparably, dimethyl sulfate (10) 
is supposed to has lower reactivity as well as toxicity enhancenment, but its higher log Kow (0.16) 
resulted in higher skin sensitization than methyl methanesulfonate. 1-Bromohexane (33) as 
another outlier shows a huge evaporation loss, and almost 75% loss of bromohexane was found 
after 5 min at room temperature.85 Indeed, 95.6% evaporative loss (fa) of 1-bromohexane was 
calculated in this bioassay. 
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Figure 4.4: Log EC3 vs log Te for SN2 reactive mechanism chemicals (triangle up (Ÿ)), two triangles down (ź) 
as outliers were not included in the regression equation 
 
Interestingly, the linear regressions of acylation and Schiff base reaction mechanisms have 
very similar slopes (í0.83 and í0.81, respectively) despite differences in the statistical fitting (r2 
= 0.87 vs 0.93), see Table 4.4 and Figures 4.5-4.6. The similar slopes indicate that variations of 
toxicity enhancement have same sensitivity to sensitization potency for both reactive 
mechanisms. Consequently, combined linear regression yields similar statistical coefficients 
(slops are í0.77 and r2 is 0.87) with an intermediate intercept (í0.82). Therefore, the new linear 
regression can be used for predicting skin sensitization for both reaction mechanisms, see Table 
4.4 and Figure 4.7. Glyoxal (23), an outlier, has high toxicity enhancement (log Te = 2.82) due to 
its high reactivity (cross linking reaction, scheme 4.1) and has low skin sensitization due to its 
low bioavailability (log Kow = í1.66). Compared with phenylacetaldehyde (24), both compounds 
belong to the Schiff base reaction mechanism and have almost the same skin sanitization 
potential (í1.62 vs í1.60). However, the difference of hydrophobicity between these two 
compounds is almost 3.5 logarithmic units (í1.66 vs 1.78).  
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Scheme 4.1: Cross linking reaction of Glyoxal via Schiff base mechanism 
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Figure 4.5: Log EC3 vs log Te for acyl transfer reactive mechanism chemicals (green cross (×)) 
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Figure 4.6: Log EC3 vs log Te for Schiff base reactive mechanism chemicals (yellow square (Ŷ)), triangle 
down (ź) as an outlier was not included in the regression equation  
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Figure 4.7: Log EC3 vs log Te for both acyl transfer reactive mechanism (green cross (×)) and Schiff base 
reactive mechanism chemicals (yellow square (Ŷ)) 
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Aromatic Michael acceptors has an unexpectedly small slope (í0.41) comparison with 
others reactive domains (Table 4.4 and Figure 4.8). This indicates that sensitization potential 
increases slightly with a significant increase of toxicity enhancement. The same trend had been 
reported in chemoassays test (slope of log kCys-peptide is í0.25)14,53 and quantum mechanics 
calculations (slope of EACT is 0.06).16 Furthermore, aliphatic Michael acceptors only yields a 
very poor linear regression with a slope of í0.23 and r2 = 0.11 (see section 4.4.2). Please keep in 
mind, aromatic and aliphatic Michael acceptors show same level of sensitivity to the skin 
sensitization, with same level of slops (í0.41 vs í0.23). Surprisingly, combined aromatic and 
aliphatic Michael acceptors are not yielding an improved linear regression (data not show). One 
explanation of low sensitivity to sensitization potency is that the anti-inÀammatory potency of 
Michael acceptors partially neutralizes their sensitization potency. And more, this specific anti-
inÀammatory potency increase with increasing reactivity, and is not detected with SNAr or SN2 
reactive sensitizers.53 The other explanation is that the high evaporation loss of Michael 
acceptors contributes to their reducing skin sensitizing ability.14,16  
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Figure 4.8: Log EC3 vs log Te for aromatic Michael addition reactive mechanism chemicals 
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4.1.4 Toxicity Enhancement for Nonsensitizers  
 
The compounds, with numbers from 43 to 55, are reported as being nonsensitizers in the 
LLNA. The toxicity enhancements for these compounds are observed. It is supposed that all of 
these compounds show narcotic toxicity only. However, results show that ethyl vanillin (48), 
vanillin (49), bromobutane (54) and 1-iodohexane (55) are excess toxic (log Te= 1.32, 1.10, 0.95 
and 1.62, respectively). The reactive capability indicates these four compounds have the 
potential to act as allergen.38  
Ethyl vanillin and vanillin, the possible prohaptens, had been confirmed that they can 
convert to more reactive compounds after appropriate biotransformation.86-87 Scheme 4.2 is 
illustrating a possible biotransformation to explain their excess toxicity in presented bioassay, 
although the carbonyl group present deactivation effect. Please keep in mind, biotransformation 
is an important factor for some allergic chemicals (especially for pro-hapten) inducing 
sensitization. Aptula et. al. had researched sensitization potency88 and high toxicity 
enhancement83 of aromatic chemicals with hydroxy, in which biotransformation of those 
chemicals plays an important role. For the rest outliers bromobutane (54) and 1-iodohexane (55), 
the evaporation loss will be the major reason for their nonsensitization.85 Indeed, bromobutane 
(54) and 1-iodohexane (55) are shown 92.4% and 93.5% evaporation loss (fa), respectively. Thus, 
bromobutane and 1-iodohexane show toxicity enhancement after correcting evaporation loss.  
Benzaldehyde (46) has a negative result in LLNA and reported as a classical nonsensitizer, 
but human repeat insult patch test indicate it is a sensitizer and equals to a moderate sensitization 
potential (EC3 value is 10%).60 And in this bioassay, benzaldehyde (46) not show a definitely 
toxicity enhancement (0.82), but it still shows a higher toxicity enhancement than others 
nonsensitizers. Moreover, 30 min bioluminescence inhibition and long term 24 h growth 
inhibition of benzaldehyde toward to Vibrio fischeri have the very similar toxicity enhancement 
with this bioassay, with log Te30 min of 0.83 and log Te24 h of 0.88, respectively. As the possible 
reaction mechanism of benzaldehyde is Schiff base formation, equation of Schiff base formation 
(see Table 4.4) is applied for prediction EC3 value of benzaldehyde and showed a moderate 
sensitization potential (EC3 value is 3%).  
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Scheme 4.2: Metabolic Transformation of Vanillin: 
 
4.1.5 Log Kow Effect the Potential of Sensitizers 
 
The bioavailability (hydrophobicity) is still an important factor, which is normally 
modelled by log Kow, although binding to skin protein is the rate-determining step at many 
hurdles for a chemical to induce skin sensitization. Previous research has documented that 
increasing hydrophobicity could increase the permeability of compounds at log Kow = 3.00 with 
no more influence at log Kow = 4.06 applying a series of n-alcohols.89 Moreover, Natsch applied 
log Kow as a surrogate for bioavailability in "battery approach" proposal to investigate the log 
Kow effect on the sensitization potential,18 in which chemicals’ log Kow either lower than í2 or 
higher than 5 is accounting for lower bioavailability, and chemicals with í0.5 < log Kow < 3 is 
accounting for higher bioavailability. In this research, the log Kow of tested compounds covers 
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over 7 orders of magnitude (from í1.71 to 5.12). Correspondingly, strong (with extreme) 
sensitizers, moderate sensitizers and nonsensitizers are observed higher bioavailability, which 
average log Kow are 1.26, 1.52 and 2.16, respectively, comparing with weak sensitizers (average 
log Kow is 4.09). While nonsensitization group has a valid hydrophobicity, but most of them lack 
reactivity, indeed most of them are not showing toxicity enhancement (log Te < 1, see Table 4.1 
and Figure 4.1).  
In Table 4.5, log Kow as a second regression parameter is applied to investigate 
contribution of hydrophobicity to sensitization potency. When modelled all sensitizers into one 
linear regression, hydrophobicity contributes to skin sensitization with superior statistical fitting 
(r2 = 0.72 and s = 0.541), comparing to the model without hydrophobicity (Table 4.4). Please 
keep in mind, the standard error of constant is huge and r2Inter is large. This confirms that 
hydrophobicity is another important factor for induction skin sensitization, and nonsensitizers 
lack reactivity or bioavailability.  
Previous investigations found that hydrophobicity (log Kow) contributes to sensitization 
potency for Schiff base10 and SN2 electrophiles,13 but not for SNAr17 and Michael addition 
electrophiles.14,53 In this research, however, hydrophobicity hardly contributes to sensitization 
potency for each reaction mechanisms (Table 4.5). Indeed, slopes of log Kow are either lesser 
than or almost equal to their standard errors for different reaction mechanisms, with no 
significant improvement of r2. No contribution of log Kow to sensitization potency in these linear 
regressions could be possibly explained by that: on one hand, log Te strongly correlate to log Kow 
(with up to 0.84 of r2Inter are observed), which means the contributions of hydrophobicity to skin 
sensitization could partly be neutralized by contributions from log Te; on the other hand, number 
of compounds are too low for using two regression parameters. The strong correlation between 
log Te and log Kow is because of Te relating to narcotic toxicity, which depends on 
hydrophobicity. Some Te data (to ciliate) exist for some sensitizers,8 which are combined with 
our Te data for extending the compounds’ number (see Figure 4.9). Michael acceptors number 
extends from 7 to 14, adding 5 pro-Michael acceptors and 2 Michael acceptors. However, 
regression coefficient reveals that there is not significant effect on skin sensitization in the 
models with or without hydrophobicity (data are not shown). This finding confirms that skin 
sensitization of Michael acceptors is only dependent on reactivity but not on hydrophobicity.14, 53 
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Smiliarlly, after extending acyl transfer electrophiles number from 6 to 10, hydrophobicity is still 
not important (data are not shown).  
 
Table 4.5: Linear regression of sensitization potency, log EC3, against the toxicity enhancement, log Te, with 
hydrophobicity, log Kow, for allergic chemicals of different reaction mechanism domainsa 
Mechanism domains n a b c r2 s r2Inter 
  log EC3= a log Te + b log Kow + c    
All sensitizers 41 í1.31 (±0.15) í0.29 (±0.08) 0.40 (±0.36) 0.72 0.541 0.81 
        
SNAr 9 í1.85 (±0.44) í0.34 (±0.34) 1.39 (±1.73) 0.85 0.561 0.85 
SN2 8 í1.14 (±0.36) í0.04 (±0.13) í0.60 (±0.65) 0.81 0.357 0.84 
Schiff base 7 í1.02 (±0.33) í0.11 (±0.16) í0.43 (±0.70) 0.94 0.221 0.93 
Acylation 6 í0.61 (±0.38) 0.12 (±0.18) í1.10 (±0.79) 0.89 0.279 0.88 
Aromatic Michael addition 7 í0.11 (±0.23) 0.12 (±0.11) í1.74 (±0.51) 0.82 0.130 0.88 
Schiff base + acylation 13 í0.76 (±0.26) 0.01 (±0.13) í0.84 (±0.54) 0.87 0.256 0.90 
a Regression equations and associated statistics are given for different reaction mechanism domains. The slopes of 
toxicity enhancement, log Te, and hydrophobicity, log Kow, are denoted by a and b, respectively; c denotes intercept 
of the regression equation; n = number of compounds; r2 = squared correlation coefficient; s = standard error of 
estimate; r2Inter = squared intercorrelation coefficient between log Te and log Kow. 
 
So far, we have no mechanistic explanation for the conflicting with literature reports that 
hydrophobicity contributes to skin sensitization for SNAr and Schiff base mechanisms. A 
possible explanation could be that for some of mechanism domains, the biological nucleophilic 
binding is involving in aqueous environment, and for others mechanism domains in the 
membrane lipid.14 
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Figure 4.9: Plot of log EC3 vs log Te of test chemicals combined with literature data (denoted by ƹ)8 
 
4.1.6 Conclusion  
 
The 24 h growth inhibition with Tetrahymena pyriformis is a useful tool for screening 
sensitization potency of allergic chemicals. Toxicity enhancement (Te) derived from chemicals 
binding to proteins and/or peptides can be used to discriminate sensitizers from weak or 
nonsensitizers. Moreover, the toxicity enhancement has the different sensitivity to sensitization 
potency for various reactive mechanism domains. In this context, we should separate aromatic 
from aliphatic MAs, and metabolic biotransformation should be considered during predicting 
nonsensitizers’ skin sensitization.  
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4.2 Application of Both Short and Long Term Bacterial Bioassays 
for Predicting Skin Sensitization Potency of Sensitizers 
4.2.1 Background  
 
In the last section, toxicity enhancement (Te) of allergic compounds toward Tetrahymena 
pyriformis had been confirmed a useful parameter for screening of skin sensitization potential of 
compounds. Moreover, short and long term toxicity with Vibrio fischeri widely useful tools had 
been employed to predict both toxicity and excess toxicity of chemicals45,55,90, although they are 
certainly two different endpoints.  
Here, short and long term toxicity for chemicals to Vibrio fischeri were determined and 
used corresponding toxicity enhancement for estimating skin sensitization potency. The 
interspecies toxicity enhancement correlations of bacteria (Vibrio fischeri) and ciliate 
(Tetrahymena pyriformis) and inter-endpoints correlations of 24 h growth and 30 min 
bioluminescence inhibition are developed and the robust linear regressions indicate that 
correlations can be employed in toxicity enhancement extrapolation through different species or 
endpoints.  
 
4.2.2 Short and Long Term Toxicity Enhancement Toward Vibrio fischeri 
 
Physicochemical properties and short term (30 min bioluminescence inhibition) and long 
term (24 h growth inhibition) toxicity with associated toxicity enhancement (Te) of 55 test 
chemicals toward Vibrio fischeri are presented in Tables 4.1 and 4.6. Interestingly, with log Kow 
covering 6.83 fold range (from í1.71 to 5.12), the Te for both short and long term assays varies 
4.97 and 3.59 orders of magnitude, respectively, indicating short-term toxicity slightly more 
sensitive for eliciting toxicity enhancement. Correspondingly, these tested chemicals only 
possess 4.10 log units for their sensitization potency (log EC3 í4.82 to í0.72, omitting 
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nonsensitizers), which could better match with Te for these two bioassays. Indeed, log Te30 min 
versus log EC3 and log Te24 h versus log EC3 obtain two linear regressions for 30 min 
bioluminescence (Figure 4.10) and 24 h growth inhibition (Figure 4.11). As mentioned in section 
4.1.3, sensitizers should be categorized by their reactive mechanisms,7 rather than by their 
chemical classes. These allergic chemicals belong to five reaction mechanisms. Correspondingly, 
five linear regressions for each reaction mechanism are summarized in Table 4.7 and Figure 4.12 
(log EC3 vs log Te30 min) and Table 4.8 and Figure 4.13 (log EC3 vs log Te24 h), respectively. 
Inspection of two tables show that each reaction mechanism yields improved statistical fitting 
and variation of slopes, which means the different reaction mechanism has different sensitivities 
to skin sensitization. The details of this discussion are given in section 4.2.3.  

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Table 4.6: Test Set of 55 Chemicals with their physicochemical properties, sensitization potency information, toxicity and toxicity enhancement of 30 
min bioluminescence and 24 h growth inhibition with Vibrio fischeri 
Number Name Kaw (25 °C)a fa30 min [%] fa24 h [%] 
log EC5030 min 
[M] 
log Te30 min 
log EC5024 h 
[M] 
log Te24 h 
1 Chlorothalonil 8.17ā10-5 0.0 0.1 í6.89 2.96 í6.17 3.01 
2 1-Fluoro-2,4-dinitrobenzene 4.00ā10-6 0.0 0.0 í4.86 2.16 í4.90 2.68 
3 1-Chloro-2,4,6-trinitrobenzene 1.00ā10-8 0.0 0.0 í4.05 1.09 í3.36 0.94 
4 2, 4-Dinitrophenyl thiocyanate 5.56ā10-9 0.0 0.0 í6.25 3.33 í4.97 2.59 
5 1-Chloro-2,4-dinitrobenzene 1.15ā10-4 0.0 0.1 í4.87 1.83 í4.26 1.78 
6 1-Brome-2,4-dinitrobenzene 1.36ā10-6 0.0 0.0 í4.75 1.36 í4.67 1.91 
7 1-Iodo-2,4-dinitrobenzene 7.93ā10-7 0.0 0.0 í5.00 1.31 í4.43 1.47 
8 Glutaraldehyde 4.49ā10-6 0.0 0.0 í4.82 4.15 í3.286 2.62 
9 2,4,6-Trinitrobenzenesulfonic acid 6.33ā10-15 0.0 0.0 í1.80 2.68 í1.50 2.01 
10 Dimethyl sulfate 1.06ā10-4 0.0 0.1 í2.76 1.75 í4.22 3.29 
11 2-Oxetanone 3.16ā10-3 1.1 3.9 í2.19 2.15 í2.86 2.67 
12 Phenyl glycidyl etherb 3.36ā10-5 0.0 0.0 í4.09 1.62 í4.00 1.94 
13 Bisphenol A diglycidyl ether 1.79ā10-9 0.0 0.0 í6.04 1.31 í4.98 1.21 
14 2-Methyl-3,1-benzoxaza-4-one 1.41ā10-4 0.0 0.2 í3.17 1.49 í3.41 1.96 
15 2,4-Dinitrobenzenesulfonic acid 1.60ā10-12 0.0 0.0 í2.01 2.71 í2.23 2.60 
16 1-Phenyl-1,2-propanedione 1.60ā10-6 0.0 0.0 í3.60 1.62 í3.21 1.55 
17 Mercaptobenzothiazole 1.48ā10-6 0.0 0.0 í5.83 2.53 í4.66 1.99 
18 Diethylsulfate 1.88ā10-4 0.1 0.2 í2.97 0.97 í2.48 0.79 
19 Benzyl glycidyl ether 6.17ā10-6 0.0 0.0 í2.90 0.72 í3.08 1.26 
20 4-Vinylpyridine 3.30ā10-4 0.0 0.4 í4.13 1.56 í3.80 1.67 
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21 Propylidenephthalide 3.99ā10-3 1.4 4.9 í3.41 0.51 í3.77 1.40 
22 Cinnamaldehyde 6.54ā10-5 0.0 0.1 í4.23 1.46 í3.86 1.59 
23 Glyoxal 1.51ā10-5 0.0 0.0 í2.24 3.06 í2.92 3.39 
24 Phenylacetaldehyde 2.24ā10-4 0.1 0.3 í4.06 1.42 í3.40 1.22 
25 Benzylideneacetone 4.78ā10-5 0.0 0.1 í4.49 1.55 í4.09 1.69 
26 2-Methyl-3-phenylacrolein 1.03ā10-4 0.0 0.1 í3.86 0.62 í3.21 0.57 
27 Dihydrocoumarin 1.29ā10-3 0.4 1.6 í3.19 1.36 í2.78 1.23 
28 10-Undecenal 2.64ā10-2 8.5 25.6 í5.87 0.86 í4.44 0.45 
29 2-phenylpropanal 2.97ā10-4 0.1 0.4 í3.99 1.16 í2.97 0.65 
30 Edaravone 3.69ā10-6 0.0 0.0 í2.61 í0.82 í3.22 0.44 
31 Hexyl cinnamic aldehyde 4.25ā10-4 0.1 0.5 n.a n.a í4.57 0.05 
32 Į-Amyl cinnamic aldehyde 3.19ā10-4 0.1 0.4 n.a n.a í3.95 í0.20 
33 1-Bromohexane 1.34ā100 82.4 94.6 í5.34 0.65 í4.19 0.45 
34 Methyl methanesulfonate 1.65ā10-4 0.1 0.2 í1.69 1.51 í3.34 3.04 
35 Pentachlorophenol 1.00ā10-6 0.0 0.0 í5.26 í0.76 í5.07 0.32 
36 Benzyl cinnamate 1.36ā10-5 0.0 0.0 n.a n.a í3.87 í0.06 
37 Benzyl benzoate 1.14ā10-4 0.0 0.1 í4.74 í0.12 í4.54 0.68 
38 Lilial 1.02ā10-3 0.4 1.3 í5.31 0.06 í4.37 0.21 
39 Diphenylcarboxylate 5.23ā10-4 0.2 0.7 í4.27 í0.21 í4.28 0.71 
40 2,4-Dichloronitrobenzene 4.78ā10-4 0.2 0.6 í3.41 í0.54 í3.67 0.50 
41 Cyclamen aldehyde 7.68ā10-4 0.3 1.0 í5.00 0.20 í3.92 0.10 
42 Phenylethyl isovalerate 1.80ā10-3 0.6 2.3 í4.69 í0.17 í4.35 0.48 
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43 Methylparaben 1.47ā10-7 0.0 0.0 í4.03 1.20 í2.87 0.55 
44 Salicylic acid 3.00ā10-7 0.0 0.0 í3.19 0.06 í3.16 0.61 
45 4-Hydroxybenzoic acid 2.85ā10-10 0.0 0.0 í2.4 -0.05 í2.46 0.44 
46 Benzaldehyde 1.09ā10-3 0.4 1.4 í3.18 0.83 í2.83 0.88 
47 4-Acetylanisole 2.37ā10-5 0.0 0.0 í3.99 1.38 í2.72 0.57 
48 Ethyl vanillin 4.49ā10-9 0.0 0.0 í3.85 1.40 í3.22 1.19 
49 Vanillin 8.78ā10-8 0.0 0.0 í3.46 1.39 í2.83 1.09 
50 Butyl alcoholc 3.60ā10-4 0.1 0.5 í1.74 0.00 í1.49 0.00 
51 Methyl salicylate 4.01ā10-3 1.4 5.0 í3.22 í0.20 í3.11 0.33 
52 Allyl acetate 5.23ā10-3 1.8 6.4 í2.88 1.05 í2.00 0.44 
53 chlorononane 3.23ā100 91.9 97.7 í6.95 1.03 í5.81 1.14 
54 bromobutane 3.56ā10-1 55.5 82.2 í3.35 í0.28 í2.79 í0.14 
55 1-Iodohexane 1.15ā100 80.1 93.7 í6.01 1.07 í5.09 1.16 
a Kaw, dimensionless Henry’s law constants in terms of airíwater partition coefficients, at 25 °C were calculated employing our model as implemented in the 
ChemProp software, using experimental or predicted Kaw at 25 °C. The compound fraction in air, fa, was calculated through eq 3.9. Log EC5030 min denotes 
logarithmic effective compound concentration after 30 min exposure yielding 50% bioluminescence inhibition of Vibrio fischeri, log EC5024 h denotes logarithmic 
effective compound concentration yielding 50% growth inhibition of Vibrio fischeri after 24 h exposure, log Te30 min and log Te24 h quantify the logarithmic 
toxicity enhancement relative to narcotic toxicity for 30 min bioluminescence and 24 h growth inhibition (eq 3.14). n.a. denotes not available because if their 
lower water solubility. b,cThe data set of phenyl glycidyl ether and butyl alcohol were cited our previous paper55 
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Figure 4.10: Log Te30 min, toxicity enhancement of test chemicals to 30 min bioluminescence inhibition with 
Vibrio fischeri, vs log EC3, calculated according eq 3.1 
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Figure 4.11: Log Te24 h, toxicity enhancement of test chemicals to 24 h growth inhibition with Vibrio fischeri, 
vs log EC3, calculated according eq 3.1 
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Figure 4.12: Skin sensitization potency (log EC3) vs toxicity enhancement (log Te30 min) to 30 min 
bioluminescence inhibition for different reaction mechanism domains. Figure A (triangle up (Ÿ)) denotes SN2 
formation, and triangle down (ź) mean outliers. Figure B (blue star (ƾ)) denotes SNAr formation, and 
triangle down (ź) means outlier. Figure C (green cross (×)) denotes acylation formation. Figure D (yellow 
square (Ŷ)) denotes Schiff base formation. Figure E (× and Ŷ) denotes acylation and both Schiff base 
formation. 
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Figure 4.13: Skin sensitization potency (log EC3) vs toxicity enhancement (log Te30 min) to 30 min 
bioluminescence inhibition for different reaction mechanism domains. Figure A (triangle up (Ÿ)) denotes SN2 
formation, and triangle down (ź) mean outliers. Figure B (blue star (ƾ)) denotes SNAr formation, and 
triangle down (ź) means outlier. Figure C (green cross (×)) denotes acylation formation. Figure D (yellow 
square (Ŷ)) denotes Schiff base formation. Figure E (black circle (Ɣ)) denotes Michaela addition formation. 
Figure F (× and Ŷ) denotes acylation and both Schiff base formation.  
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Agreement with the trend of toxicity enhancement of these chemicals toward Tetrahymena 
pyriformis, strong (and extreme) skin sensitizers yield higher Te (with average log Te30 min = 2.14 
and log Te24 h = 2.22, respectively) than moderate skin sensitizers (with average log Te30 min = 
1.34 and log Te24 h = 1.49, respectively), see Table 4.9. Contrarily, no toxicity enhancement are 
observed in weak or no sensitizers groups as expected (average log Te30 min and log Te24 h are 
lower than 1), due to a lack of reactivity for these compounds. As the same with in section 4.1.2, 
employing Te = 10 as a cut-off to discriminate sensitizers (strong and moderate) from weak 
sensitizers or nonsensitizers, where strong (and extreme) sensitizers yield 100% accuracy for 
both assays (log Te24 h = 0.94 of chemical 3 is very close to 1), moderate sensitizers yield 72.2% 
accuracy for both assays, weak sensitizers show 100% accuracy for both assays and 
nonsensitizers have 46.2% (30 min) and 84.6% (24 h) accuracy, respectively, see Table 4.9.  
Table 4.7: Linear regression of the sensitization potency, log EC3, against the 30 min bioluminescence 
inhibition toxicity enhancement, log Te30 min, for allergic chemicals of different reaction mechanism domainsa 
Mechanism domains n a c r2 s 
  log EC3= a log Te30 min + c   
All chemicals 38 í0.59 (±0.11) í1.36 (±0.18) 0.44 0.755 
   
Schiff base 7 í0.51 (±0.05) í0.93 (±0.09) 0.95 0.171 
Acylation 6 í0.47 (±0.17) í1.39 (±0.21) 0.66 0.421 
SNAr 9 í0.77 (±0.15) í1.86 (±0.32) 0.78 0.627 
SN2 8 í1.00 (±0.14) í0.95 (±0.13) 0.91 0.246 
Schiff base + acylation 13 í0.45 (±0.08) í1.21 (±0.13) 0.74 0.351 
a Regression equations and associated statistics are given for different reaction mechanism domains. The slopes of 
30 min bioluminescence inhibition toxicity enhancement, log Te30 min, is denoted by a; c denotes intercept of the 
regression equation; n = number of compounds; r2 = squared correlation coefficient; s = standard error of estimate 
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Table 4.8: Linear regression of the sensitization potency, log EC3, against the 24 h growth inhibition toxicity 
enhancement, log Te24 h, for allergic chemicals of different reaction mechanism domainsa 
Mechanism domains n a c r2 s 
  log EC3= a log Te24 h + c   
All chemicals 41 í0.71 (±0.12) í1.08 (±0.20) 0.49 0.776 
 
Aromatic Michael addition 7 í0.26 (±0.05) í1.26 (±0.06) 0.84 0.107 
Schiff base 7 í0.79 (±0.06) í0.91 (±0.10) 0.98 0.122 
Acylation 6 í0.76 (±0.13) í0.68 (±0.27) 0.90 0.232 
SNAr 9 í1.25 (±0.16) í0.83 (±0.32) 0.89 0.434 
SN2 9 í0.65 (±0.16) í0.94 (±0.25) 0.71 0.408 
Schiff base + acylation 13 í0.72 (±0.07) í0.85 (±0.10) 0.90 0.218 
a Regression equations and associated statistics are given for different reaction mechanism domains. The slopes of 
24 h growth inhibition toxicity enhancement, log Te24 h, is denoted by a; c denotes intercept of the regression 
equation; n = number of compounds; r2 = squared correlation coefficient; s = standard error of estimate 
 
Possible explanation for the low accuracy of nonsensitizers are metabolic transformation of 
some nonsensitizers to more reactive compounds and volatilization loss of the compounds.85 
Methylparaben (43), 4-ecetylanisole (47), ethyl vanillin (48) and vanillin (49) are lacking skin 
sensitization potency because of their higher activation energy.33 However, these compounds 
with methoxy group in meta and para position could be demethylated, and hydroxyl could be 
oxidized to carbon-oxygen double bond,33,37 which could form covalent bonds with nucleophiles 
via Michael addition formation, as illustrated in Scheme 4.3. Therefore, these compounds show 
toxicity enhancement in the present bioassays.  
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Scheme 4.3: Metabolic Transformation of Aromatic aldehyde, ketone and ester 
 
Although QSAR Toolbox suggests that allyl acetate (52) could react with nucleophiles 
through SN2 reaction mechanism, carboxylate ion is not a good leaving group to elicit skin 
sensitization.91 However, its toxicity enhancement observed in short term assay (log Te30 min = 
1.05) would be explained by two possible biotransformation in organism, which had been 
illustrated before.45 One pathway is allyl acetate hydrolysis catalyzed to acrylic acid and allyl 
alcohol, which is biotransformed further to an Į,ȕ-unsaturated aldehyde activated as Michael 
acceptor (Scheme 4.4, right). The other pathway is the terminal unsaturated bond of allyl acetate 
catalyzed by the monooxygenase cytochrome P450 (Scheme 4.4, left), yielding an epoxide 
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which bonds with nucleophiles through SN2 type ring-opening reactions. Interestingly, 
methylparaben (43), 4-acetylanisole (47) and allyl acetate (52) are observed toxicity 
enhancement in short term assay but not in long term assay (ciliate and bacteria), indicating short 
term assay (30 min bioluminescence inhibition) has different toxic cause comparing with long-
term assay and is easily eliciting toxicity enhancement. 
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Scheme 4.4: Metabolic Transformation of allyl acetate. Top: Allyl acetate is enzyme-catalyzed hydrolysis 
through carboxylesterase (CES) and obtaining acetic acid and allyl alcohol. Then, allyl alcohol is oxidized by 
alcohol dehydrogenase (ADH), and the oxide, acrolein, is readily binding to endogenous nucleophiles (NuH) via 
Michael addition (Right). Allyl acetate could also be oxidized at terminal double bond by cytochrome P450, 
followed by reacting with endogenous nucleophiles via SN2-type ring-opening reaction mechanism (Left) 
 
For the rest outliers chlorononane (53) and 1-iodohexane (55), the volatilization loss will 
be the major reason for their nonsensitization.85 Indeed, chlorononane (53) showed 91.9% (30 
min) and 97.9% (24 h) volatilization loss (fa) in these two bioassays, respectively. And 1-
iodohexane (55) showed 80.1% (30 min) and 93.7% (24 h) volatilization loss (fa), respectively. 
Thus, chlorononane (53) and 1-iodohexane (55) are obsreved toxicity enhancement after 
correcting for evaporation loss. As mentioned in section 4.1.3, benzaldehyde (46) is a sensitizer 
according to the human data, but a nonsensitizer in LLNA.60 And in these bioassays, 
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benzaldehyde presents a similar toxicity enhancement potential (0.83 for 30 min test and 0.88 for 
24 h test) toward Vibrio fischeri with toward Tetrahymena pyriformis (0.82). Moreover, it has 
been predicted as a moderate sensitizer in section 4.14 and shows a higher toxicity enhancement 
than others nonsensitizers in these bioassays.  
Table 4.9: The average log Kow, log Te (for 30 min bioluminescence and 24 h growth inhibition), log EC3 
values and accuracy (for 30 min bioluminescence and 24 h growth inhibition; employing Te = 10 as a cutoff) 
of different sensitization potency classes 
Sensitization 
Potency 
n 
Average log 
EC3  
Average log 
Te30 min 
Average 
log Te24 h 
Predicted classification 
Accuracy (30 min) Accuracy (24 h) 
Strong (extreme) 13 í3.27 2.14 2.22 100.0% 100.0% 
Moderate 18 í1.67 1.34 1.49 72.2% 72.2% 
Weak 11 í1.08 í0.11a 0.29 100.0% 100.0% 
Nonsensitization 13 n.a. 0.68 0.64 46.2% 69.2% 
a The number set of accuracy log Te30 min for weak sensitizers subgroup is 8 since three missing data. n.a. denotes not 
available 
 
4.2.3 Variations of Sensitivity to Skin Sensitization Potency for Five Reaction 
Mechanisms 
 
Comparison with regression coefficient of the models of log Te vs log EC3 for all 
compounds to Tetrahymena pyriformis and Vibrio fischeri (slops is í0.88, í0.77 and í0.59, 
respectively), it seem an order of decreased sensitivity to skin sensitization is 24 h growth 
inhibition (Tetrahymena pyriformis) > 24 h growth inhibition (Vibrio fischeri) > 30 min 
bioluminescence inhibition (Vibrio fischeri) (Figure 4.14, left light blue arrow). This trend is 
confirming usual understanding that long-term assay would be supposed to suggest a high 
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sensitivity to toxicological endpoint, and the result confirms that short term and long term 
toxicity are certainly two different endpoints.55  
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Figure 4.14: Comparison with sensitivity and contribution of five reactive mechanisms, black circle (Ɣ) 
denotes Michaela addition formation, yellow square (Ŷ) denotes Schiff base formation, green cross (×) 
denotes acylation formation, blue star (ƾ) denotes SNAr formation and red triangle up (Ÿ) denotes SN2 
formation, to skin sensitization with increased order (seeing top red arrow) and different sensitivity of three 
assays (30 min bioluminescence (bacteria), 24 h growth (bacteria) and 24 h growth inhibition (ciliate)) to skin 
sensitization with decreased order (seeing right light blue arrow) through their different slopes 
 
As the different reaction mechanism domains are showen various regression coefficients of 
toxicity enhancement, equation 4.1 is used for categorizing the different levels of sensitivity of 
these reaction mechanisms to skin sensitization.  
Most of chemicals in SNAr mechanism are strong (or extreme) sensitizers and show high 
skin sensitization potency (log EC3 covering 3.84 orders of magnitude), which means most of 
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them possess high reactivity. Expectedly, SNAr mechanism yields high sensitivity to 
sensitization potency for growth inhibition toward Tetrahymena pyriformis and Vibrio fischeri, 
seeing Figure 4.14. However, we have no mechanistic explanation why SNAr electrophiles show 
only moderate level of sensitivity to sensitization potency in 30min bioluminescence bioassay.  
 
Slope < 0.5:  low sensitivity  
0.5  slope  1.0: moderate sensitivity  
Slope > 1.0:  high sensitivity                                                                         (4.1) 
 
Interestingly, SN2 electrophiles show a moderate sensitivity to skin sensitization during 24 
h growth inhibition assay to bacteria, with a moderate slopes (í0.65). Whereas, its steeper slopes 
are determined within 24 h growth inhibition to ciliate and 30 min bioluminescence inhibition to 
bacteria, indicating high sensitivity to skin sensitization potency. The difference of toxicity 
enhancement observed in different organisms had been reported before.44 
The almost overlapping slopes for Schiff base and acylation mechanisms reveal these two 
different mechanisms have parallel moderate sensitivity to sensitization potency, see Fig 4.14. 
Furthermore, as discussed in above, skin sensitization potency of Schiff base electrophiles and 
acyl electrophiles can be predicted by one linear regression, because of their similar statistical 
coefficients. Table 4.10 exhibits the models with combined Schiff base and acylation 
mechanisms for three bioassays, in which 24 h growth inhibition bioassays to ciliate and bacteria 
reveal almost same moderate sensitivity to skin sensitization (slope í0.77 vs í0.72; intercept 
í0.82 vs í0.85; r2 0.87 vs 0.90; s 0.244 vs 0.218). Compared with long term bioassay, short term 
bioassay has only lower sensitivity to skin sensitization (according to Equation 4.1).  
Michael addition mechanism seems showed the lowest sensitivity to sensitization potency, 
compared with the others reaction mechanisms. Indeed, the slopes are pretty lower (í0.41 to 
ciliate and í0.26 to bacteria). David W. Roberts et .al. also found this trend for Michael acceptor 
electrophiles employing a high through put kinetic pro¿ling (HTKP) approach with a low slope 
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of log k (0.24).14 The significantly low sensitivity is causing for anti-inÀammatory potency, 
which is particularly observed for Michael acceptors but not for others mechanisms.53 Sensitivity 
of 30 min bioluminescence inhibition to skin sensitization are unknown for the partly missing 
data of log Te30 min. However, previous research confirmed that 24 h growth inhibition presents 
higher sensitivity than 30 min bioluminescence inhibition employing 14 Į,ȕ-unsaturated esters.45 
Furthermore, an early investigation suggests Michael acceptors has slightly lower slope than 
Schiff base formation during bioluminescence inhibition assay.90 Thus slope of Michael 
acceptors is supposed to be lower than Schiff base and reveals a lower sensitivity to sensitization 
potency. 
 
Table 4.10: Linear regression of Tetrahymena pyriformis and Vibrio fischeri toxicity enhancement, log Te30 min 
and log Te24 h, against the skin sensitization potency, log EC3, combined Schiff base and acylation mechanism 
together 
Different assays n a b r2 s 
  log EC3= a log Te + b   
24 h growth inhibition (ciliate) 13 í0.77 (±0.08) í0.82 (±0.11) 0.87 0.244 
24 h growth inhibition (bacteria) 13 í0.72 (±0.07) í0.85 (±0.10) 0.90 0.218 
30 min bioluminescence inhibition (bacteria) 13 í0.45 (±0.08) í1.21 (±0.13) 0.74 0.351 
 
 
4.2.4 Contribution of log Kow to Skin Sensitization Potency 
 
Inspection of Tables 4.11 and 4.12 shows that skin sensitization depends both on reactivity 
and on hydrophobicity in short and long term bioassays, modelling all chemicals together. 
Although standard error of constant and r2Inter are large, r2 as well as s are improved. This finding 
is same with finding in section 4.15 that hydrophobicity contribute to skin sensitization potency. 
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Moreover, considering the models with or without hydrophobicity indicates that contributions 
from hydrophobicity and reactivity are dependent.  
Interestingly, the hydrophilic contributions are disappeared after classified these 
compounds into different reaction mechanisms (Tables 4.11 and 4.12). Either slopes of log Kow 
are positive, or standard errors for those regression coefficients are too larger. As same as in 
section 4.1.5, the numbers of compounds are too small to obtain correct regression results. 
Excepting SNAr mechanism, the others are observed r2Inter up to 0.72 that means log Kow strongly 
correlate with log Te and not contribute to skin sensitization. Although, short and long term 
assays have differently toxic causes (physiological causes for long term and metabolic 
performance for short term)55, they show same result that skin sensitization is decided by 
compounds’ reactivity only. The result conflict with literature findings for SNAr17 and Michael 
addition reaction mechanisms14,53 that skin sensitization is dependent both on reactivity and on 
hydrophobicity. This conflict is possibly because of the different measuring produce between 
bioassay and chemoassay as well as in silico method. In literatures, reactivity of sensitizers is 
obtained not considering log Kow. In this research, however, reactivity modelled by log Te 
correlate with log Kow, detailed by log Te is affected by toxicity enhancement and narcotic 
toxicity that is considering with log Kow.  
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Table 4.11: Linear regression of Vibrio fischeri 30 min bioluminescence inhibition toxicity enhancement, log 
Te30 min, against the skin sensitization potency, log EC3, with hydrophobicity, log Kow, modela 
Mechanism 
domains 
n a b c r2 s r2Inter 
  log EC3= a log Te30 min + b log Kow + c    
All chemicals 38 í0.78 (±0.14) í0.21 (±0.09) í1.31 (±0.40) 0.51 0.717 0.82 
    
SNAr 9 í0.94 (±0.17) í0.23 (±0.14) í1.04 (±0.56) 0.85 0.560 0.56 
SN2 8 í0.99 (±0.19) 0.003 (±0.09) í0.97 (±0.36) 0.91 0.269 0.72 
Acylation 6 í0.02 (±0.36) 0.37 (±0.26) í2.29 (±0.67) 0.66 0.378 0.93 
Schiff base 7 í0.47 (±0.12) 0.03 (±0.10) í1.06 (±0.40) 0.95 0.188 0.84 
Schiff base + 
acylation 
13 í0.23 (±0.11) 0.21 (±0.08) í1.86 (±0.28) 0.84 0.289 0.83 
a Regression equations and associated statistics are given for different reaction mechanism domains. The slopes of 
toxicity enhancement, log Te, and hydrophobicity, log Kow, are denoted by a and b, respectively; c denotes intercept 
of the regression equation; n = number of compounds; r2 = squared correlation coefficient; s = standard error of 
estimate 
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Table 4.11: Linear regression of Vibrio fischeri 24 h growth inhibition toxicity enhancement, log Te24 h, against 
the skin sensitization potency, log EC3, under with hydrophobicity, log Kow, modelsa 
Mechanism 
domains 
n a b c r2 s r2Inter  
  log EC3= a log Te24 h + b log Kow + c     
All chemicals 41 í0.98 (±0.17) í0.20 (±0.10) í0.28 (±0.46) 0.54 0.688 0.76  
     
SNAr 9 í1.31 (±0.19) í0.08 (±0.01) í0.54 (±0.50) 0.90 0.447 0.14  
SN2 9 í0.61 (±0.24) 0.04 (±0.15) í1.09 (±0.67) 0.71 0.438 0.84  
Acylation 6 í0.61 (±0.32) 0.09 (±0.17) í1.03 (±0.71) 0.91 0.257 0.87  
Schiff base 7 í0.98 (±0.14) í0.11 (±0.07) í0.41 (±0.31) 0.98 0.110 0.90  
Aromatic 
Michael addition 
7 í0.25 (±0.23) 0.01 (±0.15) í1.23 (±0.66) 0.85 0.120 0.95  
Schiff base + 
acylation 
13 í0.79 (±0.21) í0.04 (±0.11) í0.70 (±0.47) 0.90 0.227 0.91  
a Regression equations and associated statistics are given for different reaction mechanism domains. The slopes of 
toxicity enhancement, log Te, and hydrophobicity, log Kow, are denoted by a and b, respectively; c denotes intercept 
of the regression equation; n = number of compounds; r2 = squared correlation coefficient; s = standard error of 
estimate 
 
Is hydrophobicity important in the model for predicting skin sensitization? 
Theoretically, hydrophobicity is important to induce skin sensitization, because of 
hydrophobicity is used to model sensitizers’ bioavailability during in sensitization process. 
Previous investigations suggest that sensitizer has to penetrate into skin firstly and then it can 
bind to skin proteins. Therefore, a nonsensitizer could be either lack reactivity (binding to skin 
proteins) or lack bioavailability (penetration into skin) to induce sensitization. In principle, we 
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can predict compounds’ skin sensitization potency according to a general equation 4.2 obtained 
from these bioassays.  
 
 ͵ ൌ ܽଵ  ௘ܶ ൅ ܿଵ     (4.2) 
 
Thus, if two different hydrophobic compounds have identical toxicity enhancement (log Te), and 
they could be have a same predicted skin sensitization potency (log EC3). However, the higher 
hydrophobic compound has a higher reactivity as compared to the lower hydrophobic compound, 
because of increasing of log Kow will decrease log Te. It is widely accepted that a higher reactive 
compound should be shown a higher skin sensitization comparing with the lower reactive 
compound. This is conflicting with the equation 4.2. Therefore, hydrophobicity is important in 
the model to correct the misprediction by equation 4.2. When we combine the hydrophobicity to 
equation 4.2, we donot observed contribution of hydrophobicity to skin sensitization.  
Why is hydrophobicity not contributing skin sensitization in these bioassays? Toxicity 
enhancement is used to predict skin sensitization and dependent on hydrophobicity, illustrating 
as following equations. 
 
 ௘ܶ ൌ  ൫ହ଴௡௔௥௖ ହ଴௘௫௣Τ ൯ ൌ  ହ଴௡௔௥௖ െ  ହ଴௘௫௣  (4.3) 
 
 ହ଴௡௔௥௖ ൌ ܽଶ ܭ௢௪ ൅ ܿଶ    (4.4) 
 
Integration of equations 4.3 and 4.4 obtains equation 4.5. 
 
 ௘ܶ ൌ ሺܽଶ ܭ௢௪ ൅ ܿଶሻ െ ହ଴௘௫௣    (4.5) 
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Compared with logEC50 narc, logEC50 exp normally has a lower value, indicating its higher toxicity 
causing chemicals’ reactivity. Correspondingly, the average slope of logEC50 exp is lower than 
slope of logEC50 narc, although the correlation coefficient is pretty poor. Thus, the logEC50 exp can 
be expressed using equation 4.6. 
 
 ହ଴௘௫௣ ൌ ܽଷ ܭ௢௪ ൅ ܾଷ ܴ ൅ ܿଷ    (4.6) 
(Log R denotes logarithm of reactivity of chemicals) 
 
Correspondingly, a new equation 4.7 for toxicity enhancement (log Te) is obtained through 
integrating equations 4.5 and 4.6, illustrating in Figure 4.15.  
 
 ௘ܶ ൌ ሺܽଶ ܭ௢௪ ൅ ܿଶሻ െ ሺܽଷ ܭ௢௪ ൅ ܿଷሻ െ ܾଷ ܴ 
ൌ ሺܽଶ െ ܽଷሻ ܭ௢௪ ൅ ሺܿଶ െ ܿଷሻ െ ܾଷ  ܴ ൌ ܽସ ܭ௢௪ െ ܾସ ܴ ൅ ܿସ  (4.7) 
 
Thus,  
  ͵ ൌ ܽଵ  ௘ܶ ൅ܿଵ ൌ ܽଵ ൈ ܽସ ܭ௢௪ െ ܽଵ ൈ ܾସ ܴ ൅ ܽଵ ൈ ܿସ ൅ ܿ 
ൌ  ܭ௢௪ ൅   ܴ ൅      (4.8) 
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Figure 4.15: Toxicity enhancement is dependent on two parts. One part is chemical’s reactivity denoting as 
log R (logarithm of reactivity). The other part is hydrophobicity denoting as log Kow. 
 
Log Kow is usually modelling bioavailability applied to investigate contribution of 
bioavailability to sensitization potency. Thus, log Kow is adding into equation 4.8 to investigate 
contribution from bioavailability, obtaining equation 4.9. An overlapping hydrophobic 
contribution from bioavailability (D log Kow) and toxicity enhancement (A log Kow) could be a 
possible reason why bioavailability not reveals contribution to skin sensitization potency, as 
illustration in Figure 4.16. 
 
 ͵ ൌ ܽଵ  ௘ܶ ൅ܿଵ ൅  ܭ௢௪ 
ൌ  ܭ௢௪ ൅   ܴ ൅  ܭ௢௪ ൅     (4.9) 
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Figure 4.16: Schematic explanation of why added log Kow (modelling bioavailability) not contributes skin 
sensitization. Log R denotes logarithm of reactivity of chemicals. The shaded area means the overlapping 
hydrophobic contribution from bioavailability and toxicity enhancement.   
 
Compared with bioassay, chemoassay will not be influenced by these overlapping 
contributions, because of chemicals’ reactivity can be measured directly and not be influenced by 
bioavailability or biometabolism.  
 
4.2.5 Interspecies and Inter-endpoints Relationships  
 
Interspecies relationship: Interspecies toxicity correlations is a good tool that could be 
applied to estimate contaminants’ toxicity through toxicity date available for other species.90 In 
this investigation, a linear regression of toxicity enhancement (Te) for 24 h growth inhibition to 
Vibrio ¿scheri and Tetrahymena pyriformis are observed, see Figure 4.17 and Equation 4.10. 
Regression coefficient is 0.76 smaller than 1, indicating that 24 h growth inhibition to bacteria is 
more sensitive than 24 h growth inhibition to ciliate for eliciting toxicity enhancement. For 
example, increasing one unit of log Te24 h (bacteria) only cause 0.76 unit changed in log Te24 h 
(ciliate). This finding is agreed by previous investigation.90 Indeed, log Te covers 3.59 log units 
for 24 bacteria assay, but log Te spans a less 3.40 log units. However, in the case of aliphatic 
epoxides, Tetrahymena pyriformis is observed more Te sensitivity than Vibrio ¿scheri.44,55  
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Figure 4.17: Log Te24 h (ciliate) vs log Te24 h (bacteria) for sensitizers, with excluding nonsensitizers  
 
 ܶୣଶସ୦ ሺሻ ൌ ͲǤ͹͸ሺേͲǤͲͺሻ ή  ܶୣଶସ୦ ሺሻ ൅ ͲǤ͵ͷሺേͲǤͳ͵ሻ 
n = 41   r2 = 0.71   s = 0.481     (4.10) 
 
Inter-endpoints Relationship: Inter-endpoints Relationship the same with interspecies 
relationship is a useful tool could be employ to predict chemical’s toxicity through toxicity date 
available for other endpoints. Inspection of Figure 4.18 and Equation 4.11 reveals a linear 
regression of log Te between 24 h growth inhibition and 30 min bioluminescence inhibition 
assays. The slope of log Te24 h (bacteria) is 1.13 larger than 1, suggesting that 30 min 
bioluminescence assay is more sensitive than 24 h growth inhibition assay. Indeed, log Te30 min is 
covering 4.97 orders of magnitude for 30 min bacterial assay, which is higher than log Te24 h that 
cover 3.59 and 3.40 log units, respectively, for 24 h growth inhibition in bacteria and ciliate 
assays. However, previous report suggests that 24 h growth inhibition to Vibrio ¿scheri is more 
sensitive than 30 min bioluminescence assay,45 which is agreeing with our normal understanding 
that long term bioassay is more sensitive than short term bioassay. Please keep in mind, this 
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different sensitivity between 24 h growth and 30 min bioluminescence inhibition is dependent on 
chemical class and chemical toxic process.55 In this investigation, the compounds are covering 
five major reaction mechanisms, thus the different sensitivity from different reaction 
mechanisms could be neutralized. 
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Figure 4.18: Log Te30 min (bacteria) vs log Te24 h (bacteria) for sensitizers, with excluding nonsensitizers and 
Michael acceptors  
 
 ܶୣଷ଴୫୧୬ ሺሻ ൌ ͳǤͳ͵ሺേͲǤͳʹሻ ή  ܶୣଶସ୦ ሺሻ െ ͲǤͶͳሺേͲǤʹͲሻ 
n = 34   r2 = 0.75   s = 0.633     (4.11) 
 
In summary, the good models of interspecies correlation relationship between Vibrio 
¿scheri and Tetrahymena pyriformis and inter-endpoints correlation relationship between short 
and long term bioassays can be used for predicting chemical’s toxicity through toxicity date 
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available for other species or endpoints. However, metabolic capabilities for different species or 
endpoints are different, which could affect models and should be considered. Comparing to 
Tetrahymena pyriformis, Vibrio ¿scheri had been determined to has a higher metabolic 
capability in 24 h growth inhibition. Moreover, 30 min bioluminescence inhibition (Vibrio 
¿scheri) shows a higher metabolic capability than 24 h growth inhibition (Vibrio ¿scheri). For 
example, 4-acetylanisole (47) and allyl acetate (52) show a narcotic level toxicity to Vibrio 
¿scheri in 24 h growth inhibition assay (log Te24 h = 0.57 and 0.44, respectively) , but they 
existing excess toxicity to Vibrio ¿scheri yield toxicity enhancements in short term bioassays 
discussed in section 4.2.2, with log Te30 min = 1.03 and log Te24 h = 1.14. Although, the two 
compounds, two nonsensitizers, are not including in the inter-endpoints model, the difference of 
metabolic capability for the short and long term bioassays can affect building inter-endpoints 
model. In this inter-endpoints model,  
The different slopes indicate that sensitivity of bioassays to toxicity enhancement decrease 
in order 30 min bioluminescence inhibition (Vibrio ¿scheri) > 24 h growth inhibition (Vibrio 
¿scheri) > 24 h growth inhibition (Tetrahymena pyriformis). Moreover, log Te for each assay 
span 4.97, 3.59 and 3.40 log units, respectively, and agree with this order. Please keep in mind, 
some of compounds’ log Te30 min are even minus, such as edaravone (30), pentachlorophenol (35), 
2,4-dichloronitrobenzene (40) and so on. These minus log Te30 min values indicate that their 
experimental toxicity data are unusually lower than narcotic toxicity and could affect sensitivity 
order. The order, however, is contrary to the sensitivity of these three bioassays to skin 
sensitization (see above). The possible reasons are, on one hand, biological reaction of chemicals 
to elicit toxicity enhancement are certainly different to elicit skin sensitization, although the 
chemical reaction mechanisms of both toxicological endpoints are partly same; and on the other 
hand, hydrophobicity (log Kow) has great effect to toxicity enhancement but not to skin 
sensitization (as discussed in section 4.2.4). In Increasing hydrophobicity will decrease the 
toxicity enhancement.44 Hydrophobicity shows negligible contribution to sensitization potency 
within these bioassays. Seeing 2-phenylpropanal (29) and 10-undecenal (28) as two excellent 
examples, both of log EC3 and log Kow of 10-undecenal higher than 2-phenylpropanal (í1.40 vs 
í1.33 and 4.12 vs 1.96, respectively), but 10-undecenal elicits lower Te for all three bioassays 
than 2-phenylpropanal’ (with 0.62 vs 0.91 to ciliates, 0.45 vs 0.65 (24 h) and 0.86 vs 1.16 (30 
min) to bacteria).  
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Figure 4.19: Observed log Te30 min versus calculated log Te30 min of bioluminescence inhibition to Vibrio fischeri 
for aromatic Michael acceptors 
 
 
ܶୣଷ଴୫୧୬ሺሻ ൌ ͳǤ͵ͶሺേͲǤͲ͵ሻ ή ܶୣଷ଴୫୧୬ሺሻ െ ͲǤͷͻሺേͲǤͲͶሻ 
n = 4   r2 = 0.99   s = 0.024     (4.12) 
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Table 4.13: Comparison observed log Te30 min for Michael acceptors with their calculated log Te30 min through 
log Te24 h 
Name log Te24 h 
log Te30 min 
(observed ) 
log Te30 min 
(calculated ) 
4-Vinylpyridine (20) 1.67 1.56 1.48 
Cinnamaldehyde (22) 1.59 1.46 1.39 
Benzylideneacetone (25) 1.69 1.55 1.50 
2-Methyl-3-phenylacrolein (26) 0.57 0.62 0.24 
Hexyl cinnamic aldehyde (31) 0.05 > í0.86a í0.35 
Į-Amyl cinnamic aldehyde (32) í0.20 > í 0.57a í0.63 
Benzyl cinnamate (36) í0.06 > í0.93a í0.47 
a Log Te30 min obtained according to their maximum water solubility.  
 
As mentioned above that the data is missing for aromatic Michael acceptors, the inter-
endpoint correlation model between short and long term toxicity (  ௘ܶଷ଴௠௜௡ ሺሻ ൌ
ͳǤͳ͵ሺേͲǤͳʹሻ ή  ௘ܶଷ଴௠௜௡ ሺሻ െ ͲǤͶͳሺേͲǤʹͲሻ ) had applied for predicting toxicity 
enhancement for selected Michael acceptors, according to their log Te24 h. Correspondingly, a 
good linear regression (seeing equation 4.12 and Figure 4.19) between the observed log Te30 min 
and calculated log Te30 min indicated that the inter-endpoint correlation model is an useful tool for 
estimating toxicity enhancement of compounds through toxicity data available for other endpoint. 
Moreover, the calculated log Te30 min values for hexyl cinnamic aldehyde (31), Į-amyl cinnamic 
aldehyde (32) and benzyl cinnamate (36) indicated that only narcotic toxicity expressed during 
short term bioassay, illustrated in Table 4.13. And this lack of reactive capability could be 
explanting the fact that all these compounds are weak sensitizers.  
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4.2.6 Conclusion 
 
Generally, 24 h growth inhibition toward Vibrio ¿scheri presents high sensitivity and 
contribution to skin sensitization compared with 30 min bioluminescence inhibition; moreover, 
Vibrio ¿scheri suggest higher sensitivity than Tetrahymena pyriformis in the assay of 24 h 
growth inhibition. Good interspecies correlation relationship between Vibrio ¿scheri and 
Tetrahymena pyriformis and inter-endpoints correlation relationship between short and long term 
bioassays are obtained; moreover, the promising interspecies and inter-endpoints correlations are 
covering different reactive mechanisms, which can applied to predict toxicity enhancement 
through toxicity enhancement data available for other species or endpoints. Our results indicate 
that the 24 h growth and 30 min bioluminescence inhibition with Vibrio ¿scheri are useful tools 
to evaluate allergic chemicals’ skin sensitization potency and can be applied to classify 
chemicals as sensitizers or weak sensitizers or non-sensitizers. 
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4.3 Identification Skin Sensitizers Using Kinetic Glutathione 
Chemoassay and Evaluation Their Skin Sensitization Potential 
through Integrating Bioassays Data.  
 
4.3.1 Background  
 
In the sections 4.1 and 4.2, toxicity enhancements are successfully applied for predicting 
allergic compounds’ skin sensitization potency, with the acceptable accuracy. This is based on 
the fact that chemical reaction mechanisms, binding to proteins or peptides, are partly same for 
the aquatic toxicity enhancement and skin sensitization, although their biological reaction 
mechanisms are entirely different.  
As the ability of an allergic chemical, either directly or after metabolic or abiotic 
transformation, binding to skin proteins is a key step to induce skin sensitization, the most 
straightforward approach is proposed and evaluated by measuring the reactivity of test 
compounds with peptides or proteins.26,38,92 A new kinetic glutathione (GSH) chemoassay was 
been introduced and applied to determine compounds second-order reaction rate constants, 
kGSH.61,76 Thus, the purpose of this research work applies this new kinetic GSH chemoassay to 
monitor the test compounds’ skin sensitization potential. Moreover, an integrated platform is 
proposed for screening skin sensitization through combining this chemoassay data and the 
previous bioassay data.  
 
4.3.2 Chemical Reactivity of Selected Compounds  
 
As mentioned in the section 1.4.2.2, measuring reactivity of compounds with peptides 
and/or proteins will be the most straightforward method for prediction their skin sensitization 
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potential. In this research work, the GSH (glutathione) chemoassay is applied to the selected 
compounds (see Table 4.14), covering four sensitization potency classes (strong (& 
extreme)/moderate/weak/nonsensitization). GSH chemoassay had been successfully applied for 
evaluation the thiol reactivity of a series of Michael acceptors.61,76 As the thiol group is a soft 
nucleophile, GSH will be expected to readily bind to Michael acceptors, but not to Schiff base 
electrophiles.  
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Table 4.14: Second order thiol reactivity rate constants, kGSH, for selected compounds binding to glutathione 
Number Name 
Cysteine 
(remain%)a 
kGSH log kGSH log kCys-peptideb 
1 Chlorothalonil n.a. n.s.c n.s.c 0.65 
2 1-Fluoro-2,4-dinitrobenzene n.a. 90c 1.95c 0.98 
3 1-Chloro-2,4,6-trinitrobenzene n.a. 
Very high 
reactivitye 
Very high 
reactivitye 
2.00 
4 2,4-Dinitrophenyl thiocyanate n.a. 1500 3.18c 2.20 
5 1-Chloro-2,4-dinitrobenzene 0 3 0.48c –0.65 
6 1-Brome-2,4-dinitrobenzene n.a. 5 0.70c –0.47 
7 1-Iodo-2,4-dinitrobenzene n.a. 4 0.60c –0.44 
8 Glutaraldehyde 69.8 1.025 0.011  
9 2,4,6-Trinitrobenzenesulfonic acid n.a. 0.336 –0.474 0.53 
10 Dimethyl sulfate n.a. 0.451 –0.346  
11 2-Oxetanone n.a. 1.449 0.161  
12 Phenyl glycidyl ethe n.a. 0.261 –0.583  
13 Bisphenol A diglycidyl ether 57.5 n.s. n.s.  
14 2-Methyl-3,1-benzoxaza-4-one n.a. 16.685 1.223  
15 2,4-Dinitrobenzenesulfonic acid n.a. 0.155 -0.81 -2.33 
16 1-Phenyl-1,2-propanedione 52.9 0.129 –0.89  
17 Mercaptobenzothiazole 2.5 n.r. n.r.  
18 Diethylsulfate n.a. 0.282c –0.55c  
19 Benzyl glycidyl ether n.a. 3.969 0.60  
20 4-Vinylpyridine 7.9 8.683 0.94  
21 Propylidenephthalide 85.7 n.s. n.s.  
22 Cinnamaldehydc 29.4 5.48 d 0.74d  
23 Glyoxal 43.5 0.215 –0.67  
24 Phenylacetaldehyde 39.3 n.s. n.s.  
25 Benzylideneacetone 5.3 2.59d 0.41d  
26 2-Methyl-3-phenylacrolein 89.6 0.15d –0.84d  
27 Dihydrocoumarin 100 n.r. n.r.  
28 10-Undecenal n.a. n.s. n.s.  
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29 2-phenylpropanal 51.8 n.s. n.s.  
30 3-Methyl-1-phenyl-2-pyrazoline-5-one n.a. n.r. n.r.  
31 Methyl methanesulfonate 7.0 0.38c –0.42c  
32 Hexyl cinnamic aldehyde 100 n.r.d n.r.d  
33 Į-Amyl cinnamic aldehyde 99.4 n.r.d n.r.d  
34 1-Bromohexane 85.9 n.r. n.r.  
35 Pentachlorophenol 86.0 n.s. n.s. n.a.  
36 Benzyl cinnamate n.a. n.r. n.r.  
37 Benzyl benzoate 99.8 n.s. n.s.  
38 Lilial 86.0 n.s. n.s.  
39 Diphenylcarboxylate n.a. n.s. n.s.  
40 2,4-Dichloronitrobenzene n.a. n.r. n.r. –3.47 
41 Cyclamen aldehyde 81.1 n.s. n.s.  
42 Phenylethyl isovalerate n.a. n.r. n.r.  
43 Methylparaben 96.4 n.r. n.r.  
44 Salicylic acid 96.5 0.05 –1.30  
45 4-Hydroxybenzoic acid 100 n.r. n.r.  
46 Benzaldehyde 92.8 n.r. n.r.  
47 4-Acetylanisole 95.3 0.05 -1.30  
48 Ethyl vanillin 98.9 0.07 -1.19  
49 Vanillin 96.8 0.03 -1.52  
50 Butyl alcohol 100 n.r. n.r.  
51 Methyl salicylate 99.7 0.06 –1.22  
52 Allyl acetate n.a. n.r. n.r.  
53 chlorononane n.a. n.r. n.r.  
54 bromobutane 86.2 0.02 –1.70  
55 1-Iodohexane 67.8 n.r. n.r.  
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aThe cysteine depletion data for selected compounds cites from literature.92 bThe reaction rate constant data 
of SNAr electrophiles with cys-peptide during direct peptide reactivity assay (DPRA) cites from literature.53 cThe 
data cites from my colleague Daniel Heinzelmann unpublished data; dThe data cites from my colleague Dr. 
Alexander Böhme unpublished data. eMeasurement is complicated due to very high reactivity from my colleague 
Daniel Heinzelmann unpublished data. n.a. denotes not available; n.r. means not reactivity; n.s. means not solution 
in the measuring buffer. 
 
The strong (with extreme) and moderate sensitizers: Compared with weak sensitizers or 
nonsensitizers (see below), strong (with extreme) and moderate sensitizers have higher reactivity. 
Indeed, most of them show higher values of second reaction rate constant (log kGSH). Contrarily, 
weak sensitizers or nonsensitizers show either no significant reaction or low log kGSH values, 
which are even lower than –1.  
Glutathione (GSH) is a soft nucleophile and should be bind easily to soft electrophiles, 
such as Michael acceptor, but not to hard electrophiles, such as Schiff base agents. Thus, the 
different reaction mechanism domains of these sensitizers are expected to show different levels 
of sensitivity. Good example is comparing cinnamaldehyde (22) and glyoxal (23). Although, 
they have almost same skin sensitization potency (log EC3 = –1.64 and –1.62, respectively), the 
thiol reactivity of cinnamaldehyde (22) is 25-fold higher than glyoxal (23) has (kGSH 5.48 vs 0.22 
L mol–1 min–1).  
The chemical reactivity data are unavailable for some compounds, causing of lacking 
water solubility, such as propylidenephthalide (21) and phenylacetaldehyde (24), or lacking 
chemical reactivity with GSH, such as dihydrocoumarin (27) and hexyl cinnamic aldehyde (32). 
Consequently, it is hard drawing a linear plot of chemical reactivity vs skin sensitization. 
However, skin sensitization potential of SNAr electrophiles is widely evaluated recently, and 
reported some useful model for prediction their sensitization potential.17,53,93-94 According to 
literature data, sensitizers via SNAr reaction mechanism reveals a linear plot of reactivity with 
skin sensitization (Figure 4.20 and eq 4.13).53 
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 ͵ ൌ െͲǤͶͷሺേͲǤͳͲሻ ή  ݇େ୷ୱି୮ୣ୮୲୧ୢୣ െ͵ǤʹͳሺേͲǤͳ͸ሻ 
r2 = 0.77, s = 0.351, n = 8, F = 20.63   (4.13) 
 
In this section of work, a plot of log EC3 vs log kGSH shows in Figure 4.20, with eq 4.14: 
 
 ͵ ൌ െͲǤͷ͸ሺേͲǤͳ͹ሻ ή  ݇ୋୗୌ െʹǤͻʹሺേͲǤͳ͹ሻ 
r2 = 0.68, s = 0.334, n = 7, F = 10.51   (4.14) 
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Figure 4.20: Skin sensitization, log EC3, vs reactivity, log k, for SNAr reactive mechanism chemicals. 
Squares (Ŷ) denote literature data measured employing Cys-peptide (Ac-RFAACAA, MW 750.1) and circle 
(Ɣ) denote experimental data measured employing GSH (glutathione). Triangle down (ź) indicates outlier 
excluding in the regression equation 
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Strangely, comparison of log kGSH with log kCys-peptide suggests that glutathione is more 
readily and sensitively binding to SNAr electrophiles, see Table 4.14. Indeed, the slope of log 
kGSH is steeper than log kCys-peptide has (–0.56 vs –0.45), with slightly lower correlation coefficient 
(r2 = 0.77 vs 0.68). 
The weak sensitizers: Inspection of Table 4.14, six of ten weak sensitizers reveal no 
significant reaction with GSH (glutathione), and the remaining four weak sensitizers have no 
reactivity data due to their poor water solubility. These four weak sensitizers are supposed to 
lack chemical reactivity. This view is supported by the lower toxicity enhancements of them, see 
Tables 4.2 and 4.6.  
Hexyl cinnamic aldehyde (32) and Į-Amyl cinnamic aldehyde (33) are two Michael 
acceptors that are supposed to readily bind to proteins or peptides via Michael addition. However, 
they showed no significant reaction with GSH. A possible reason is the long alkyl substitution at 
Į-position that will reduce the Michael acceptors reactivity, which bases on two factors: On the 
one hand, the attached alkyl group has a positive inductive effect that reduces the electrophilic 
character of the Į-position carbon. On the other hand, steric hindrance from the attached alkyl 
group will protect them from binding to nucleophiles. Moreover, previous direct peptide 
reactivity assay (DPRA) result confirmed that it employed cysteine peptide during 24 h 
incubation, see Table 4.14.92 Although there is no availably comparable literature data of 
reactivity potential of benzyl cinnamate (36), another Michael acceptor, this chemoassay 
demonstrates benzyl cinnamate was no reaction with glutathione.  
2,4-Dichloronitrobenzene (40) is a weak sensitizer and demonstrate no reactivity in this 
chemoassay. Moreover, 2,4-dichloronitrobenzene had been demonstrated to have a much lower 
rate constant with log k (Cys-peptide) = –3.47. That is even lower than the oxidation loss from the 
oxygen and DMSO,  ݇ୋୗୗୋ
୮ୱୣ୳ୢ୭= –2.73, although these two peptides (cysteine vs glutathione) 
are supposed to have different sensitivity binding to electrophiles. Thus, the lower reaction rate 
constant of 2,4-dichloronitrobenzene will be masked by the oxidation loss from the oxygen and 
DMSO during this chemoassay.  
Unfortunately, the two Schiff base electrophiles, lilial (38) and cyclamen aldehyde (41), 
show no reaction with GSH, because of their poor water solubility (log Sw are –4.00 and –3.63 at 
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25 °C, respectively). However, both compounds are supposed to have no reaction with GSH, 
because they had been determined to have no reaction with cysteine or lysine peptides (with the 
less depletion cysteine or lysine peptides).92 Due to lower water solubility, reactivity data of 
benzyl benzoate (37) and diphenyl carboxylate (39) are not available. However, literature data 
confirmed that benzyl benzoate (37) had even less than 1% of cysteine and lysine peptides 
depletion during DPRA.92  
The nonsensitizers: As has been mentioned before, the nonsensitizers are failed eliciting 
sensitization for either lack of reactivity or lack of bioavailability.18,85 However, all the 
nonsensitizers are expected to have bioavailable since their hydrophobicity (log Kow) is ranging 
from 0.88 to 2.75, except two hydrophobic compounds chlorononane (53) and 1-Iodohexane (55) 
with log Kow is 5.02 and 4.05, respectively. Thus, the major reason for not existing sensitization 
is lacking reactivity for these compounds. Indeed, seven of them are not reactive with GSH and 
the remaining six of them have lower reactivities with log kGSH lower than –1.  
Interestingly, benzaldehyde (46) revealed no reactivity in the chemoassay. The human data, 
however, suggested it is a moderate sensitizer (EC3 = 10%).60 Moreover, our bioassays 
confirmed it is a moderate sensitizer with EC3 = 3% (seeing section 4.1.4). The possible reason 
is that the model nucleophile GSH is lacking sensitivity for binding to compounds via Schiff 
base formation as compared with Michael acceptors.  
Chlorononane (53), bromobutane (54) and 1-iodohexane (55) indicated a siginificantly 
lower chemical reactivity (see Table 4.14). However, inspection of Tables 4.2 and 4.6, they 
showed definite toxicity enhancement in either long or short term bioassays after correcting for 
volatilization and sorption loss. Moreover, ethyl vanillin (48) and vanillin (49) show lacking 
reactivity with pretty lower log kGSH (–1.19 and –1.60, respectively). However, the bioassays 
data indicate they have definitely toxicity enhancement, which could be explained by the 
metabolic transformation (see section 4.1.4). Thus, sensitizers (electrophilic agents) could 
directly bind to glutathione (nucleophilic agent) in this chemoassay approach, regardless of 
bioavailability or biometabolism, compared with bioassays.  
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4.3.3 Integrated Platform of Chemoassay and Bioassays for Predicting Skin 
Sensitization  
 
Skin sensitization is an important and complex endpoint correlated with biological 
biochemical and chemical processes, such as penetration through the surface of skin to stratum 
corneum, binding to skin proteins or peptides and T-cell response. A lot of additional approaches, 
such as in vitro, in silico and in chemico, are proposed and evaluated for replacing current animal 
test. These nonanimal approaches could only consider part of complex processes, and if a 
compound fails any one of these processes then skin sensitization will fail to be induced. A 
generally accepted view by scientists is that one single test cannot replace the current animal test, 
and an integrated platform of various approaches is proposed to identify the sensitizing 
compounds and evaluate their skin sensitization potential.  
Based on this view, for each chemical three bioassays and one chemoassay are performed, 
named with (1) 24h growth inhibition assay with Tetrahymena pyriformis, (2) 24h growth 
inhibition assay with Vibrio fischeri, (3) 30min bioluminescence inhibition with Vibrio fischeri 
and (4) kinetic glutathione chemoassay. Moreover, the first step of compound eliciting 
sensitization penetrate the surface of skin to stratum corneum (epidermal bioavailability), which 
has been often correlated with log Kow as a simpler indicator in penetration models.  
Score identification: Identifying scores of individual in vitro data, one possible approach, 
is illustrated in Table 4.15 for developing an integrating platform. In which, log Kow in the model 
indicate bioavailability in skin, considering log Kow inside the range between –0.5 and 3 to be 
high bioavailability with score 2 and log Kow outside this range to be less bioavailability with 
score 1.11,18 Toxicity enhancement, log Te, considers capability of compounds binding to skin 
proteins or peptides, with score 0 for log Te < 0.5, score 1 for 0.5  log Te < 1, score 2 for 1  log 
Te < 2, score 3 for 2  log Te < 3 and score 4 for 3  log Te. Kinetic glutathione chemoassay is 
also integrated into the platform, with score 0 for log kGSH < – 1 or n.r. (not reactive in kinetic 
glutathione chemoassay), score 1 for – 1  log kGSH < 0, score 2 for 0  log kGSH < 1, score 3 for 
1  log kGSH < 2 and score 4 for log kGSH  2.  
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Table 4.15: Score setting of hydrophobicity, three bioassays and chemoassay for each compound 
Score log Kow log Te24 h ciliate log Te24 h bacteria log Te30 min bacteria log kGSH 
0  < 0.5 < 0.5 < 0.5 < – 1 or n.r. 
1 < – 0.5 or > 3 0.5 to < 1 0.5 to < 1 0.5 to < 1 – 1 to < 0 
2 – 0.5 to 3 1 to < 2 1 to < 2 1 to < 2 0 to < 1 
3  2 to < 3 2 to < 3 2 to < 3 1 to < 2 
4   3  3  3  2 
n.r. denotes no reactivity in kinetic glutathione chemoassay 
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Table 4.16: Toxicity enhancement data and thiol reactivity data transformed to scores for each compound 
Number Name 
Sensitization 
classes 
log Kow 
log Te30 min 
bacteria 
log Te24 h
bacteria 
log Te24 h 
ciliate 
log 
kGSH 
Average 
scoresa 
Multiplied 
scoresb 
1 Chlorothalonil Extreme 1 3 4 3 n.s. 3.33 11 
2 1-Fluoro-2,4-dinitrobenzene Extreme 2 3 3 3 3 3 14 
3 1-Chloro-2,4,6-trinitrobenzene Extreme 2 2 1 2 4c  3 14 
4 2, 4-Dinitrophenyl thiocyanate Extreme 2 4 3 3 4 3.5 16 
5 1-Chloro-2,4-dinitrobenzene Extreme 2 2 2 3 2 2.25 11 
6 1-Brome-2,4-dinitrobenzene Extreme 2 2 2 3 2 2.25 11 
7 1-Iodo-2,4-dinitrobenzene Strong 2 2 2 2 2 2 10 
8 Glutaraldehyde Strong 2 4 3 3 2 3 14 
9 2,4,6- Trinitrobenzenesulfonic acid Strong 1 3 3 4 1 2.75 12 
10 Dimethyl sulfate Strong 2 2 4 2 1 2.25 11 
11 2-Oxetanone Strong 1 3 3 3 2 2.75 12 
12 Phenyl glycidyl ether Strong 2 2 2 2 1 1.75 9 
13 Bisphenol A diglycidyl ether Moderate 1 2 2 3 n.s. 2.33 8 
14 2-Methyl-3,1-benzoxaza-4-one Strong 2 2 2 2 3 2.25 11 
15 2,4-Dinitrobenzenesulfonic acid Moderate 1 3 3 3 1 2.5 11 
16 1-Phenyl-1,2-propanedione Moderate 2 2 2 2 1 1.75 9 
17 Mercaptobenzothiazole Moderate 2 3 2 2 0 1.75 9 
18 Diethylsulfate Moderate 2 1 1 1 1 1 6 
19 Benzyl glycidyl ether Moderate 2 1 2 2 2 1.75 9 
20 4-Vinylpyridine Moderate 2 2 2 2 2 2 10 
21 Propylidenephthalide Moderate 2 1 2 2 n.s. 1.66 7 
22 Cinnamaldehydec Moderate 2 2 2 2 2 2 10 
23 Glyoxal Moderate 1 4 4 3 1 3 13 
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24 Phenylacetaldehyde Moderate 2 2 2 2 n.s. 2 8 
25 Benzylideneacetone Moderate 2 2 2 2 2 2 10 
26 2-Methyl-3-phenylacrolein Moderate 2 1 1 1 1 1 6 
27 Dihydrocoumarin Moderate 2 2 2 2 0 1.5 8 
28 10-Undecenal Moderate 1 1 1 1 n.s. 2 4 
29 2-phenylpropanal Moderate 2 2 1 1 n.s. 1.33 6 
30 3-Methyl-1-phenyl-2-pyrazoline-5-one Moderate 2 0 0 1 0 0.25 3 
31 Hexyl cinnamic aldehyde Weak 1 n.a. 0 0 1 0.33 2 
32 Į-Amyl cinnamic aldehyde Weak 1 n.a. 0 0 0 0 1 
33 1-Bromohexane Weak 1 1 0 2 0 0.75 4 
34 Methyl methanesulfonate Moderate 1 2 4 4 0 2.5 11 
35 Pentachlorophenol Weak 1 0 0 1 n.s. 0.33 2 
36 Benzyl cinnamate Weak 1 na 0 1 0 0.33 2 
37 Benzyl benzoate Weak 1 0 1 0 n.s. 0.33 2 
38 Lilial Weak 1 0 0 0 n.s. 0 1 
39 Diphenylcarboxylate Weak 1 0 1 1 n.s. 0.67 3 
40 2,4-Dichloronitrobenzene Weak 1 0 1 1 0 0.5 3 
41 Cyclamen aldehyde Weak 1 0 0 0 n.s. 0 1 
42 Phenylethyl isovalerate Weak 1 0 0 0 0 0 1 
43 Methylparaben NS 2 2 1 1 0 1 6 
44 Salicylic acid NS 2 0 1 0 0 0.25 3 
45 4-Hydroxybenzoic acid NS 2 0 0 0 0 0 2 
46 Benzaldehyde NS 2 1 1 1 0 0.75 5 
47 4-Acetylanisole NS 2 2 1 1 0 1 6 
48 Ethyl vanillin NS 2 2 2 2 0 1.5 8 
49 Vanillin NS 2 2 2 2 0 1.5 8 
50 Butyl alcohol NS 2 0 0 0 0 0 2 
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51 Methyl salicylate NS 2 0 0 0 0 0 2 
52 Allyl acetate NS 2 2 0 0 0 0.5 4 
53 chlorononane NS 1 2 2 1 0 1.25 6 
54 bromobutane NS 2 0 0 1 0 0.25 3 
55 1-Iodohexane NS 1 2 2 2 0 1.5 7 
Sensitization classes were determined according to EC3 values: extreme, < 0.1%; strong, 0.1 to 1%; moderate, 1 to 10%; weak, 10 to 100%; and 
nonsensitizer, >100 %. log Kow, logarithmic octanol/water partition coefficients, were predicted employing EPISuite and the score of log Kow for each compound 
obtained through Table 4.14. log Te30 min bacteria, toxicity enhancement of compounds in 30 min bacteria bioluminescence inhibition assay, and log Te24 h bacteria, 
toxicity enhancement of compounds in 24 h growth bacteria inhibition assay, are from Table 4.5, and corresponding score obtained through Table 4.14. log Te24 h 
ciliate, toxicity enhancement of compounds in 24 h ciliate growth inhibition assay, are from Table 4.1 and the score obtained through Table 4.14. NS denotes the 
compound is a nonsensitizer. n.s. means not solution during the chemoassay with missing reactivity data and excluding in average scores and multiplied score 
calculation. aAverage scores only considers toxicity enhancement and thiol reactivity data responding for reactivity capability. bMultiplied scores from adding log 
Kow score, toxicity enhancement scores and thiol reactivity score. cvery high reactivity consider the score 4  
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The average score, considering reactive capability only, and multiplied score, combining 
bioavailability with chemical reactivity, apply to evaluate skin sensitization potential of 
compounds. The box plots of average scores vs skin sensitizations and multiplied scores vs skin 
sensitizations potential are shown in Figures 4.21 and 4.22. Both box plots yield the same trend 
that is strong (with extreme) sensitizer subcategory has the highest score, followed by moderate 
sensitizers, nonsensitizers and weak sensitizers. Compared with average scores, the same trend 
presented in multiplied scores indicates hydrophobicity dose not contribute significantly to skin 
sensitization potential. This agrees with the fact that the binding of sensitizers to skin proteins 
and/or peptides is the key step for inducing skin sensitization. The nonsensitizers show higher 
scores than weak sensitizers. The possible reason is discussed in section 4.1.4 and 4.2.3 that 
some nonsensitizers show toxicity enhancement through biotransformation in bioassays. This is 
confirmed by comparing bioassays data (toxicity enhancement) to chemoassay data (reactivity) 
of nonsensitizers (see Tables 4.2, 4.6 and 4.14).  
 
Table 4.17: Accuracy evaluation of each sensitization classifications application average scores 
Sensitization 
classification 
n Average score  
Predicted classification 
Sensitizer Nonsensitizer Accuracy 
Strong (extreme ) 13 > 2 12 1 92.3% 
Moderate 18 1 to 2 13 5 72.2% 
Weak 11 < 1 0 11 100.0% 
nonsensitizer 13 < 1 4 9 69.2% 
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Table 4.18: Accuracy evaluation of each sensitization classifications application multiplied scores  
Sensitization 
classification 
n Average scores 
Predicted classification 
Sensitizer Nonsensitizer Accuracy 
Strong (extreme ) 13 > 10 12 1 92.3% 
Moderate 18 5 to 10 15 3 83.3% 
Weak 11 < 5 0 11 100.0% 
nonsensitizer 13 < 5 6 7 53.8% 
 
Application the scores for evaluating skin sensitization are illustrated in Tables 4.17 and 4.18. 
Strong (extreme) and weak sensitizers shown great accuracy in average scores, with 92.3% and 
100.0%, respectively. There are four moderate sensitizers with higher scores than 2, thus the 
accuracy is 72.2%. Four nonsensitizers are predicted as to sensitizers resulting for the lower 
accuracy (69.2%), according to average scores. The reason for these four nonsensitizers 
obtaining higher scores is that these nonsensitizers show toxicity enhancement through 
biotransformation in the bioassays, see Tables 4.2 and 4.6. Although, these compounds are 
nonsensitizers in LLNA, they still exhibit sensitization potency for their capability of binding to 
proteins in the bioassays. Again, strong (extreme) and weak sensitizers show great accuracy in 
multiplied scores with 92.3% and 100.0%, respectively. Moderate sensitizers show improved 
accuracy, comparing with average scores (72.2% vs 83.3%). However, the accuracy, 53.8% only, 
for nonsensitizers is decreased in multiplied scores, with more nonsensitizers predicted as 
sensitizers. This indicates that a nonsensitizers is lacking either reactivity or bioavailability.  
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Figure 4.21: Average scores, responding reactivity capability of compounds, vs potency of sensitization 
according to them EC3 values: extreme, < 0.1%; strong, 0.1 – 1%; moderate, 1 – 10%; weak, 10 – 100%; and 
nonsensitizer, > 100 % 
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Figure 4.22: Multiplied scores, combined bioavailability and reactivity capability of compounds, vs potency of 
sensitization according to them EC3 values: extreme, < 0.1%; strong, 0.1 – 1%; moderate, 1 – 10%; weak, 10 
– 100%; and nonsensitizer, >100 % 
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4.3.4 Conclusion  
 
The kinetic glutathione chemoassay is a useful tool for determining chemical reactivity of 
compounds. The results indicate that chemical reactivity of sensitizers strongly correlates with 
their skin sensitization potential, with strong (extreme) sensitizers have the highest reactivity 
followed by moderate sensitizers, weak sensitizers as well as nonsensitizer. It confirms the fact 
that key step in the skin sensitization processes is formation of a covalent adduct between 
sensitizers and proteins or peptides in the skin. Compared with bioassays, this kinetic 
chemoassay could directly measure reactive ability of sensitizers, regardless of bioavailability or 
biometabolism. The integrated platform of this chemoassay data and previously discussed three 
bioassays data is a sensitive and powerful tool for evaluating skin sensitization potential. 
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4.4 Prediction of Skin Sensitization Potential of Aliphatic Į,ȕ-
Unsaturated Compounds Using Thiol Reactivity and Aquatic 
Toxicity Enhancement 
 
4.4.1 Background  
 
As mentioned in section 4.1, aliphatic Michael acceptors yielded only a very poor linear 
regression in the model of log EC3 vs log Te, compared with aromatic Michael acceptors alone. 
Moreover, combination of aromatic and aliphatic Michael acceptors has no improvement for 
linear regression. This indicates that subcategorizations of Michael acceptors with diverse 
structures are recommended. Moreover, previously reported models for predicting MAs’ skin 
sensitization are normally excluding several acrylates, such as methyl acrylate (4) and ethyl 
acrylate (5), because of their skin sensitization are usually over-predicted by previous 
models.14,16  
Interestingly, hydrophobicity, modeling penetration, another important parameter had been 
confirmed to show a contribution to skin sensitization for some mechanism domains (such as 
Schiff base and SN2),10,13 but not to Michael addition.14,28,53 However, hydrophobicity shows an 
essential contribution to aquatic toxicity (48 h growth inhibition of Tetrahymena pyriformis) for 
Michael acceptors.61,95 Moreover, the different classes of aliphatic Michael acceptors indicated a 
difference in the dependences of their aquatic toxicity on hydrophobicity, because of their small 
but systematic difference in chemical structure.61,95  
Thus, the purpose of this research is to check: (ĉ) Whether the new kinetic glutathione 
chemoassay can be used to predict skin sensitization of aliphatic Michael acceptors? (Ċ) Should 
aliphatic Michael acceptors be treated separately through their differently chemical classes? (ċ) 
Is reported low reactivity regression coefficient characterize for Michael acceptors? (Č) Is it true 
that sensitization potential of Michael acceptors is only dependent on reactivity but not on 
hydrophobicity? To answer these questions, thiol reactivity, second-order reaction rate constants, 
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kGSH, and aquatic toxicity enhancements toward Tetrahymena pyriformis, Te, of selected 21 
aliphatic Į,ȕ-unsaturated compounds are determined.  
 
 4.4.2 Reactivity and Toxicity Data  
 
Information of thiol reactivity toward glutathione, the second-order rate constants (kGSH), 
and aquatic toxicity enhancement (Te), toward Tetrahymena pyriformis of all 21 aliphatic Į,ȕ-
unsaturated compounds with their physicochemical properties is summarized in Tables 4.19 and 
4.20. Thiol reactivity covers almost 3 orders of magnitude (from log kGSH í1.48 for citral to log 
kGSH 1.51 for 2-hydroxyethyl acrylate), excluding para-benzoquinone that is most reactive, 
which is almost 2.5 log units higher than 2-hydroxyethyl acrylate has, see Table 4.20. Moreover, 
almost 3.60 log units of toxicity enhancement is signification larger than the variation of log EC3 
without para-benzoquinone. 
For both log EC3 vs log kGSH and log EC3 vs log Te, the correlations are unsatisfactory 
(correlation coefficients are 0.58 and 0.44, respectively), without subcategorization, see eqs. 4.15 
and 4.16. Although some of compounds (belonging to moderate sensitizers) lack toxicity 
enhancements, the average log Te of 9 moderate sensitizers is 1.21, indicating an obvious toxicity 
enhancement. Expectedly, two of extreme and strong sensitizers, para-benzoquinone and methyl 
2-octynoate, both show toxicity enhancements (log Te 4.00 and 1.25, respectively). 
Unsurprisingly, the remaining 9 weak sensitizers lack toxicity enhancement, with as average log 
Te = 0.79, although three acrylates, butyl acrylate, methyl acrylate and ethyl acrylate, show 
significant toxicity enhancement, see Table 4.20. These three acrylates will be discussed below. 
In summary, the two extreme and strong sensitizers have the highest toxicity enhancements, 
followed by moderate sensitizers and weak sensitizers. 
 
 ͵ ൌ െͲǤ͵ͻሺേͲǤͲͺሻ ή  ݇ୋୗୌ െͳǤʹͲሺേͲǤͳʹሻ 
n = 21,   r2 = 0.58,   s = 0.537    (4.15) 
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 ͵ ൌ െͲǤͷͷሺേͲǤͳͶሻ ή  ܶୣ െ ͲǤ͹ͶሺേͲǤʹͳሻ 
n = 21,   r2= 0.45,   s = 0.615    (4.16) 
 
 ͵ ൌ െͲǤʹʹሺേͲǤͳ͵ሻ ή  ݇ୋୗୌ െͳǤʹͳሺേͲǤͳʹሻ 
n = 20,   r2 = 0.13,   s = 0.522    (4.17) 
 
 ͵ ൌ െͲǤʹ͵ሺേͲǤͳ͸ሻ ή  ܶୣ െ ͳǤͲʹሺേͲǤʹͲሻ 
n = 20,   r2 = 0.11,   s = 0.528    (4.18) 
 
Benzoquinone, the most reactive (log kGSH ) and highly sensitizing (log EC3 ), has a data 
point pretty far away from the ones of the others compounds, see Figures 4.23 and 4.24, and 
therefore may leverage the slope and intercept of eqs 4.15 and 4.16. We consider regression 
analysis without this compound, resulting in inferior statistic, see eqs 4.17 and 4.18. However, 
the poor statistics (with or without Benzoquinone) from both log EC3 against log kGSH and log 
EC3 against log Te indicate that such aliphatic MAs cannot be modelled without 
subcategorization. Therefore, separate these aliphatic MAs into different chemical classes 
subcategories should be considered. For the analysis these 21 aliphatic Į,ȕ-unsaturated 
compounds are divided into 4 subgroups: 5 acrylates, 5 other esters, 4 ketones and 7 aldehydes.  
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Table 4.19: Test Set of 21 compounds with Their Information of Physicochemical Properties, Sensitization 
Potency, Toxicity and Toxicity Enhancement Toward 24 h Growth Inhibition with Tetrahymena pyriformis 
Number Name CAS Structure log Kowa 
Sensitization 
potency 
log EC3 
[M]b 
5 Į,ȕ-Unsaturated Acrylates 
1 
2-Hydroxyethyl 
acrylate 
818-61-1 O
O
OH
 
í0.21 Moderate í1.92 
2 
2-Ethylhexyl 
acrylate 
103-11-7 
 
4.09 Weak í1.27 
3 Butyl acrylate 141-32-2 
O
O
 
2.36 Weak í1.07 
4 Methyl acrylate 96-33-3 O
O
 
0.80 Weak í0.63 
5 Ethyl acrylate 140-88-5 O
O
 
1.32 Weak í0.55 
5 Į,ȕ-Unsaturated Other Esters 
6 
Methyl 2-
octynoate 
111-12-6 
O
O
 
2.60 Strong í2.53 
7 
Methyl 2-
nonynoate 
111-80-8 
O
O
 
3.10 Moderate í1.83 
8 Diethyl maleate 141-05-9 
O
O
O
O
 
2.20 Moderate í1.47 
9 
Ethylene glycol 
dimethacrylate 
97-90-5 
O
O
O
O  
2.21 Weak í0.85 
O
O
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10 
Methyl 
methacrylate 
80-62-6 O
O
 
1.38 Weak í0.005 
4 Į,ȕ-Unsaturated Ketones 
11 ȕ-Damascone 23726-91-2 
O  
4.42 Moderate í1.46 
12 L-Carvone 6485-40-1 
O
 
2.71 Weak í1.07 
13 Į-Cetone 127-51-5 O
 
4.84 Weak í0.98 
14 
para-
Benzoquinone 
106-51-4 O O
 
0.25 Extreme  í4.04 
7 Į,ȕ-Unsaturated Aldehydes 
15 trans-2-Decenal 3913-81-3 O  
3.55 Moderate í1.79 
16 2,4-Heptadienal 4313-03-5 O  
1.86 Moderate í1.44 
17 2,4-Hexadienal 142-83-6 O  
1.73 Moderate í1.44 
18 Safranal 116-26-7 
O
 
3.22 Moderate í1.30 
19 Perillaldehyde 2111-75-3 
O  
3.13 
 
Moderate í1.27 
20 trans-2-Hexenal 6728-26-3 O  
1.58 Moderate í1.25 
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21 Citral 5392-40-5 
O  
3.45 Weak í1.07 
     a Log Kow, Logarithmic octanol/water partition coefficients, were predicted employing EPISuite,82 bSensitization 
classes was determined according to EC3 values:26 extreme, < 0.1%; strong, 0.1 to 1%; moderate, 1 to 10%; weak, 
10 to 100%; and nonsensitizer, > 100%, log EC3 represents the molar-based EC3 values, calculated using eq 3.1. 
 
 
 
Table 4.20: Test Set of 21 compounds with Information of thiol reactivity (log kGSH), Toxicity (log EC50) and 
Toxicity Enhancement (log Te) Toward with Tetrahymena pyriformis (24 h Growth Inhibition) 
Number Name log kGSH log Kaw [25Û]a fa [%] fs [%] log EC50 [M] log Te 
5 Į,ȕ-Unsaturated Acrylates 
1 2-Hydroxyethyl acrylate 1.51 6.526 0.00 0.00 í3.99 3.18 
2 2-Ethylhexyl acrylate í0.08 5.843 31.15 25.30 í5.04 0.49 
3 Butyl acrylate 0.93c 3.931 12.19 11.81 í4.41 1.37 
4 Methyl acrylate 1.06c 2.890 5.43 0.00 í3.73 2.04 
5 Ethyl acrylate 1.03 c 3.178 7.16 3.70 í3.82 1.68 
5 Į,ȕ-Unsaturated Other Esters 
6 Methyl 2-octynoate 0.44 4.984 6.05 13.68 í4.59 1.34 
7 Methyl 2-nonynoate 0.14 5.361 7.95 17.58 í4.85 1.16 
8 Diethyl maleate 0.51 7.201 0.02 10.56 í3.66 0.76 
9 
Ethylene glycol 
dimethacrylate 
í0.55 7.021 0.03 10.64 í3.56 0.65 
10 Methyl methacrylate í1.14 c 3.265 8.12 4.16 í2.06 í0.13 
4 Į,ȕ-Unsaturated Ketones 
11 ȕ-Damascone 0.46 6.752 7.25 27.88 í5.05 0.39 
12 L-Carvone í0.66 5.210 4.87 14.54 í3.98 0.74 
13 Į-Cetone í0.71 6.777 16.41 31.15 í5.05 0.08 
14 para-Benzoquinone 6.29 1.908 0.00 0.00 í5.29 4.00 
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7 Į,ȕ-Unsaturated Aldehydes 
15 trans-2-Decenal 1.00 c 5.451 16.96 21.09 í4.93 0.85 
16 2,4-Heptadienal 0.75 c 4.275 5.72 7.91 í3.98 1.37 
17 2,4-Hexadienal 0.83 c 4.768 4.32 6.89 í4.01 1.51 
18 Safranal í0.49 5.478 7.95 18.52 í4.40 0.61 
19 Perillaldehyde í0.75 5.372 8.22 17.81 í4.30 0.59 
20 trans-2-Hexenal 1.40 4.279 5.91 5.72 í4.02 1.66 
21 Citral í1.48 5.263 20.08 20.31 í4.15 0.17 
a Kaw, the dimensionless Henry’s law constants in terms of airíwater partition coefficients, were using 
experimental or predicted Kaw employing EPISuite at 25 °C. The compound fraction in air, fa, was calculated 
through eq 3.9 and sorption loss of compounds, fs was calculated through eq 3.10. Log EC50 denotes logarithmic 
effective compound concentration yielding 50% growth inhibition of the Tetrahymena pyriformis after 24 h 
exposure (eq 3.6), log Te quantify the Logarithmic toxicity enhancement relative to narcotic toxicity for 24 h growth 
inhibition (eq 3.14). cThe data of thiol reactivity of compounds cited from literatures.61,76,96 
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Figure 4.23: Calculated skin sensitization, log EC3, vs determined thiol reactivity in terms of the 2nd-order 
rate constant, log kGSH, of 21 aliphatic Michael acceptors 
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Figure 4.24: Calculated skin sensitization, log EC3, vs toxicity enhancement, log Te, of test compounds toward 
Tetrahymena pyriformis 
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Scheme 4.5: Metabolic Transformation of 2-hydroxyethyl acrylate. Oxidation of hydroxyl group of 2-
hydroxyethyl acrylate mediated by alcohol dehydrogenase (ADH), yielding the allyl acetate. Hydrolysis catalyzed 
through carboxylesterase (CES) obtaining acetic acid and allyl alcohol (Top). Epoxidized terminal double bond by 
cytochrome P450, reaction with endogenous nucleophiles via SN2-type ring-opening reaction mechanism (Left). 
Oxidation of allyl alcohol mediated by alcohol dehydrogenase (ADH), yielding the electrophile acrolein reacting as 
a Michael acceptor with endogenous nucleophiles (NuH) (Right). 
 
4.4.3 Relationship of Thiol Reactivity with Skin Sensitization 
 
In case of acrylate subgroup (except 2-ethylhexyl acrylate as an outlier), the reactivity is 
significantly higher than for the other esters subgroup, see Table 4.20 and Figure 4.25. The 
increased side chain slightly reduces reactivity of these acrylates, illustrating of same lever of 
their log kGSH (log kGSH 0.93 of butyl acrylate almost equates to 1). The higher reactivity of 2-
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hydroxyethyl acrylate resulting high sensitization and toxicity enhancement potential compared 
with other homologues can be explained by oxidation or/and metabolic transformation45, see 
Scheme 4.5. The two biotransformation pathways45 yielding an epoxide (Scheme 4.5, left) and 
ethylene (Scheme 4.5, right) would correspondingly increase the reactivity potency. Figure 4.25 
shows the plot of log EC3 versus log kGSH for these acrylates. 2-ethylhexyl acrylate, as an outlier, 
is found far from his homologues acting as an ester that belongs to the other ester subgroup. 
Accordingly, 2-ethylhexyl acrylate is not included in the regression analysis, and the 
corresponding regression line is eq 4.19. The large regression coefficient of log kGSH (2.05) 
indicates that the skin sensitization is very sensitive to reactivity.  
log kGSH [M
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Figure 4.25: Skin sensitization, log EC3, vs thiol reactivity, log kGSH, for acrylate (Ŷ) and other ester (Ɣ) 
subgroups. The outlier is 2-ethylhexyl acrylate acting (ź) as another ester compound (log EC3 [mol/L] 
predicted = ˉ1.40 vs experimental = ˉ1.27). 
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Figure 4.26: Skin sensitization, log EC3, vs thiol reactivity, log kGSH, for ketone (Ÿ) and aldehyde (ƾ) 
subgroups. trans-2-hexenal (Ÿ) is an outlier 
 
 ͵ ൌ െʹǤͲͷሺേͲǤͻ͵ሻ ή  ݇ୋୗୌ ൅ͳǤʹͺሺേͳǤͲ͹ሻ 
n = 4,   r2 = 0.71,   s = 0.416    (4.19) 
 
The unexpectedly large intercept possibly comes from the high reactivity but low 
sensitization potential. Indeed, butyl acrylate, methyl acrylate and ethyl acrylate show a high 
reactivity compared with other esters group, see Table 4.18, but only a weak sensitization 
potential. This is illustrated through the example of comparing methyl acrylate and ethyl acrylate 
with ethylene glycol dimethacrylate. They are weaker sensitizers, with log EC3 í0.63, í0.55 and 
í0.85, respectively. For methyl acrylate and ethyl acrylate, however, they show essentially high 
reactivity (log kGSH 1.06 and 1.03) and toxicity enhancements (log Te 1.86 and 1.66), but 
ethylene glycol dimethacrylate has only low reactivity (log kGSH í0.55) and narcosis-level 
toxicity (log Te 0.62). Volatilization loss of these three weaker sensitizers account for the 
unmatched skin sensitization and reactivity. Previous researches found 100% evaporative loss of 
ethyl acrylate was monitored after 5 min under simulated LLNA conditions14 and all of these 
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three sensitizers are higher volatile compared with others.16 2-Ethylhexyl acrylate (showed as the 
triangle down in Figure 4.25) is an outlier that can be well predicted using eq 4.20 from the other 
ester subgroup (predicted log EC3 í1.40 vs experimental log EC3 í1.27). A possible 
explanation is that increased side branch chain will reduce the reactive capability. Moreover, its 
high hydrophobicity, almost 2 log unit larger than its homologues such as butyl acrylate, methyl 
acrylate and ethyl acrylate, decreases the reactivity97 as well as toxicity enhancement (log Te is 
0.31).44 Indeed, the Dkk value is 4.17 indicating obvious narcosis-level toxicity,97 see Table 4.21. 
Furthermore, the most important point is that 2-ethylhexyl acrylate has a much lower calculated 
vapour pressure value (lower volatility) than methyl acrylate, ethyl acrylate, and methyl 
methacrylate (í0.71 vs 1.95 vs 1.61 vs 1.59, respectively).16 
 
Table 4.21: The basic information of outlier: 2-ethylhexyl acrylate 
Name Structure 
log 
Kow 
log 
Koa 
log EC3 [mol/L] 
predicteda  
log EC3 [mol/L] 
experimental 
DKkb 
2-Ethylhexyl 
acrylate 
O
O
 
4.09 5.843 í1.40 í1.27 4.17 
a The predicted skin sensitization potential, log EC3, through eq 4.12. bvalue of DKk calculated according 
equation DKk = log Kow í log kGSH, which is cited from literature97 
 
For the other ester subgroup, the plot of log EC3 versus log kGSH is illustrated in Figure 
4.25. Compounds in this subgroup either alkyl substitution on Į-C, ethylene glycol 
dimethacrylate and methyl methacrylate, or on ȕ-C, methyl 2-octynoate and methyl 2-nonynoate, 
except diethyl maleate, an ethoxycarbonyl substituted on the ȕ-C. Correspondingly, the reactivity 
of these compounds is significantly affected by the substituent. As substituent is alkyl, which 
reduces the reactivity of Michael acceptors, it is supposed that reactivity of this subgroup is 
lower than the acrylate subgroup, see Figure 4.25. Eq 4.12 is a linaer regression between log EC3 
and log kGSH, in which the log kGSH regression coefficient is 1.26 indicating a moderate 
sensitivity of reactivity toward sensitization as compared to the acrylate subgroup (2.05). Diethyl 
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maleate as a moderate sensitizer has the highest reactivity (log kGSH is 0.51) in the subgroup, 
which is because the ethoxycarbonyl substituted on the ȕ-C is an electron withdrawing group. 
Although the steric hindrance effect of ethoxycarbonyl will reduce the reactivity, the induction 
effect will essentially increase reactivity of diethyl maleate. The net effect is that the reactivity of 
diethyl maleate is increased and higher than other compounds in this subgroup, but it is still 
lower than for compounds from acrylate subgroup.  
 
 ͵ ൌ െͳǤʹ͸ሺേͲǤ͵ʹሻ ή  ݇ୋୗୌ െͳǤͷͲሺേͲǤʹͲሻ 
r2 = 0.84,   n = 5,   s = 0.450     (4.20) 
 
Omitting diethyl maleate, a new linear regression eq 4.21 is coming, with a slight change 
of log kGSH regression coefficient (1.26 vs 1.55) and intercept (í1.50 vs í1.73) and an improved 
correlation coefficient (r2 = 0.84 vs 0.99). A pseudo trend is seem that a novel linear regression 
curve will be exist for the compounds with electric withdrawing group either on Į-C or on ȕ-C 
increasing reactivity. 
 
 ͵ ൌ െͳǤͷͷሺേͲǤͳͲሻ ή  ݇ୋୗୌ െͳǤ͹͵ሺേͲǤͲ͹ሻ 
r2 = 0.99,   n = 4,   s = 0.126     (4.21) 
 
For the limited dataset, there are only four compounds in the ketone subgroup, but with a 
good linear regression (r2 = 0.99), see eq 4.22 and Figure 4.26. Benzoquinone as most reactive 
compound far from the other compounds will affect the statistical fitting as mentioned above. 
Removal of benzoquinone results in a similar linear regression eq 4.23, only with slight change 
of the log kGSH regression coefficient from 0.43 to 0.38, hardly effect on the intercept or 
correlation coefficient. Employing eq 4.23 yields no significant difference between calculated 
(log EC3 í3.68) and experimental sensitization potential (log EC3 í4.04) for benzoquinone. The 
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successful prediction of skin sensitization of benzoquinone confirms previous research 
outcome98 that extreme sensitization potential of benzoquinone solely result from its high thiol 
reactivity as a Į,ȕ-unsaturated ketone, but not from some special reaction mechanism. The log 
kGSH regression coefficient (0.43) for ketone subgroup is significantly lower than two other ester 
subgroups (2.05 and 1.26, respectively) indicating lack of sensitivity of reactivity toward to skin 
sensitization.  
 
 ͵ ൌ െͲǤͶ͵ሺേͲǤͲͳሻ ή  ݇ୋୗୌ െͳǤ͵ͲሺേͲǤͲ͵ሻ 
r2 = 0.99,   n = 4,   s = 0.050    (4.22) 
 
 ͵ ൌ െͲǤ͵ͺሺേͲǤͲͷሻ ή  ݇ୋୗୌ െͳǤʹͻሺേͲǤͲ͵ሻ 
r2 = 0.98,   n = 3,  s = 0.050    (4.23) 
 
For aldehyde subgroup, the thiol reactivity covers almost 3 log units (trans-2-hexenal 1.40 
vs citral í1.48); interestingly, skin sensitization potency only spans 0.72 orders of magnitude 
(trans-2-decenal í1.79 vs citral í1.07). Still, a linear relationship between log EC3 and log kGSH 
for aldehyde subgroup is obtained (eq 4.24). This unmatched magnitude of thiol reactivity with 
skin sensitization indicates that the significantly increased reactivity only slightly increases the 
skin sensitization potential. Inspection of Figure 4.26 reveals trans-2-hexenal (showed as a 
triangle) as an outlier with the highest reactivity in this subgroup, but an only moderate 
sensitization potential. Lower hydrophobicity of trans-2-hexenal could be the possible 
explanation. With the removal of trans-2-hexenal from the regression of log EC3 with log kGSH, 
an improved linear regression eq 4.25 reveals, accounting for the remaining 6 aldehydes. 
Although the log kGSH regression coefficient is increased from 0.13 to 0.21 accompanied by a 
superior statistical fitting (0.40 vs 0.78), it is still the lowest slope compared with other 
subgroups (2.05 vs 1.26 vs 0.43 vs 0.21), indicating an inferior sensitivity toward sensitization 
potential. 
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 ͵ ൌ െͲǤͳ͵ሺേͲǤͲ͹ሻ ή  ݇ୋୗୌ െͳǤ͵ͶሺേͲǤͲ͹ሻ 
r2 = 0.40,   n = 7,   s = 0.191    (4.24) 
 
 ͵ ൌ െͲǤʹͳሺേͲǤͲ͸ሻ ή  ݇ୋୗୌ െͳǤ͵ͻሺേͲǤͲͷሻ 
r2 = 0.78,   n = 6,   s = 0.127    (4.25) 
 
Compared with SNAr and SN2 reaction mechanisms, a lower slope (0.25) of regression line 
between skin sensitization and chemical reactivity (log kCys-peptide) for Michael acceptors was 
reported.14,53 This difference indicates that great reactivity increasing results in a lower increase 
of skin sensitization potential for Michael acceptors. Another moderate sensitivity of reactivity to 
skin sensitization for Michael acceptors had been reported, with a much steeper slope (0.81) of 
reactivity toward 4-nitrobenzenethiol (NBT).66 But, the selected Michael acceptors have either 
difunctional groups or more than one mechanism,66 which is the possible reason for the steeper 
slope. In this research, similar levels of contribution of reactivity to skin sensitization shows for 
ketones and aldehydes, compared with previous reports (0.43 vs 0.21 vs 0.25).14,53 Interestingly, 
the same level of contribution of toxicity enhancement (the slopes are 0.41 vs 0.26) to skin 
sensitization for aromatic Michael acceptors was found, employing two aquatic toxicity 
enhancement bioassays (24 h growth inhibition toward to Tetrahymena pyriformis and Vibrio 
fischeri). Contrarily, log kGSH regression coefficient of aliphatic Į,ȕ-unsaturated esters (acrylates 
and other esters) reveal stronger relationship between reactivity and skin sensitization.  
It is supposed that the sensitivity of thiol reactivity to sensitization decreases in the order 
acrylates > other esters > ketones> aldehydes, according to their difference of slopes. Indeed, the 
rate-determining step for Michael addition reaction is formation of the intermediate (Scheme 4.6), 
which is dependent on the capability of different Y functional groups to stabilize the negative 
charge. For the difference of pattern on the Į,ȕ-unsaturated compounds, the decreasing order of 
Y groups is: ester (-COOR) > aldehyde (-COH) >ketone (-COR). Please keep in mind that 
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ketones and aldehydes show similar sensitivity to skin sensitization, explained by their same 
level of slopes (í0.43 and í0.21, respectively), although the log kGSH regression coefficient of 
ketones is two times larger than for aldehydes’. The essentially different sensitivity of these 
subgroups toward skin sensitization strongly indicates that aliphatic Į,ȕ-unsaturated compounds 
should be treated with separated models, according to their different chemical classes.  
CH2
O
Y
+ Nu H O-
Y
Nu
+ H+ O
Y
Nu H
 
Scheme 4.6: Michael Addition formation of the Nucleophile (Nu-H) to Į,ȕ-unsaturated compounds: 
Aldehydes (Y = H), Ketones (Y = alkyl), and Esters (Y = OR) 
 
4.4.4 Relationship of Toxicity Enhancement with Skin Sensitization 
 
To confirm that a separated treatment of aliphatic Į,ȕ-unsaturated compounds is necessary, 
aquatic toxicity enhancement, employing 24 h growth inhibition, of these selected Į,ȕ-
unsaturated compounds toward Tetrahymena pyriformis is determined. As the same with above, 
considering all of the compounds together is shown a poor correlation between skin sensitization 
potential and toxicity enhancement, see eq 4.18 and Figure 4.27. Thus, each of subgroups is 
analysed separately. 
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Figure 4.27: Skin sensitization, log EC3, vs toxicity enhancement, log Te, for acrylate (Ŷ) and other ester (Ɣ) 
subgroups. The outlier is 2-ethylhexyl acrylate acting (ź) 
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Figure 4.28: Skin sensitization, log EC3, vs toxicity enhancement, log Te, for ketone (Ÿ) and aldehyde (ƾ) 
subgroups. trans-2-hexenal (ź) is an outlier 
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Eq 4.26 shows a linear regression between log EC3 and log Te for the acrylate group. 
Although the slope of log Te is significantly lower than slope of log kGSH, indicating toxicity 
enhancement less sensitivity to sensitization potential compared with reactivity, it is still much 
steeper than the reported slope of the rate constant36 (log kCys-peptide 0.25). Again, the intercept is 
the largest one as compared with all other groups. Eq 4.27 shows the linear relationship between 
log EC3 and log Te for other ester subgroup, which has statistical coefficients similar to eq 4.20, 
reflecting similar sensitivity of toxicity enhancement and reactivity to sensitization potential.   
 
 ͵ ൌ െͲǤ͸ʹሺേͲǤ͵ͷሻ ή  ܶୣ ൅ ͲǤʹͶሺേͲǤ͹͹ሻ 
n = 4,   r2 = 0.66,  s = 0.483    (4.26) 
 
 ͵ ൌ െͳǤ͸ͶሺേͲǤʹ͵ሻ ή  ܶୣ െ ͲǤͳͲሺേͲǤʹͳሻ 
n = 5,   r2 = 0.94,  s = 0.266    (4.27) 
 
Surprisingly, no improvements of linear regression analysis are found for the separated 
ketone (without para-benzoquinone) and aldehyde subgroups (eqs 4.28 and 4.29), with similar 
log Te regression coefficients and inferior statistics fits compared with no separate analysis (eq 
4.18). These improvements confirm that separate analysis of these subgroups is still superior 
than analysing them together.  
 ͵ ൌ െͲǤͳͳሺേͲǤ͹͸ሻ ή  ܶୣ െ ͳǤͳ͵ሺേͲǤ͵͹ሻ 
n = 3,   r2= 0.02,  s = 0.356    (4.28) 
 
 ͵ ൌ െͲǤʹ͸ሺേͲǤʹͲሻ ή  ܶୣ െ ͳǤͳ͹ሺേͲǤͳͻሻ 
n = 6,   r2 = 0.29,   s = 0.227    (4.29) 
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It is seems that the thiol reactivity, log kGSH, is superior parameter as compared to toxicity 
enhancement, log Te, to predict skin sensitization of selected Į,ȕ-unsaturated compounds. This is 
based on the fact that sensitizers as electrophilic agents could directly bind to glutathione as 
nucleophilic agent, in this chemoassay approach with dependence on bioavailability, which is 
highly connected with hydrophobicity, or biometabolism. In the bioassay, however, 
bioavailability or biotransformation could be significantly affect toxicity enhancement.  
 
4.4.5 Influence of Contribution to Skin Sensitization 
 
Inspection of models of combination hydrophobicity with reactivity and hydrophobicity 
with toxicity enhancement (Tables 4.22 and 4.23), hydrophobicity reveals contributions to skin 
sensitization potential for the all compounds, reflecting with the minus slopes of log Kow and 
larger correlation coefficient compared to the models without log Kow. Please keep in mind, the 
standard error of intercept almost equal to the intercept in the model combining log Kow with log 
Te. As the same with mentioned in sections 4.1.5 and 4.2.4, hydrophobicity possibly reveals 
contribution to skin sensitization, but we cannot obtain a deficient conclusion, because of the 
limited dataset.  
Hydrophobicity is supposed to be an important parameter for skin sensitization that is 
influencing the penetration of sensitizer into skin. Especially, hydrophobicity is important to 
correct the underestimate of sensitizers with high hydrophobicity (as discussed in section 4.2.4). 
In this section, hydrophobicity is only weakly correlating with toxicity enhancement for 
contribution to skin sensitization. This means toxicity enhancement has litter or no influence by 
hydrophobicity, unless narcotic toxicity is greater than reactive toxicity, reflecting that log Te 
decreases with increasing log Kow.44 The difference of hydrophobic contribution could partly 
explain why the thiol reactivity (log kGSH) is a parameter superior to toxicity enhancement (log Te) 
to predict skin sensitization (mentioned above), although the correlation coefficient is lower 
(0.27 vs 0.47).  
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Table 4.23: Linear regression of the skin sensitization, log EC3 [mol/L], against the logarithmic second-order 
rate constant of reaction with glutathione, log kGSH [L mol–1 min–1], with hydrophobicity, log Kow, for aliphatic 
Į,ȕ-unsaturated carbonyla 
Chemical classes n a b c r2 s r2Inter 
 log EC3= a log kGSH + b log Kow + c   
All compounds 20 í0.36 (±0.15) í0.19 (±0.10) í0.71 (±0.30) 0.27 0.491 0.66 
Acrylates 4 í4.63 (±1.14) í0.69 (±0.28) 4.92 (±1.58) 0.96 0.220 0.96 
Other esters 5 í0.92 (±0.49) í0.51 (±0.32) í0.29 (±1.39) 0.89 0.460 0.71 
Ketones 4 í0.41 (±0.01) 0.04 (±0.01) í1.45 (±0.03) 0.99 0.015 0.98 
Aldehydes 6 í0.28 (±0.01) í0.16 (±0.02) í0.93 (±0.04) 0.99 0.025 0.90 
a Regression equations and associated statistics are given for 4 acrylates, 5 other esters, 4 ketones, 6 aldehydes 
and all compounds (excluding benzoquinone). The slopes of thiol reactivity, log kGSH, and hydrophobicity, log Kow, 
are denoted by a and b, respectively; c denotes intercept of the regression equation; n = number of compounds; r2 = 
squared correlation coefficient; s = standard error of estimate 
Previous researches confirmed that skin sensitization potential of Michael acceptors is only 
dependent on the reactivity and has no significant contribution from hydrophobicity.14,53 
Contribution, however, from hydrophobicity to skin sensitization is observed in SN210 and Schiff 
base sensitizers.13 Previous aquatic toxicity investigation suggested that hydrophobic 
contribution for aliphatic aldehydes is more than twice as large as for ketones, and is marginal 
for selected esters. Please keep in mind that skin sensitization is a different toxicological 
endpoint from aquatic toxicity, although their reaction mechanism is partly same.  
The result indicates that hydrophobicity shows possible contribution to skin sensitization in 
the situation of either or both combinations with reactivity or/and toxicity enhancement for all of 
subgroups. Because of the datasets are too small, we cannot make a definite decision.  
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Table 4.23: Linear regression of the skin sensitization, log EC3 [mol/L], against the aquatic toxicity 
enhancement toward to ciliate, log Te [mol/L], with hydrophobicity, log Kow, for aliphatic Į,ȕ-unsaturated 
carbonyla 
Chemical classes n a b c r2 s r2Inter 
 log EC3= a log Te+ b log Kow + c   
All compounds 20 í0.71 (±0.19) í0.40 (±0.12) 0.47 (±0.46) 0.47 0.418 0.80 
Acrylates 4 í2.14 (±0.13) í1.18 (±0.09) 4.64 (±0.36) 0.99 0.055 0.97 
Other esters 5 í2.27 (±0.53) 0.63 (±0.48) í1.06 (±1.30) 0.97 0.240 0.86 
Ketones 4 í1.20 (±0.19) í0.39 (±0.17) 0.86 (±0.76) 0.99 0.190 0.97 
Aldehydes 6 í1.24 (±0.45) í0.57 (±0.23) 1.36 (±1.06) 0.72 0.165 0.94 
a Regression equations and associated statistics are given for 4 acrylates, 5 other esters, 4 ketones, 6 aldehydes 
and all compounds (excluding benzoquinone). The slopes of aquatic toxicity enhancement, log Te, and 
hydrophobicity, log Kow, and intercept of the regression equations are denoted by a, b and c, respectively; r2 = 
squared correlation coefficient; s = standard error of estimate 
 
4.4.6 Conclusion 
 
The kinetic glutathione chemoassay is a useful tool for predicting the skin sensitization 
potential of aliphatic Į,ȕ-unsaturated compounds. The results reveal that aliphatic MAs should 
be treated separately in different chemical subgroups, and the sensitivity to skin sensitization 
from these subgroups decreases in the order acrylates > other esters > ketones> aldehydes. 
Moreover, hydrophobicity, log Kow, vary different contribution to sensitization potential for 
different Michael acceptors subgroups. Skin sensitization potential, in the case of acrylate and 
aldehyde subgroups, strongly correlates with hydrophobicity. In the case of other ester and 
ketone subgroups, contribution from hydrophobicity to sensitization potential appeared in 
combination with either reactivity (other ester subgroup) or toxicity enhancement (ketone 
subgroup).   
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5. Summary  
 
In this thesis, toxicity enhancements (toward Tetrahymena pyriformis and Vibrio fischeri) 
and chemical reactivity (in terms of the second-order rate constants) of 76 organic compounds 
are determined for predicting their skin sensitization potential. The investigation comprises four 
parts: (1) The 24 h growth inhibition with Tetrahymena pyriformis as a nonanimal method is 
employed to predict skin sensitization potency; (2) Toxicity enhancements of organic 
compounds against Vibrio fischeri in short and long term bioassays are applied to predict skin 
sensitization; (3) Application a kinetic GSH chemoassay to monitor compounds’ skin 
sensitization potential and combining this chemoassay data with bioassays data for 
discriminating sensitizers from nonsensitizers; (4) Prediction of skin sensitization potential of 21 
aliphatic Į,ȕ-unsaturated compounds is employed in combining chemoassay with bioassay data. 
The main results and conclusions are summarized briefly as follows: 
In section 4.1, a linear regression equation of toxicity enhancement vs skin sensitization 
(log EC3 = í0.88·log Te í0.83; r2 = 0.61, n = 41) is obtained for all allergic sensitizers without 
nonsensitizers. This linear regression is improved by classifying these sensitizers into five 
different reaction mechanistic domains. Correspondingly, variations of slopes of toxicity 
enhancement are observed for the five reaction mechanisms, indicating that a decreasing order of 
sensitivity of toxicity enhancements to skin sensitization potential is SNAr > SN2 > acylation § 
Schiff base > aromatic Michael addition. Applying log Te  = 1 as a threshold to discriminate 
sensitizers from nonsensitizers yields good accuracies, with 100.0%, 77.7%, 100.0% and 69.2% 
accuracy for strong (with extreme) sensitizers, moderate sensitizers, weak sensitizers and 
nonsensitizers, respectively. The results suggests that 24 h growth inhibition assay with 
Tetrahymena pyriformis is a useful tool and could be applied for screening skin sensitization of 
allergic chemicals. This bioassay could reduce animal testing. In this context, however, we 
should separate aromatic from aliphatic MAs. Moreover, metabolic biotransformation should be 
considered during predicting nonsensitizers’ skin sensitization. 
In section 4.2, toxicity enhancements (log Te) versus skin sensitization (log EC3) yields 
two linear regression models for 30 min bioluminescence inhibition assay (log EC3 = í0.59·log 
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Te30 min –1.36; r2 = 0.44, n = 38) and 24 h growth inhibition assay (log EC3 = í0.71·log Te24 h –
1.08; r2 = 0.49, n = 41) to Vibrio fischeri. Again, regarding log Te =1 as threshold to discriminate 
sensitizers from nonsensitizers, good accuracy for each different sensitizer class is obtained. 
Comparing with interspecies and inter-endpoints, a decreasing order of sensitivities to skin 
sensitization is found that is 24 h growth inhibition (Tetrahymena pyriformis) > 24 h growth 
inhibition (Vibrio fischeri) > 30 min bioluminescence inhibition (Vibrio fischeri). Moreover, the 
robust interspecies correlations between Vibrio fischeri and Tetrahymena pyriformis and inter-
endpoint correlation between short and long term assay can be used for estimating toxicity 
enhancements of compounds through toxicity enhancement data available for surrogate species 
or endpoints. 
In section 4.3, a kinetic glutathione (GSH) chemoassay is applied for measuring chemicals’ 
reactivity. The results show that the skin sensitization potential of compound is strongly related 
to their chemical reactivity. Moreover, comparing with bioassays, this kinetic chemoassay can 
directly measure reactive ability of sensitizers and is more sensitive to evaluate skin sensitization, 
because of not influence through bioavailability or metabolism. As one single test cannot replace 
the current animal test to identify sensitizing compounds, an integrated platform of combining 
this chemoassay data (log kGSH), three bioassays data (log Te) and hydrophobicity (log Kow) is 
proposed. This integrated platform is sensitive and powerful for evaluating skin sensitization 
potential, obtaining better accuracy for each sensitizing classifications. 
In section 4.4, for selected 21 aliphatic Į,ȕ-unsaturated compounds, linear regressions of 
skin sensitization versus thiol reactivity and skin sensitization versus toxicity enhancement show 
the same level of slopes as reported in literature. However, the linear regressions are significantly 
improved after classifying these 21 compounds into four chemical subgroups. Correspondingly, 
four different slopes for each subgroup indicate correspondingly different sensitivities to 
sensitization potency, with a decreasing order acrylates (slope is í2.05) > other esters (slope is 
í1.26) > ketones (slope is í0.43) > aldehydes (slope is í0.21). Compared to 24 h inhibition 
bioassay, the GSH chemoassay is confirmed to be a more sensitive tool for predicting skin 
sensitization of aliphatic MAs, because it is not affected by bioavailability or metabolism. 
Although the datasets are too limited to give a definite decision, hydrophobicity reveals 
contribution to skin sensitization for aliphatic MAs, which is contrary to literature reports that 
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skin sensitization potential of MAs is only dependent on reactivity, but not on hydrophobicity. 
This section study suggests that aliphatic MAs should be separated into different chemical 
subgroups for analysis, and their skin sensitization potency depends both on reactivity and on 
hydrophobicity and can be predicted using kinetic glutathione chemoassay as well as 24 h 
growth inhibition bioassay.  
Regarding the successful application of bioassays and chemoassay to predict skin 
sensitization of compounds, the further work could focus on the following points: 
1. Prediction of the sensitization potential of pre-haptens and pro-haptens. Modified 
bioassays combining with metabolic enzymes, such as S9 enzyme or P450 enzyme, 
could be applied to predict pro-hapten’s skin sensitization, and a modified 
chemoassay combined with oxidants, such as H2O2, could be utilized to predict pre-
hapten’s skin sensitization.  
2. Evaluation of the correlation between toxicity enhancement and skin sensitization 
potency of nonsensitizers. As some nonsensitizers exert toxicity enhancement after 
biotransformation during bioassays, a further aquatic toxicity enhancement of an 
extended number of nonsensitizers should be measured. 
3. Classifying skin sensitizers into soft and hard electrophiles to predict skin 
sensitization. Skin sensitization potency of soft electrophiles (sensitizers) can be 
predicted by the kinetic GSH chemoassay. Moreover, skin sensitization potency of 
hard electrophiles (sensitizers) could be evaluated through kinetic 4-(4-nitrobenzyl) 
pyridine (NBP) chemoassay,99 for example.  
4. Evaluation of the skin sensitization of aliphatic Į,ȕ-unsaturated compounds with 
electron withdrawing group either on Į-C or on ȕ-C. The extended aliphatic Į,ȕ-
unsaturated Michael acceptors should be evaluated to confirm the relationship 
between toxicity enhancement and skin sensitization potency..  
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